热点在线丨珀莱雅: 珀莱雅化妆品股份有限公司2022年年度报告(英文版)
来源:证券之星
2023-04-20 17:36:08
<p> Annual Report 2022</p><p>Stock Code: 603605 Stock Abbreviation: Proya</p><p>Bond Code: 113634 Bond Abbreviation : Proya Convertible Bond</p><p style="text-align: center"><img style="display:block;margin:auto;" width="450" src="http://www.xcctv.cn/uploadfile/2022/0610/20220610100822639.jpg" /></br>【资料图】</p><p> Proya Cosmetics Co., Ltd.</p><p> Annual Report 2022</p><p> Annual Report 2022</p><p> Important Notes</p><p>I. The Board of Directors, Board of Supervisors, directors, supervisors and senior management</p><p> of the Company warrant that the content of the Annual Report is authentic, accurate and</p><p> complete, free from false records, misleading statements and major omissions, and shall be</p><p> jointly and severally liable therefore.</p><p>II. All directors of the Company attended the meeting of the Board of Directors.</p><p>III. Pan-China Certified Public Accountants (Special General Partnership) has issued a standard</p><p> unqualified audit report to the Company.</p><p>IV. HOU Juncheng, chairman of the Company, and WANG Li, CFO of the Company and Head</p><p> of Accounting Department, represent and warrant that the financial report in the Annual</p><p> Report is authentic, accurate and complete.</p><p>V. The profit distribution plan or capital reserve capitalization plan for the Reporting Period</p><p> approved by the Board of Directors</p><p>Based on the total share capital as of the record date on which equity distribution is implemented, the</p><p>Company proposes to distribute to all shareholders registered a cash dividend of RMB8.7 (tax inclusive)</p><p>per 10 shares, and convert the capital reserve into share capital in the proportion of 4 shares for every 10</p><p>shares held, but give no bonus shares. Based on the total share capital of 283,519,469 shares on December</p><p>inclusive) and a total of 113,407,788 shares will be converted.</p><p>In case of a change in the Company"s total share capital due to the conversion of convertible bonds before</p><p>the record date for equity distribution, the Company maintain the said distribution and conversation ratios</p><p>and yet adjust the total distribution and conversion amounts.</p><p>VI. Disclosure of risks involved in forward-looking statements</p><p>√ Applicable □ Not applicable</p><p>Any future plan, development strategy and other descriptions contained in the forward-looking statements</p><p>herein shall not be deemed as the Company"s substantial commitments to investors. Investors should note</p><p>that investment involves risks.</p><p>VII. Whether there is any non-operating capital occupation by a controlling shareholder and</p><p> other related parties</p><p>No</p><p>VIII. Whether there is any external guarantee provided in violation of specified decision-making</p><p> procedures</p><p>No</p><p> Annual Report 2022</p><p>IX. Whether the majority of the directors are unable to warrant the authenticity, accuracy and</p><p> completeness of the Annual Report disclosed by the Company</p><p>No</p><p>X. Major risk tips</p><p>The Company has described the existing risks in details in this Report. Refer to "(IV) Possible risks", "VI.</p><p>Discussion and Analysis of the Company"s Future Development", "Section III Management Discussion</p><p>and Analysis".</p><p>XI. Other</p><p>□ Applicable √ Not applicable</p><p> Annual Report 2022</p><p> Contents</p><p> Financial statements signed and sealed by the Legal Representative, CFO of the Company,</p><p>Documents and person in charge of Accounting Department</p><p>Available Original copy of the audit report stamped by the accounting firm and signed and sealed by</p><p> for certified public accountants.</p><p>Inspection Original copies of all documents and announcements of the Company disclosed during the</p><p> Reporting Period in newspapers designated by China Securities Regulatory Commission.</p><p> Annual Report 2022</p><p> Section I Definitions</p><p>I. Definitions</p><p>In this report, unless the context otherwise requires, the following terms have the following meanings:</p><p> Definition</p><p> Proya Cosmetics, this</p><p> refers to Proya Cosmetics Co., Ltd.</p><p> Company, or the Company</p><p> Huzhou Branch of Proya Cosmetics Co., Ltd., a branch of the</p><p> Huzhou Branch refers to</p><p> Company</p><p> Shanghai Branch of Proya Cosmetics Co., Ltd., a branch of the</p><p> Shanghai Branch refers to</p><p> Company</p><p> Hangzhou Proya Trade Co., Ltd., a wholly-owned subsidiary</p><p> Proya Trade refers to</p><p> of the Company</p><p> Hanna Cosmetics Co., Ltd., a wholly-owned subsidiary of the</p><p> Korea Hanna refers to</p><p> Company</p><p> Anya (Huzhou) Cosmetics Co., Ltd., a wholly-owned</p><p> Anya (Huzhou) refers to</p><p> subsidiary of Korea Hanna</p><p> Yueqing Laiya Trading Co., Ltd., a wholly-owned subsidiary</p><p> Yueqing Laiya refers to</p><p> of the Company</p><p> Huzhou UZERO Trading Co., Ltd., a wholly-owned</p><p> Huzhou UZERO refers to</p><p> subsidiary of the Company</p><p> Mijing Siyu (Hangzhou) Cosmetics Co., Ltd., a wholly-owned</p><p> Mijing Siyu (Hangzhou) refers to</p><p> subsidiary of the Company</p><p> Zhejiang Meiligu Electronic Commerce Co., Ltd., a wholly-</p><p> Meiligu refers to</p><p> owned subsidiary of the Company</p><p> Huzhou Chuangdai E-commerce Co., Ltd., a wholly-owned</p><p> Chuangdai Electronics refers to</p><p> subsidiary of Meiligu</p><p> Hangzhou Boxin Trading Co., Ltd., a wholly-owned</p><p> Hangzhou Boxin refers to</p><p> subsidiary of Meiligu</p><p> Hapsode (Hangzhou) Cosmetics Co., Ltd., a wholly-owned</p><p> Hapsode (Hangzhou) refers to</p><p> subsidiary of the Company</p><p> Hapsode Co., Ltd., a wholly-owned subsidiary of Hapsode</p><p> Korea Hapsode refers to</p><p> (Hangzhou)</p><p> Huzhou Hapsode Trading Co., Ltd., a wholly-owned</p><p> Huzhou Hapsode refers to</p><p> subsidiary of Hapsode (Hangzhou)</p><p> Danyang Hapsode Cosmetics Trading Co., Ltd., a wholly-</p><p> Danyang Hapsode refers to</p><p> owned subsidiary of Hapsode (Hangzhou)</p><p> Hangzhou Proya Commercial Management Co., Ltd., a</p><p> Proya Commercial refers to</p><p> wholly-owned subsidiary of the Company</p><p> Hangzhou Tiedingxian Catering Management Co., Ltd., a</p><p> Tiedingxian refers to</p><p> holding subsidiary of Proya Commercial</p><p> Hangzhou Tielexin Aini Catering Management Co., Ltd., a</p><p> Tielexin Aini refers to</p><p> wholly-owned subsidiary of Proya Commercial</p><p> Hangzhou Xiake Bar Catering Management Co., Ltd., a</p><p> Xiake Bar refers to</p><p> wholly-owned subsidiary of Proya Commercial</p><p> Annual Report 2022</p><p> Hangzhou Luxiaotie Fitness Co., Ltd., a wholly-owned</p><p>Luxiaotie refers to</p><p> subsidiary of Proya Commercial</p><p> Hangzhou Donghai Wangchao Catering Management Co.,</p><p>Donghai Wangchao refers to</p><p> Ltd., a wholly-owned subsidiary of Proya Commercial</p><p> Hong Kong Keshi Trading Co., Ltd., a holding subsidiary of</p><p>Hong Kong Keshi refers to</p><p> the Company</p><p> Hongkong Xinghuo Industry Limited, a wholly-owned</p><p>Hongkong Xinghuo refers to</p><p> subsidiary of the Company</p><p> Hong Kong Zhongwen Electronic Commerce Co., Limited, a</p><p>Hong Kong Zhongwen refers to</p><p> wholly-owned subsidiary of Hongkong Xinghuo</p><p> Hong Kong Xuchen Trading Limited, a wholly-owned</p><p>Hong Kong Xuchen refers to</p><p> subsidiary of Hongkong Xinghuo</p><p> Proya Europe SARL, a wholly-owned subsidiary of Hongkong</p><p>Proya Luxembourg refers to</p><p> Xinghuo</p><p> Shanghai Zhongwen Electronic Commerce Co., Ltd., a</p><p>Shanghai Zhongwen refers to</p><p> wholly-owned subsidiary of the Company</p><p> Huzhou Niuke Technology Co., Ltd., a holding subsidiary of</p><p>Huzhou Niuke refers to</p><p> the Company</p><p> Hangzhou Wanyan Culture Media Co., Ltd., a wholly-owned</p><p>Hangzhou Wanyan refers to</p><p> subsidiary of Huzhou Niuke</p><p> Hong Kong Wanyan Electronic Commerce Co., Limited, a</p><p>Hong Kong Wanyan refers to</p><p> wholly-owned subsidiary of Huzhou Niuke</p><p> Huzhou Younimi Cosmetics Co., Ltd., a wholly-owned</p><p>Huzhou Younimi refers to</p><p> subsidiary of the Company</p><p> Korea Younimi Cosmetics Co., Ltd., a holding subsidiary of</p><p>Korea Younimi refers to</p><p> the Company</p><p> Ningbo TIMAGE Cosmetics Co., Ltd., a holding subsidiary of</p><p>Ningbo TIMAGE refers to</p><p> the Company</p><p> Hangzhou TIMAGE Cosmetics Co., Ltd., a wholly-owned</p><p>Hangzhou TIMAGE refers to</p><p> subsidiary of Ningbo TIMAGE</p><p> Ningbo Keshi Trading Limited, a holding subsidiary of the</p><p>Ningbo Keshi refers to</p><p> Company</p><p> Zhejiang Beute Cosmetics Co., Ltd., a wholly-owned</p><p>Zhejiang Beute refers to</p><p> subsidiary of the Company</p><p> Ningbo Proya Enterprise Consulting Management Co., Ltd., a</p><p>Ningbo Proya refers to</p><p> wholly-owned subsidiary of the Company</p><p> Zhejiang Qingya Culture Art Communication Co., Ltd., a</p><p>Zhejiang Qingya refers to</p><p> holding subsidiary of the Company</p><p> Boya (Hong Kong) Investment Management Co., Limited, a</p><p>Boya (Hong Kong) refers to</p><p> wholly-owned subsidiary of the Company</p><p>Japan OR refers to O&R Co., Ltd., a holding subsidiary of Boya (Hong Kong)</p><p> Ningbo Tangyu Trading Co., Ltd., a wholly-owned subsidiary</p><p>Ningbo Tangyu refers to</p><p> of Japan OR</p><p> Hangzhou Weiluoke Cosmetics Co., Ltd., a wholly-owned</p><p>Hangzhou Weiluoke refers to</p><p> subsidiary of the Company</p><p> Annual Report 2022</p><p> Hangzhou Yizhuo Culture Media Co., Ltd., a wholly-owned</p><p> Hangzhou Yizhuo refers to</p><p> subsidiary of the Company</p><p> Hangzhou Oumisi Trading Co., Ltd., a wholly-owned</p><p> Hangzhou Oumisi refers to</p><p> subsidiary of the Company</p><p> Guangzhou Qianxi Network Technology Co., Ltd., a wholly-</p><p> Guangzhou Qianxi refers to</p><p> owned subsidiary of the Company</p><p> Proya (Hainan) Cosmetics Co., Ltd., a wholly-owned</p><p> Proya (Hainan) refers to</p><p> subsidiary of the Company</p><p> Shenggelan (Hangzhou) Cosmetics Co., Ltd., a wholly-owned</p><p> Singuladerm (Hangzhou) refers to</p><p> subsidiary of the Company</p><p> Xuzhou Laibo Information Technology Co., Ltd., a wholly-</p><p> Xuzhou Laibo refers to</p><p> owned subsidiary of the Company</p><p> Proya (Zhejiang) Cosmetics Co., Ltd., a wholly-owned</p><p> Proya (Zhejiang) refers to</p><p> subsidiary of the Company</p><p> CSRC refers to China Securities Regulatory Commission</p><p> SSE refers to Shanghai Stock Exchange</p><p> Pan-China Certified Public Accountants (Special General</p><p> Pan-China refers to</p><p> Partnership)</p><p> CSC refers to China Securities Co., Ltd.</p><p> Company Law refers to Company Law of the People"s Republic of China</p><p> Securities Law refers to Securities Law of the People"s Republic of China</p><p> Articles of Association refers to Articles of Association of Proya Cosmetics Co., Ltd.</p><p> RMB/RMB’0,000 refers to Renminbi Yuan/Renminbi 10,000 Yuan</p><p> Reporting Period refers to January 1, 2022 to December 31, 2022</p><p> Section II Company Profile and Key Financial Indicators</p><p>I. Company Information</p><p>Chinese name of the Company Proya Cosmetics Co., Ltd.</p><p>Short name of the Company in Chinese 珀莱雅</p><p>English name of the Company Proya Cosmetics Co., Ltd.</p><p>Abbreviation of English name of the</p><p> Proya</p><p>Company</p><p>Legal representative of the company HOU Juncheng</p><p>II. Contact Details</p><p> Board Secretary Securities Affairs Representative</p><p>Name WANG Li WANG Xiaoyan</p><p>Mailing address Xihu District, Hangzhou City, Zhejiang Road, Xihu District, Hangzhou City,</p><p> Province Zhejiang Province</p><p>Telephone 0571-87352850 0571-87352850</p><p>Fax 0571-87352813 0571-87352813</p><p>Email proyazq@proya.com proyazq@proya.com</p><p> Annual Report 2022</p><p>III. General Information</p><p> No. 588, Xixi Road, Liuxia Street, Xihu District,</p><p>Registered address</p><p> Hangzhou City, Zhejiang Province</p><p> For details, please refer to the Announcement on</p><p> Amending the Articles of Association and Applying for</p><p>Historical changes in the Company"s</p><p> Changing Business Registration (No.2019-008) disclosed</p><p>registered address</p><p> by the Company on the designated media on February 27,</p><p> Proya Building, No. 588 Xixi Road, Xihu District,</p><p>Office address of the Company</p><p> Hangzhou City, Zhejiang Province</p><p>Postal code of the registered office address 310023</p><p>Company website http://www.proya-group.com</p><p>Email proyazq@proya.com</p><p>IV. Information Disclosure and Place for Obtaining the Report</p><p>Media for the Company"s information</p><p> Shanghai Securities News, Securities Times</p><p>disclosure</p><p>CSRC"s designated website for the</p><p> http://www.sse.com.cn</p><p>Company"s Annual Report disclosure</p><p>The Company"s Annual Report may be Board of Director"s Office, Proya Building, No. 588 Xixi</p><p>obtained at Road, Xihu District, Hangzhou City, Zhejiang Province</p><p>V. Stock Information</p><p> Stock Information</p><p> Stock abbreviation</p><p> Stock class Stock exchange Stock abbreviation Stock code</p><p> before changes</p><p> Shanghai Stock</p><p> A share Proya 603605 None</p><p> Exchange</p><p>VI. Other Relevant Information</p><p> Pan-China Certified Public Accountants (Special</p><p> Name</p><p> General Partnership)</p><p> Auditor of the</p><p> Block B, China Resources Building, No. 1366,</p><p> Company Office address</p><p> Qianjiang Road, Jianggan District, Hangzhou</p><p> (domestic)</p><p> Name of the signing</p><p> YIN Zhibin, WANG Xiaokang</p><p> accountant</p><p> Sponsor Name China Securities Co., Ltd.</p><p> performing Room 2203, North Tower, Shanghai Securities</p><p> Office address</p><p> continuous Building, No. 528, Pudong South Road, Shanghai</p><p> supervisory Names of the sponsor"s</p><p> GE Liang, WANG Zhan</p><p> duty during the signing representatives</p><p> Reporting Period of continuous January 4, 2022 - December 31, 2023</p><p> Annual Report 2022</p><p> Period supervision</p><p>VII. Major Accounting Data and Financial Indicators for the Past Three Years</p><p>(I) Major Accounting Data</p><p> Unit: Yuan Currency: RMB</p><p> Major accounting Year-on-year</p><p> data change (%)</p><p> Operating revenue 6,385,451,424.00 4,633,150,538.43 37.82 3,752,386,849.02</p><p> Net profit</p><p> attributable to</p><p> shareholders of the</p><p> listed company</p><p> Net profit</p><p> attributable to</p><p> shareholders of the</p><p> listed company net</p><p> of non-recurring</p><p> profit or loss</p><p> Net cash flow from</p><p> operating activities</p><p> As of the end of As of the end of Year-on-year As of the end of</p><p> Net assets</p><p> attributable to</p><p> shareholders of the</p><p> listed company</p><p> Total assets 5,778,071,824.19 4,633,049,783.03 24.71 3,636,882,185.29</p><p>(II) Key Financial Indicators</p><p> Year-on-year</p><p> Key financial indicators 2022 2021 2020</p><p> change (%)</p><p> Basic earnings per share</p><p> (RMB/share)</p><p> Diluted earnings per share</p><p> (RMB/share)</p><p> Basic earnings per share net of</p><p> non-recurring profit and loss 2.80 2.83 -1.06 2.34</p><p> (RMB/share)</p><p> Weighted average ROE (%) Up by 3.70</p><p> percentage points</p><p> Weighted average ROE net of Up by 3.09</p><p> non-recurring profit and loss (%) percentage points</p><p>Explanation on the Company"s major accounting data and financial indicators for the recent three years as</p><p> Annual Report 2022</p><p> of the end of the Reporting Period</p><p> □ Applicable √ Not applicable</p><p> VIII. Differences in Accounting Data under Chinese and International Accounting Standards</p><p> (I) Difference in net profit and net assets attributable to shareholders of the listed company in the</p><p> financial report disclosed in accordance with International accounting standards and Chinese</p><p> accounting standards</p><p> □ Applicable √ Not applicable</p><p> (II) Differences in net profit and net assets attributable to shareholders of the listed company in</p><p> the financial report disclosed in accordance with International accounting standards and</p><p> Chinese accounting standards</p><p> □ Applicable √ Not applicable</p><p> (III) Description of differences between international and Chinese accounting standards:</p><p> □ Applicable √ Not applicable</p><p> IX. Major Financial Data for 2022 by Quarter</p><p> Unit: Yuan Currency: RMB</p><p> Q1 Q2 Q3 Q4</p><p> (January - March) (April - June) (July - September) (October - December)</p><p>Operating revenue 1,254,357,336.99 1,371,585,907.30 1,336,130,787.67 2,423,377,392.04</p><p>Net profit</p><p>attributable to</p><p>shareholders of the</p><p>listed company</p><p>Net profit</p><p>attributable to</p><p>shareholders of the</p><p>listed company net</p><p>of non-recurring</p><p>profit and loss</p><p>Net cash flow from</p><p>operating activities</p><p> Description of differences between quarterly data and disclosed regular report data</p><p> □ Applicable √ Not applicable</p><p> X. Non-recurring Profit and Loss Items and Amounts</p><p> √ Applicable □ Not applicable</p><p> Unit: Yuan Currency: RMB</p><p> Amount for Note (if Amount for Amount for</p><p> Non-recurring profit and loss item</p><p> Gain or loss on disposal of non-current</p><p> assets</p><p> Unauthorized approval, no formal</p><p> Annual Report 2022</p><p> Amount for Note (if Amount for Amount for</p><p> Non-recurring profit and loss item</p><p>approval, or occasional tax refund or</p><p>reduction</p><p>Government grants recognized in profit or</p><p>loss for the current period (excluding</p><p>government grants that are closely related</p><p>to the Company"s business operations and</p><p>gained at a fixed amount or quantity</p><p>according to national standards)</p><p>Capital occupation fees charged to the non-</p><p>financial enterprises and included in profit</p><p>or loss for the current period</p><p>Gains when the investment cost of</p><p>acquiring a subsidiary, an associate and a</p><p>joint venture is less than the fair value of the</p><p>identifiable net assets of the invested entity</p><p>Gains or losses from exchange of non-</p><p>monetary assets</p><p>Gains or losses from entrusting others with</p><p>investment or asset management</p><p>Asset impairment provision accrued for</p><p>force majeure such as natural disasters</p><p>Gains or losses from debt restructuring</p><p>Enterprise restructuring fees, such as</p><p>staffing expenses and integration fees</p><p>Profit and loss of the part exceeding fair</p><p>value generated from transaction with</p><p>unreasonable transaction price</p><p>Current net gains or losses of subsidiaries</p><p>established by business combination</p><p>involving enterprises under common</p><p>control from the beginning of the period to</p><p>the combination date</p><p>Gains or losses on contingencies that have</p><p>no relation with the normal operation of the</p><p>Company</p><p>Gains or losses from change in fair value by</p><p>held-for-trading financial assets, derivative</p><p>financial assets, held-for-trading financial</p><p>liabilities and derivative financial</p><p>liabilities, and investment income from</p><p>disposal of held-for-trading financial</p><p>assets, derivative financial assets, held-for-</p><p>trading financial liabilities, derivative</p><p> Annual Report 2022</p><p> Amount for Note (if Amount for Amount for</p><p> Non-recurring profit and loss item</p><p>financial liabilities and other debt</p><p>investments, excluding the effective</p><p>hedging businesses related with normal</p><p>operations of the Company</p><p>Reversal of provision for impairment of</p><p>receivables and contract assets individually 2,782,350.76</p><p>tested for impairment</p><p>Gains or losses from outward entrusted</p><p>loaning</p><p>Gains or losses from changes in the fair</p><p>values of Investment real estate that are</p><p>subsequently measured using the fair value</p><p>model</p><p>Impact of a one-time adjustment on current</p><p>profit and loss according to the</p><p>requirements of tax and accounting laws</p><p>and regulations</p><p>Custody fees of entrusted operation</p><p>Other non-operating revenue and expenses</p><p> -2,926,959.81 -3,078,442.83 -6,810,805.57</p><p>besides the above items</p><p>Other items that conform to the definition</p><p>of non-recurring profit or loss</p><p>Less: Effect of income tax 3,689,885.55 1,917,310.27 1,042,102.64</p><p>Effect of minority equity (after tax) 5,802,406.15 2,314,480.49 688,969.45</p><p> Total 28,886,986.92 8,026,545.18 6,073,394.19</p><p> The reasons should be explained for the non-recurring profit and loss items defined by the Company</p><p> according to the definition of the Explanatory Announcement No.1 on Information Disclosure for</p><p> Companies Offering Their Securities to the Public: Non-recurring Profit and Loss, and the definition of</p><p> the non-recurring profit and loss items listed in the Explanatory Announcement No.1 on Information</p><p> Disclosure for Companies Offering Their Securities to the Public: Non-recurring Profit and Loss as</p><p> recurring profit and loss items.</p><p> □ Applicable √ Not applicable</p><p> XI. Items Measured at Fair Value</p><p> √ Applicable □ Not applicable</p><p> Unit: Yuan Currency: RMB</p><p> Amount of impact</p><p> Item Opening balance Ending balance Current change</p><p> on the current profit</p><p> Receivable 0.00</p><p> financing</p><p> Other equity 56,402,400.00 146,402,400.00 90,000,000.00 0.00</p><p> Annual Report 2022</p><p> instrument</p><p> investments</p><p> Total 59,644,400.00 146,402,400.00 86,758,000.00 0.00</p><p> XII. Other</p><p> □ Applicable √ Not applicable</p><p> Section III Management Discussion and Analysis</p><p> I. Business Discussion and Analysis</p><p> RMB6.385 billion operating revenue, up by 37.82% YOY</p><p> including RMB6.362 billion prime operating revenue, up by 37.69% YOY</p><p> RMB23 million non-operating revenue</p><p> Prime operating revenue:</p><p> (1) By channel</p><p> Change in</p><p> Change in Change in</p><p> Amount 2020 over Proportion Proportion Proportion</p><p> Channel (RMB100 the previous of 2022 of 2021 of 2020</p><p> previous year previous year</p><p> million) year (%) (%) (%)</p><p> YOY (%) YOY (%)</p><p> YOY (%)</p><p> Direct sales 44.78 59.79 76.16 79.63 70.40 60.66 42.45</p><p> Online Distribution 13.10 16.79 8.56 34.36 20.58 24.27 27.56</p><p> Subtotal 57.88 47.50 49.54 58.59 90.98 84.93 70.01</p><p> Household</p><p> chemicals</p><p> Offline</p><p> Others 1.31 -32.32 -30.50 -32.81 2.06 4.19 7.43</p><p> Subtotal 5.74 -17.62 -38.03 -23.12 9.02 15.07 29.99</p><p> Total 63.62 37.69 23.28 20.26 100.00 100.00 100.00</p><p> Note: The percentage of sales from each channel is the proportion of its sales in the prime operating</p><p> revenue.</p><p> (2) By brand</p><p> Change in</p><p> Change in Change in</p><p> Amount 2020 over Proportion Proportion Proportion</p><p> Brand (RMB100 the previous of 2022 of 2021 of 2020</p><p> previous year previous year</p><p> million) year (%) (%) (%)</p><p> YOY (%) YOY (%)</p><p> YOY (%)</p><p> Proya 52.64 37.46 28.25 12.43 82.74 82.87 79.66</p><p>Self-</p><p> TIMAGE 5.72 132.04 103.48 - 8.99 5.33 -</p><p>owned</p><p> OR 1.26 509.93 - - 1.98 - -</p><p>brands</p><p> Hapsode 1.87 188.27 - - 2.94 - -</p><p> Annual Report 2022</p><p> Other</p><p> brands</p><p> Subtotal 63.12 40.74 26.63 19.11 99.22 97.05 94.48</p><p> Cross-</p><p>Agency border</p><p>brands agency</p><p> brands</p><p>Total 63.62 37.69 23.28 20.26 100.00 100.00 100.00</p><p> Note: The proportion of sales of each brand is the proportion of its sales in the prime operating revenue;The</p><p> data of OR and Hapsode is incorporated into that of other brands in 2021 and therebefore, but is separately</p><p> listed in 2022 and thereafter.</p><p> (3) By category</p><p> Change in Change in Change in 2020</p><p> Amount Proportion Proportion Proportion</p><p> Category (RMB100 of 2022 of 2021 of 2020</p><p> previous year previous year previous year</p><p> million) (%) (%) (%)</p><p> YOY (%) YOY (%) YOY (%)</p><p> Skincare</p><p> (including 54.84 38.56 22.70 11.38 86.20 86.10 86.50</p><p> cleansing)</p><p> Make-up</p><p> cosmetics</p><p> Body & hair 1.26 509.93 - - 1.98 - -</p><p> Others 0.00 -100.00 -41.05 0.47 0.00 0.52 1.09</p><p> Total 63.62 37.69 23.28 20.26 100.00 100.00 100.00</p><p> Note: The " Body & hair " category is included in the "Skincare (including cleansing)" category before</p><p> RMB817 million net profit attributable to shareholders of the listed company, up by 41.88% YOY</p><p> RMB789 million net profit attributable to shareholders of the listed company net of non-recurring profit</p><p> and loss, up by 38.80% YOY</p><p> Indicator 2022 2021 2020 Notes</p><p> Mainly due to the increased</p><p> gross profit margin.</p><p> Mainly due to:</p><p> online direct sales; 2. Hero</p><p> product strategy;</p><p> Mainly due to:</p><p> as Hapsode) and increased</p><p> Annual Report 2022</p><p> spending in image</p><p> promotion.</p><p>Of which: image promotion fee</p><p>rate</p><p> Mainly due to:</p><p> increased by 67.15% YOY</p><p> (an absolute increase of</p><p> RMB51.43 million);</p><p> R&D expense ratio was</p><p> with 3.55% for the same</p><p> period last year).</p><p> Mainly due to:</p><p>rate (time/year) 2. Decreased average</p><p> balance of accounts</p><p> receivable.</p><p>days (days)</p><p>(time/year)</p><p>II. The Company"s Industry Situation during the Reporting Period</p><p>According to the Guidelines for the Industry Classification of Listed Companies by the CSRC, the</p><p>Company falls under chemical raw material and chemical product manufacturing (classification code:</p><p>C26); according to the Industrial Classification for National Economic Activities (GB/T 4754-2017), the</p><p>Company falls under the manufacturing of daily chemical products (C268) and further under the</p><p>manufacturing of cosmetics (C2682).</p><p>According to statistics from the National Bureau of Statistics, in 2022, the total retail sales of consumer</p><p>goods reached RMB43,973.3 billion, down by 0.2% YOY; the total retail sales of cosmetics reached</p><p>RMB393.6 billion, down by 4.5% YOY (covering consumer goods above designated units).</p><p>III. The Company"s Business Operations during the Reporting Period</p><p>(I) Main business</p><p>The Company seeks to build a new domestic cosmetics industry platform, and is primarily engaged in</p><p>R&D, production and sales of cosmetic products. Main brands owned by the Company include Proya,</p><p>TIMAGE, Off&Relax, Hapsode, CORRECTORS, INSBAHA, UZERO and Anya. The Company"s own</p><p>brands have covered fields such as popular skincare, make-up, body & hair, and high-efficiency skincare:</p><p> Annual Report 2022</p><p>(1) Proya, focusing on technology skincare, designed for young white-collar female customers, priced at</p><p>RMB200 to RMB500, sold both online and offline.</p><p>(2) Hapsode, customized for young skin, especially for college students and other young female customers,</p><p>priced at RMB50 to RMB150, sold mainly online.</p><p>TIMAGE, a professional make-up brand with a new Chinese style, priced at RMB150 to RMB300, sold</p><p>online.</p><p>Off&Relax, developed and made in Japan, focusing on scalp care, priced at RMB150 to RMB200, sold</p><p>mainly online.</p><p>CORRECTORS, a high-efficiency skincare brand, priced at RMB260 to RMB600, sold online.</p><p>(II) Business models</p><p>Mainly online sales, supplemented by offline sales.</p><p>Online sales are mainly operated through direct sales and distribution. Direct sales are mainly carried out</p><p>on platforms such as Tmall, TikTok, JD, Kwai, and Pinduoduo. Distribution platforms include Taobao,</p><p>JD, and Vipshop.</p><p>Offline sales are mainly operated through dealers. Channels include cosmetics franchise stores,</p><p>supermarkets, and single-item stores.</p><p>Self-production is the main production model of the Company, supplemented by OEM production. The</p><p>skincare products of the Company are self-produced while make-up products are both self-produced and</p><p>OEM-produced. The Company has self-built skincare and make-up factories.</p><p>Independent R&D is the main R&D model of the Company, supplemented by industry-university-research</p><p>cooperation. The Company has maintained R&D cooperation with front-end research institutions and</p><p>high-quality raw material suppliers including the Institute of Microbiology, Chinese Academy of Sciences,</p><p>Zhejiang University of Technology, BASF China, Ashland China, Royal DSM Shanghai, LIPOTRUE</p><p>S.L., and Shenzhen Siyomicro Bio-tech.</p><p>IV. Analysis of Core Competitiveness during the Reporting Period</p><p>√ Applicable □ Not applicable</p><p>The Company"s core competitiveness is mainly embodied by:</p><p>The Company adheres to the guidance of the 6*N strategy and puts it into practice amid the rapidly</p><p>changing market; consolidates and deepens the refined operation management system highlighting "R&D,</p><p>products, contents, operation"; constructs a self-driven organization featuring "culture-strategy-</p><p>mechanism-talents".</p><p>With a keen insight into consumers" needs, the Company keeps sharpening the strengths of hero products,</p><p>as well as building and improving the matrix of core hero products based on R&D and relying on quick</p><p>response and organizational capabilities.</p><p>The Company has built a self-driven and agile organization to serve brands in the second echelon that</p><p>have taken shape as well as brands under incubation. By building our own MCN team and content</p><p> Annual Report 2022</p><p>marketing team, the Company strengthens the internally circular ecosystem and connects Proya brands</p><p>with the external ecosystem.</p><p>V. Main Operations during the Reporting Period</p><p>Proya:</p><p>During the Reporting Period, Proya continued to deepen the "Hero Product Strategy"; primarily expanded</p><p>and upgraded the categories and efficacy of Elastic Brightening Youth Essence, Ruby Essence, and</p><p>Advanced Original product families; launched Advanced Original Face Cream, Advanced Original Face</p><p>Mask, and other new products; upgraded the Elastic Brightening Youth Activating Eye Cream, the Deep</p><p>Ocean Energy Wrinkless and Firming Moisture Cream, and the Advanced Original Essence to version 2.0,</p><p>which further solidified the mindset of the three product families; continued to explore high-end product</p><p>categories by launching the Inaugurating Nourishing Face Oil. These products give consumers more</p><p>options and better product experiences.</p><p>In 2022, Proya ranked 1st in the essence category, 4th in the mask category, 4th in the eye cream category,</p><p>and 9th in the face cream category on Tmall.</p><p>TIMAGE:</p><p>During the Reporting Period, TIMAGE further completed the deployment of facial make-up product lines,</p><p>and strengthened the impression of a "professional make-up artist" for consumers. Based on the facial</p><p>make-up category, TIMAGE created two segments of "Contour Line" and "Base Make-up". In addition</p><p>to contour, highlighter, and primer, TIMAGE created another six categories including liquid foundation,</p><p>concealer, and setting spray. The large base make-up category was supplemented while maintaining</p><p>advantages in contour lines, so that the base make-up category could establish a wider presence.</p><p>In 2022, the "tri-colored contour palette" and "dual-colored highlighter palette" of TIMAGE maintained</p><p>their advantages in the highlighter category, led the growth for the brand aggressively, improved product</p><p>penetration, and brought a large number of new customers to the brand. The tri-colored contour palette</p><p>ranked 1st in the highlighter category on Tmall. The dual-colored highlighter palette ranked 2nd in the</p><p>highlighter category on Tmall. The face primer ranked 1st in the sun block/primer category on Tmall. The</p><p>newly-launched tri-colored concealer palette ranked 1st in the concealer category on Tmall. The newly-</p><p>launched setting spray ranked top 10 in the setting spray category on Tmall.</p><p>Off&Relax (OR):</p><p>During the Reporting Period, the Company continued to optimize the product structure and facilitated the</p><p>construction of a scalp health care system for the brand.</p><p>Making scalp health a focus for the brand penetrating the market, OR solves users" pain points by rapidly</p><p>building two flagship products "Off&Relax Hot Spring Water SPA Shampoo" and "Off&Relax Hot Spring</p><p>Water Hair Mask". Based on the existing market environment and the characteristics of Japanese brands,</p><p>OR sorts out product selling points, provides various scalp and hair care products for high-net-value</p><p>consumers, who care user experience of cleansing and care products, to satisfy the demands of different</p><p>consumers.</p><p>Hapsode:</p><p>During the Reporting Period, Hapsode focused on building two cleansing products: Amino Acid Crystal</p><p>and Multiple Acids Purely Cleansing Mud Musk. Cleansing products allow the Company to rapidly reach</p><p> Annual Report 2022</p><p>young consumers with oily skin. Also, Hapsode completes the brand and category portfolio by launching</p><p>highly-effective skin cleansing products such as the "Ultra Soothing Facial Mask " and the "Oil Control</p><p>Balanced Serum", builds up a pyramid-typed product system for oily skin, and gradually improves</p><p>consumers" recognition of Hapsode as "an expert for the care of oily skin".</p><p>Proya:</p><p>During the Reporting Period, the Proya brand continuously built its brand around the "spirit of discovery",</p><p>focused on socially important issues such as gender equality, mental health and intimate relationships, and</p><p>created and communicated brand content on issues related to young people"s growth and the target</p><p>audience for long-lasting effects. The Company carried out brand marketing events as follows:</p><p>(1) "Next Stop, Decisive Turn" in January: Proya delivered the hope for the new year with poems and</p><p>gave the audience a beautiful wish for good luck by organizing a subway poetry exhibition.</p><p>(2) "Gender is Not the Borderline, Prejudice is" on Women"s Day in March: Aiming at gender equality</p><p>once again, Proya invited the female soccer WANG Shuang and the Nanxing Hexingtang Lion Dance</p><p>Team to shoot a documentary. Efforts were made to unite with seven brands to continuously strive for "a</p><p>gender equal world" with concrete actions.</p><p>(3) "Visible Only to Moms" on Mother"s Day in May: Proya told the stories of "mothers", who are one of</p><p>the target consumer groups of the brand, to all family members, and invited experts of different fields to</p><p>participate in topic discussions. Differentiated from the "Thank You Mother" topic in the same period, the</p><p>event drummed up more discussions about the "division of household labor and responsibilities".</p><p>(4) "Dare to love, dare not to love" on the Chinese Valentine"s Day in August: Proya worked with</p><p>FUJIFILM and photographers to discuss with consumers the form of self presentation in love in the way</p><p>of pictures and texts. Meanwhile, the Company proposed the brand technology mindset of "A Scientific</p><p>Choice for Skin" while working with the original content platform Zhihu to seek the answer to the question</p><p>"what is the best scientific choice for skin", and better help consumers understand the knowledge of</p><p>scientific skin care so they can choose products more wisely.</p><p>(5) "The Smallest Thing Is Important" in September: Proya advocated for school bullying victims, held</p><p>the attention to the signs of campus bullying that seem "insignificant", and called on the public to realize</p><p>the "multi-faced look" of campus bullying, so as to light up the road ahead for those growing amidst bullies.</p><p>(6) World Mental Health Day in October: Proya continued on the "Echo Project" brand marketing</p><p>campaign, paid sustaining attention to the mental health of young people, and output the brand attitude of</p><p>Proya. Joining hands with Beijing New Sunshine Charity Foundation, Douban, Owspace, Fangsuo</p><p>Commune, The Mind, Xiaoyuzhou Podcast APP, and xinli001.com, Proya presented everyone the</p><p>multiple possibilities of "emotional outlets".</p><p>(7) Pop-up series at 9 stores in 8 cities across China in November: By understanding the youngsters"</p><p>“Coffee & Alcohol Pop Up” mindset, Proya effectively integrated its hero products into a popular lifestyle</p><p>of young people, delivering a young brand image by catering to a lifestyle that better suits young</p><p>consumers.</p><p>TIMAGE:</p><p>During the Reporting Period, TIMAGE comprehensively deepened the brand recognition of "Chinese</p><p>make-up, original beauty" and had a dialog with Chinese female consumers with its unique</p><p>professionalism and aesthetics. By means of cross-border marketing, brand responsibility and care, and</p><p>brand values delivery, TIMAGE carried out the following marketing events:</p><p> Annual Report 2022</p><p>(1) "Unfiltered You" on Women"s Day in March: Photographers were invited to output the opinions of</p><p>"original beauty", speak out for the brand, and interpret the concept of original beauty as female artists.</p><p>Starting from the insight into "filters", the event presents the brand concept and aesthetic tonality of</p><p>original beauty.</p><p>(2) "Witness the Original Beauty" in April: TIMAGE worked with Hippocampus, a professional</p><p>photography organization, to provide ID photo make-up of "original beauty". Hippocampus set up special</p><p>make-up tables at its 180 stores. Large-screen advertisements were launched in 5 major cities and online</p><p>topics were promoted to most searched hashtags to encourage consumers to share their changes in the</p><p>make-up before taking an ID photo over the years.</p><p>(3) "Life is Beautiful" in June: TIMAGE collaborated with the One Way Street Library to start topics.</p><p>Many art workers, music critics, directors, writers, and screenwriters sent articles and photos of their</p><p>experiences to share and output positive content. TIMAGE also produced peripheral sachets and gave</p><p>them to consumers for free.</p><p>(4) "Origin at the Beginning of Autumn" in August: TIMAGE produced a video with three female content</p><p>KOLs to present the life attitude that "It is Never too Late to Do" and encourage everyone to find more</p><p>possibilities in life.</p><p>(5) "You Are Beautiful in Every Single Way" in October: TIMAGE released the first high-quality brand</p><p>promotion film to set the latest visual identity of the brand, complete the full-chain communication loop</p><p>from "original beauty" to "Chinese make-up", and showcase the brand tonality of TIMAGE as well as its</p><p>attitude toward women"s intrinsic growth.</p><p>(6) "See Your Beauty" in December: By producing thank-you letters and peripheral gifts, TIMAGE</p><p>interacted with fans to express its gratitude for the support of fans.</p><p>Proya:</p><p>Online:</p><p>(1) Tmall flagship store</p><p>During the Reporting Period, the Company continued to consolidate the hero product matrix strategy and</p><p>created super-hero products throughout the Internet. Combining factors of consumers, goods, and venues,</p><p>the Company deeply maintains the members and regular customers of stores, improves their possibilities</p><p>of repurchase and per customer transaction, increases the penetration into populations and high-value users</p><p>in tier 1 and tier 2 cities; heightens the ranking in core categories and draws the attention of consumers;</p><p>values the operation of self live-streaming and improves the proportion of self live-streaming. During</p><p>the "6.18" and "11.11" shopping festivals in 2022, the gross merchandise volume (GMV) of Proya</p><p>Flagship Store ranked 5th on Tmall Beauty and 1st among all Chinese products. In 2022, the GMV of</p><p>Proya Flagship Store ranked 4th on Tmall Beauty and 1st among all Chinese products.</p><p>(2) TikTok</p><p>During the Reporting Period, the Company strengthened self live-streaming and multi-matrix account</p><p>operation: increased the consumer maintenance efficiency while stepping up the maintenance of members</p><p>and fans; optimized the product structure, and dramatically increased the proportion of hero products and</p><p>the per customer transaction of stores. During the "6.18" and "11.11" shopping festivals in 2022, Proya</p><p>ranked 1st both on TikTok Beauty and among all Chinese products. In 2022, Proya ranked 3rd on TikTok</p><p>Beauty and 1st among all Chinese products.</p><p>(3) JD</p><p> Annual Report 2022</p><p>During the Reporting Period, the Company deeply implemented the hero product strategy and further</p><p>improved the sales proportion of hero products through efficient operation; improved the experience of</p><p>members, attracted new high-value customers, and increased the repurchase ratio to have a better insight</p><p>into the population and lock target consumers; optimized the quality of advertisement content, expanded</p><p>advertisement channels, and operated various channels in a more refined manner. During the "6.18" and</p><p>"11.11" shopping festivals in 2022, Proya ranked 1st both on JD Beauty and among all Chinese products.</p><p>In 2022, Proya ranked 10th on JD Beauty, and ranked 1st among all Chinese products.</p><p>Offline:</p><p>(1) Household chemicals: Corresponding rating systems are matched for strongly influential areas and</p><p>weekly influential areas of the brand to manage outlets in an targeted and differentiated manner. The</p><p>business logic is now driven by "dynamic sales" instead of "channel policies", so as to optimize bad</p><p>inventory in channels, ensure maximum benefits for retailers, and keep close eyes on the fund, inventory,</p><p>and benefits of retailers.</p><p>(2) Supermarkets: The brand power enables the department store channel to improve existing counters,</p><p>upgrade the image, and enhance the efficiency. The "Coffee & Alcohol Pop Up" initiative is held through</p><p>brand marketing campaigns at 9 stores in 8 cities including Hangzhou, Shenzhen, Ningbo, Suzhou,</p><p>Wenzhou, and Xi"an, so as to reach young target customers, strengthen the communication with the young</p><p>population, and promote the strategic cooperation between the brand and key systems. Also, the</p><p>cooperation with supermarkets is shrunk strategically.</p><p>(1) Organization: The Company continuously improves the organizational structure, opens up the brand</p><p>planning mode that connects both the upper level and the lower level, builds a management mode</p><p>integrating a product and delivery capability-focused "middle platform" and an "agile front", continues to</p><p>deepen the application of digital technologies, and promotes the incubation and growth of new businesses</p><p>through the empowerment of platforms and digitalization.</p><p>(2) Talents: The Company continuously promotes the talent supply chain mechanism for young and</p><p>international talents based on business needs, steps up the introduction of talents for research, development,</p><p>and information application, accurately and rapidly identifies, and efficiently utilizes talents, and gradually</p><p>builds a dynamic, competent and self-driven talent team through the combination of training and practices.</p><p>Through the dual-channel management, the Company improves the talent density, facilitates talent</p><p>development, and builds a talent echelon.</p><p>(3) Mechanism: The Company deepens a performance culture featuring high investment, high</p><p>performance and high returns, improves a performance management system emphasizing targets, process</p><p>and results; flexible utilizes the diversified incentive system covering short-term (quarterly performance</p><p>and project incentives), middle-term (annual performance dividends) and long-term (equity incentives and</p><p>partners) incentives. Also, the Company deepens the application of the project system, builds up a three-</p><p>level project management system consisting of the Company, business divisions, and departments, and</p><p>puts efforts on the end-to-end value chain and internal control projects to continuously hone the</p><p>organization capability.</p><p>During the Reporting Period, the Company took the R&D Innovation Center and the International</p><p>Academy of Sciences as the engine for innovation; improved the R&D of all key stages from raw material</p><p>to finished products, including fundamental research, formula development, physical and chemical</p><p> Annual Report 2022</p><p>analysis, raw material and product efficacy evaluation, etc. The Company continues to push the</p><p>construction of the International Academy of Sciences to conduct the research of skin texture, design</p><p>active substances, and verify their efficacy. The R&D Innovation Center continues to focus on researching</p><p>and developing new skin care and make-up products. Now the Shanghai R&D Center is under construction</p><p>and the Japan R&D Center is under preparation.</p><p>(1) Patents: During the Reporting Period, the Company newly applied for 21 national invention patents,</p><p>licensed invention patents and 17 design patents, totaling 32 patents obtained. As of the end of the</p><p>Reporting Period, the Company had 107 nationally licensed invention patents, 19 utility model patents,</p><p>and 99 design patents, totaling 225 patents obtained.</p><p>(2) Standard releasing: During the Reporting Period, the Company participated the drafting of two newly</p><p>released group standards, namely the TZHCA 017-2022 Hair Growth and Rest Period Quantity Ratio Test</p><p>Method and the T/ZHCA 019-2022 Cosmetics Anti-dandruff Efficacy Test Method. As of the end of the</p><p>Reporting Period, the Company had led or participated in the development of 14 national standards, 3</p><p>industry standards, and 14 group standards.</p><p>(3) Achievements and awards: During the Reporting Period, the Company was granted the following</p><p>honorable titles, including the Hangzhou "Kunpeng" Enterprise, One of the Top Ten Enterprise in China"s</p><p>Light Industry ad Cosmetics Industry, One of the Top 100 Enterprises in Hangzhou Manufacturing</p><p>Industry, Third Prize in National Commercial Technology Advancement Award, Top Ten Make-up</p><p>Brands of Zhejiang in 2021. At the IFSCC International Cosmetic Science Conference, the Company</p><p>presented a number of its scientific achievements.</p><p>(4) Strategic cooperation: During the Reporting Period, the Company deepened the strategic cooperation</p><p>with existing partners, and performed strategic cooperation with Zhejiang Peptites Biotech Co., Ltd.</p><p>(1) Procurement and planning:</p><p>During the Reporting Period, the Company"s supply chain system integrated the data and information from</p><p>various information platforms and timely calculated the demand for raw materials based on the demand</p><p>at the terminal while synchronizing inventory of suppliers, procurement cycle, and logistic information.</p><p>In the end, these information is accurately and agilely transmitted to all departments through the supply</p><p>chain information platform to reach a balance between terminal sales and productivity and provide a back-</p><p>end support for promotions on 6.18 and 11.11.</p><p>The Company has organized multiple training sessions for suppliers in terms of sustainable development,</p><p>actively adopts sustainable packaging, and achieves remarkable effect in reducing plastics, using</p><p>environmentally-friendly materials, and minimizing packaging.</p><p>(2) Production:</p><p>Based on market sales and needs, the Company makes productivity arrangement in advance, adheres to</p><p>lean manufacturing, and keeps improving production efficiency by using automated, intelligent, and</p><p>digital technologies. During the Reporting Period, the Company expanded some workshops, added</p><p>multiple production lines, and enhanced productivity to meet the demands during the 6.18 and 11.11</p><p>shopping festivals. In addition, the Company further strengthened the full-process quality management</p><p>and risk management, regularly held communication meetings of quality experiences for consumers,</p><p>received market feedback as soon as possible, and implemented project-specific management and closed-</p><p>loop tracking.</p><p>During the Reporting Period, the Company completed the "Massive Safety Training For A Million</p><p>Employees" program, allowing all employees to master and grasp laws and regulations related to safe</p><p> Annual Report 2022</p><p>production, enhance their awareness safe production hazards, and improve the safety emergency response</p><p>capability. The Huzhou Factory installed the independent fire control and management platform of the</p><p>provincial fire and rescue corps to systematically manage the fire control work. The Company upgraded</p><p>and renovated the fire-fighting system to control the whole process of smoke exhaust.</p><p>(3) Logistics:</p><p>During the Reporting Period, the Company continued to improve the logistics management system and</p><p>initiated the installation of the automated three-dimensional warehouse equipment. The Company was</p><p>rated as the winner of the "China Logistics Industry Golden Ant Award 2021 and 2022" by the organizing</p><p>committee of the LET-a CeMAT ASIA</p><p>(I) Analysis of main business</p><p> Unit: Yuan Currency: RMB</p><p> Amount for the</p><p> Amount for the</p><p> Account same period last Change ratio (%)</p><p> current period</p><p> year</p><p> Operating revenue 6,385,451,424.00 4,633,150,538.43 37.82</p><p> Operating cost 1,934,850,203.65 1,554,155,646.61 24.50</p><p> Selling expenses 2,785,837,352.95 1,991,534,076.73 39.88</p><p> General and administrative</p><p> expenses</p><p> Financial expenses -40,996,523.01 -7,484,395.13 447.76</p><p> Research and development</p><p> expenses</p><p> Net cash flow from operating</p><p> activities</p><p> Net cash flow from investing</p><p> -298,215,550.57 -341,823,618.60 Not applicable</p><p> activities</p><p> Net cash flow from financing</p><p> -65,251,320.73 489,615,295.96 -113.33</p><p> activities</p><p>Cause for change in operating revenue: mainly due to increased online sales.</p><p>Cause for change in operating cost: mainly due to increased operating costs resulting from the increase of</p><p>operating revenue.</p><p>Cause for change in sales expenses: In 2022, sales expenses amounted to RMB2.786 billion, accounting</p><p>for 43.63% of the operating revenue (compared with 42.98% for the same period last year). Selling</p><p>expenses increased by RMB794 million or 39.88% YOY, mainly due to an increase of RMB746 million</p><p>or 44.60% YOY in the image promotion expenses in the current period (used for the incubation of new</p><p>brands such as TIMAGE, OR, and brand re-shaping).</p><p>Cause for change in general and administrative expenses: In 2022, administrative expenses amounted to</p><p>RMB327 million, accounting for 5.13% of the operating revenue (compared with 5.12% for the same</p><p>period last year). General and administrative expenses increased by RMB90.31 million or 38.11% YOY,</p><p>mainly due to increased equity incentive expense for restricted shares, employee compensation, and</p><p>service fees.</p><p>Cause for change in financial expenses: The general impact of interest income and foreign exchange gains</p><p>and losses reduced financial expenses by RMB33.51 million.</p><p> Annual Report 2022</p><p> Cause for change in R&D expenses: In 2022, R&D expenses amounted to RMB128.01 million, an increase</p><p> of RMB51.43 million YOY, accounting for 2.00% of the operating revenue (compared with 1.65% for the</p><p> same period last year). In 2022, the parent company"s R&D expense ratio was 4.31% (compared with 3.55%</p><p> for the same period last year).</p><p> Cause for change in net cash flow from operating activities: 1. mainly due to the YOY increase in the</p><p> operating revenue and the increase in cash received from commodity sales; 2. increased payment for goods;</p><p> Cause for change in net cash flow from investment activities: a YOY increase of RMB44million, mainly</p><p> due to decreased cash flow from investment activities caused by the disposal of the 52% equity of</p><p> Shanghai Healthlong Biochemical Technology Co., Ltd in the previous period. The event is not recognized</p><p> in the current period.</p><p> Causes for change in net cash flow from financing activities: a YOY decrease of RMB555 million, mainly</p><p> due to that (1) the cash received from absorbing investment (equity incentive expense for restricted shares)</p><p> is increased by RMB165 million; (2) the cash received from reclaiming borrowings is decreased by</p><p> RMB647 million (RMB747million of fund raised in the previous period by issuing the "Proya Convertible</p><p> Bond"); (3) the cash paid related to financing activities is increased by RMB43 million; (4) the cash paid</p><p> to distribute dividends, profits, or repay interest is increased by RMB28 million.</p><p> A detailed description of major changes in the Company"s activities, profit composition or sources of profit</p><p> during the current period</p><p> □ Applicable √ Not applicable</p><p> √ Applicable □ Not applicable</p><p> For details, see the analysis in "1. Analysis of changes in accounts in the Income Statement and the Cash</p><p> Flow Statement", "(I) Analysis of main business", "V. Main Operations during the Reporting Period",</p><p> "Section III Management Discussion and Analysis" of this report.</p><p> (1). Main business activities by industry, product, region and sales model</p><p> Unit: Yuan Currency: RMB</p><p> Main business activities by industry</p><p> Gross Change in Change in Change in</p><p> profit operating operating gross profit</p><p> Industry Operating revenue Operating cost</p><p> margin revenue cost YOY margin YOY</p><p> (%) YOY (%) (%) (%)</p><p>Household Up by 3.32</p><p>chemicals 6,361,763,550.69 1,916,352,535.29 69.88 37.69 24.03 percentage</p><p>industry points</p><p> Main business activities by product</p><p> Gross Change in Change in Change in</p><p> profit operating operating gross profit</p><p> Product Operating revenue Operating cost</p><p> margin revenue cost YOY margin YOY</p><p> (%) YOY (%) (%) (%)</p><p>Skincare 5,483,643,868.53 1,616,998,071.19 70.51 38.56 29.68 Up by 2.02</p><p> Annual Report 2022</p><p>(including percentage</p><p>cleansing) points</p><p> Up by 9.16</p><p>Make-up</p><p>cosmetics</p><p> points</p><p> Up by 11.73</p><p>Body & hair 125,659,396.08 47,687,457.85 62.05 509.93 365.92 percentage</p><p> points</p><p>Others 0.00 0.00 - -100.00 -100.00</p><p> Up by 3.32</p><p>Total 6,361,763,550.69 1,916,352,535.29 69.88 37.69 24.03 percentage</p><p> points</p><p> Main business activities by region</p><p> Gross Change in Change in Change in</p><p> profit operating operating gross profit</p><p> Region Operating revenue Operating cost</p><p> margin revenue cost YOY margin YOY</p><p> (%) YOY (%) (%) (%)</p><p> Up by 0.03</p><p>Northeast</p><p>China</p><p> points</p><p> Up by 6.61</p><p>North China 69,783,559.44 26,385,241.51 62.19 9.94 -6.42 percentage</p><p> points</p><p> Up by 8.26</p><p>East China 712,780,874.13 298,564,036.15 58.11 4.34 -12.84 percentage</p><p> points</p><p> Up by 2.51</p><p>South China 44,924,050.01 18,046,419.43 59.83 -41.91 -45.33 percentage</p><p> points</p><p> Decreased by</p><p>Central China 149,971,246.18 61,852,910.54 58.76 -15.39 -11.34</p><p> percentage</p><p> points</p><p> Up by 0.22</p><p>Northwest</p><p>China</p><p> points</p><p> Up by 1.09</p><p>Southwest</p><p>China</p><p> points</p><p> Up by 46.97</p><p>Hong Kong</p><p>and overseas</p><p> points</p><p> Up by 0.90</p><p>Others (e-</p><p>commerce)</p><p> points</p><p> Annual Report 2022</p><p> Up by 3.32</p><p>Total 6,361,763,550.69 1,916,352,535.29 69.88 37.69 24.03 percentage</p><p> points</p><p> Main business activities by sales model</p><p> Gross Change in Change in Change in</p><p> profit operating operating gross profit</p><p> Sales model Operating revenue Operating cost</p><p> margin revenue cost YOY margin YOY</p><p> (%) YOY (%) (%) (%)</p><p> Up by 2.63</p><p>Online 5,788,034,421.87 1,684,190,321.43 70.90 47.50 35.26 percentage</p><p> points</p><p> Up by 2.60</p><p>Offline 573,729,128.82 232,162,213.86 59.53 -17.62 -22.60 percentage</p><p> points</p><p> Up by 3.32</p><p>Total 6,361,763,550.69 1,916,352,535.29 69.88 37.69 24.03 percentage</p><p> points</p><p> Description of main business activities by industry, product, region and sales model</p><p> (1) Description of growth in household chemicals: The growth in prime operating revenue this year was</p><p> mainly due to RMB5.788 billion online sales (accounting for 90.98% of the prime operating revenue), an</p><p> increase of RMB1.864 billion or 47.50% YOY.</p><p> (2) Description of growth in make-up cosmetics: mainly due to RMB572 million sales of TIMAGE that</p><p> falls under the make-up cosmetics category during the Reporting Period, an increase of RMB326million</p><p> or 132.04% YOY.</p><p> (3) Description of growth in body and hair: mainly due to RMB126 million sales of OR that falls under</p><p> the Body & hair category during the Reporting Period, an increase of RMB105 million or 509.93% YOY.</p><p> (4) Description of growth in others: No income of other categories is reported this year, mainly due to that</p><p> the Company no longer operated the cross-border brand agency business.</p><p> (5) Description by region: The sales of other regions declined, except e-commerce, Hong Kong and</p><p> overseas, East China, and North China, mainly due to a YOY fall in offline sales.</p><p> (2). Analysis table of production and sales</p><p> √ Applicable □ Not applicable</p><p> Change in Change Change in</p><p> Major</p><p> Unit Production Sales Inventory production in sales inventory</p><p> products</p><p> YOY (%) YOY (%) YOY (%)</p><p> Household</p><p> Piece 314,064,556 276,025,390 90,180,032 42.44 27.66 72.95</p><p> chemicals</p><p> Description of production and sales</p><p> The quantities in the above table include self-produced and OEM products, excluding the quantity of</p><p> products produced through cross-border brand agency.</p><p> (3). Performance of major purchase contracts and major sales contracts</p><p> □ Applicable √ Not applicable</p><p> Annual Report 2022</p><p> (4). Cost statement analysis</p><p> Unit: RMB</p><p> Statement by industry</p><p> Proportio</p><p> Proportion n% in</p><p> % in total Amount for the total cost YOY Descri</p><p> Cost Amount for the</p><p> Industry cost for same period for the change ption</p><p> composition current period</p><p> the current last year current ratio (%)</p><p> period (%) period</p><p> (%)</p><p> Raw materials 66.20 63.18 29.97</p><p> Labor and</p><p> manufacturing 107,432,847.50 5.61 81,119,950.03 5.25 32.44</p><p>Household cost</p><p>chemicals 316,528,909.0</p><p> Outsourcing 302,956,467.34 15.81 20.49 -4.29</p><p> industry 8</p><p> Freight 237,269,640.00 12.38 11.09 38.49</p><p> Subtotal 100.00 100.00 24.03</p><p> Statement by product</p><p> Proportio</p><p> Proportion n in total</p><p> in total Amount for the cost for YOY Descri</p><p> Cost Amount for the</p><p> Product cost for same period the same change ption</p><p> composition current period</p><p> the current last year period ratio (%)</p><p> period (%) last year</p><p> (%)</p><p> Raw materials 75.97 73.31 34.39</p><p> Labor and</p><p> manufacturing 101,753,659.87 6.29 74,591,026.00 5.98 36.42</p><p>Skincare cost</p><p>(including 113,127,555.8</p><p> Outsourcing 92,297,157.26 5.71 9.07 -18.41</p><p>cleansing) 1</p><p> Freight 194,513,686.83 12.03 11.64 34.08</p><p> Subtotal 100.00 100.00 29.68</p><p> Raw materials 40,084,933.46 15.93 62,041,264.64 23.55 -35.39</p><p>Make-up</p><p> Labor and</p><p>cosmetics 5,679,187.63 2.26 6,528,924.03 2.48 -13.01</p><p> manufacturing</p><p> Annual Report 2022</p><p> cost</p><p> Outsourcing 174,194,228.29 69.21 64.91 1.88</p><p> Freight 31,708,656.87 12.60 23,869,561.68 9.06 32.84</p><p> Subtotal 251,667,006.25 100.00 100.00 -4.46</p><p> Raw materials 175,079.76 0.37 - - -</p><p> Labor and</p><p> manufacturing - 0.00 - - -</p><p>Body &</p><p> cost</p><p> hair</p><p> Outsourcing 36,465,081.79 76.46 8,307,839.73 81.17 338.92</p><p> Freight 11,047,296.30 23.17 1,927,244.65 18.83 473.22</p><p> Subtotal 47,687,457.85 100.00 10,235,084.38 100.00 365.92</p><p> Raw materials - - - - -</p><p> Labor and</p><p> manufacturing - - - - -</p><p>Others cost</p><p> Outsourcing - - 24,114,635.62 98.16 -100.00</p><p> Freight - - 452,529.45 1.84 -100.00</p><p> Subtotal - - 24,567,165.07 100.00 -100.00</p><p> Other explanations</p><p> None</p><p> (5). Changes in consolidation due to changes in the equity of major subsidiaries during the</p><p> Reporting Period</p><p> √ Applicable □ Not applicable</p><p> For details, see "VIII. Changes in the Consolidation Scope", "Section X Financial Report".</p><p> (6). Significant changes or adjustments to the Company"s business activities, products or services</p><p> during the Reporting Period</p><p> □ Applicable √ Not applicable</p><p> (7). Major sales customers and major suppliers</p><p> A. The Company"s major customers</p><p> √ Applicable □ Not applicable</p><p> The sales of top five customers amounted to RMB798.31million, accounting for 12.55% of the total annual</p><p> sales; the sales of related parties of such top five customers amounted to RMB0, accounting for 0.00% of</p><p> the total annual sales.</p><p> Circumstances where a single customer contributed to more than 50% of the total sales, top 5 customers</p><p> included a new customer, or the Company relied heavily on a small number of customers during the</p><p> Reporting Period</p><p> □ Applicable √ Not applicable</p><p> Annual Report 2022</p><p>B. The Company"s major suppliers</p><p>√ Applicable □ Not applicable</p><p>The purchase amount of top 5 suppliers amounted to RMB393.25million, accounting for 20.57% of the</p><p>total annual purchase amount; the purchase amount of related parties of such top 5 suppliers amounted to</p><p>RMB0, accounting for 0.00% of the total annual purchase amount.</p><p>Circumstances where a single supplier accounted for more than 50% of the total procurement, top 5</p><p>suppliers included a new supplier, and the Company relied heavily on a small number of suppliers during</p><p>the Reporting Period</p><p>□ Applicable √ Not applicable</p><p>Other explanations</p><p>None</p><p>√ Applicable □ Not applicable</p><p> Unit: RMB</p><p> Change for the</p><p> Expense item 2022 2021 Growth rate (%)</p><p> current period</p><p> Selling</p><p> expenses</p><p> General and</p><p> administrative 327,296,749.37 236,988,519.23 90,308,230.14 38.11</p><p> expenses</p><p> Research and</p><p> development 128,009,104.49 76,583,650.83 51,425,453.66 67.15</p><p> expenses</p><p> Financial</p><p> -40,996,523.01 -7,484,395.13 -33,512,127.88 Not applicable</p><p> expenses</p><p>(1). Statement of R&D investment</p><p>√ Applicable □ Not applicable</p><p> Unit: RMB</p><p> Expensed R&D investment for the 128,009,104.49</p><p> current period</p><p> Capitalized R&D investment for the 0.00</p><p> current period</p><p> Total R&D investment 128,009,104.49</p><p> Total R&D investment in operating 2.00</p><p> revenue (%)</p><p> Capitalization of R&D investment (%) 0.00</p><p>(2). Statement of R&D personnel</p><p>√ Applicable □ Not applicable</p><p> Annual Report 2022</p><p>Number of R&D personnel 229</p><p>Percentage of R&D personnel (%) 7.21</p><p> Educational background structure</p><p>Educational level Number of persons</p><p>PhD 4</p><p>Master 69</p><p>Bachelor 123</p><p>Associate 31</p><p>High school and below 2</p><p> Age structure</p><p>Age range Number of persons</p><p>Under 30 (exclusive) 100</p><p>(3). Description</p><p>□ Applicable √ Not applicable</p><p>(4). Cause for significant changes in the composition of R&D personnel and the impact on the future</p><p> development of the Company</p><p>□ Applicable √ Not applicable</p><p>√ Applicable □ Not applicable</p><p> Unit: RMB</p><p> Amount for the</p><p> Amount for the Growth rate</p><p> Item same period Description</p><p> current period (%)</p><p> last year</p><p> Mainly due to:</p><p> operating revenue and the</p><p> Net cash flow</p><p> increase in cash received from</p><p> from</p><p> operating</p><p> activities</p><p> goods;</p><p> image promotion fees.</p><p> Net cash flow Mainly due to the disposal of</p><p> from - Not the 52% equity of Shanghai</p><p> -298,215,550.57</p><p> investing 341,823,618.60 applicable Healthlong Biochemical</p><p> activities Technology Co., Ltd. in the</p><p> Annual Report 2022</p><p> previous period. The event is</p><p> not recognized in the current</p><p> period.</p><p> Mainly due to:</p><p> absorbing investment (equity</p><p> incentive expense for</p><p> restricted shares) is increased</p><p> by RMB165 million;</p><p> reclaiming borrowings is</p><p>Net cash flow decreased by RMB647million</p><p>from (RMB747million of fund</p><p> -65,251,320.73 489,615,295.96 -113.33</p><p>financing raised for the previous period</p><p>activities by issuing the "Proya</p><p> Convertible Bond");</p><p> financing activities is</p><p> increased by RMB43 million;</p><p> dividends, profits, or repay</p><p> interest is increased by</p><p> RMB28 million.</p><p>Cash received</p><p>from the sale</p><p>of goods and 7,088,465,997.21 38.17</p><p>the rendering</p><p>of services</p><p>Other cash</p><p> Mainly due to the increased</p><p>received</p><p> bank interest and government</p><p>related to 99,500,140.40 54,614,521.56 82.19</p><p> subsidies received in the</p><p>operating</p><p> current period.</p><p>activities</p><p>Cash paid for</p><p> Mainly due to the expanded</p><p>goods</p><p>purchased 2,241,842,834.78 38.69</p><p>and services</p><p> production.</p><p>received</p><p>Payments of Mainly due to the expanded</p><p>various types 660,096,624.31 432,668,333.55 52.56 sales scale and the improved</p><p>of taxes profitability of the Company.</p><p>Other cash Mainly due to the expanded</p><p>paid related to 1,864,985,801. sales scale and the increased</p><p>operating 02 payment for image promotion</p><p>activities expenses.</p><p> Annual Report 2022</p><p> Net cash</p><p> received from</p><p> disposal of Mainly due to the increased</p><p> fixed assets, cash receipts from disposals</p><p> intangible of fixed assets in the current</p><p> assets and period</p><p> other long-</p><p> term assets</p><p> Mainly due to the new equity</p><p> investment of RMB90 million</p><p> Cash paid for</p><p> investments</p><p> Holdings Co., Ltd. in the</p><p> current period.</p><p> Mainly due to the disposal of</p><p> equity in Shanghai Healthlong</p><p> Biochemical Technology Co.,</p><p> Other cash</p><p> Ltd. and payment of other</p><p> paid related to</p><p> investing</p><p> investment activities in the</p><p> activities</p><p> previous period. The event is</p><p> not recognized for the current</p><p> period.</p><p> Mainly due to the receipt of</p><p> payment for the equity</p><p> Cash received</p><p> incentive expense for</p><p> from capital 165,676,000.00 700,000.00 23,568.00</p><p> restricted shares from</p><p> contributions</p><p> employees in the current</p><p> period.</p><p> Mainly due to the issuance of</p><p> “Proya Convertible Bond” in</p><p> Cash received</p><p> the previous period for</p><p> from 300,000,000.00 946,996,018.87 -68.32</p><p> RMB747 million. This event</p><p> borrowings</p><p> is not recognized in the</p><p> current period.</p><p> Mainly due to the payment for</p><p> Other cash</p><p> acquisition of minority equity</p><p> paid related to</p><p> financing</p><p> Cosmetics Co., Ltd. in the</p><p> activities</p><p> current period.</p><p>(II) Description on significant changes in profit caused by non-primary business activities</p><p>□ Applicable √ Not applicable</p><p>(III) Analysis of assets and liabilities</p><p>√ Applicable □ Not applicable</p><p> Annual Report 2022</p><p> Unit: RMB</p><p> Amount as</p><p> Amount as</p><p> of the end in total in total YOY</p><p> of the end of</p><p> Item of the assets assets change Description</p><p> the previous</p><p> current (%) (%) ratio (%)</p><p> period</p><p> period</p><p> Mainly due to</p><p> increased cash</p><p> Cash and cash 3,161,003, 2,391,048,24</p><p> equivalents 085.05 9.81</p><p> operating activities</p><p> in the current period.</p><p> Mainly due to the</p><p> reduced balance of</p><p> Receivable</p><p> financing</p><p> bills as of the end of</p><p> the current period.</p><p> Mainly due to the</p><p> increased</p><p> prepayment for</p><p> Prepayments 1.58 1.26 56.63 image promotion</p><p> .15 1</p><p> expenses as of the</p><p> end of the current</p><p> period.</p><p> Mainly due to the</p><p> increased stock</p><p> quantity for 1Q2023</p><p> Inventories 11.58 9.67 49.36 arising from the</p><p> expanded sales</p><p> scope of the</p><p> Company.</p><p> Mainly due to the</p><p> new equity</p><p> Other equity investment of</p><p> instrument 2.53 1.22 159.57 RMB90 million to</p><p> investments Hangzhou Gaolang</p><p> Holdings Co., Ltd.</p><p> in the current period.</p><p> Mainly due to the</p><p> additional</p><p> investment in the</p><p> Construction 207,378,93 108,678,896.</p><p> in progress 5.86 27</p><p> Production Base</p><p> Construction Project</p><p> (Phase I) and the</p><p> Annual Report 2022</p><p> Amount as</p><p> Amount as</p><p> of the end in total in total YOY</p><p> of the end of</p><p> Item of the assets assets change Description</p><p> the previous</p><p> current (%) (%) ratio (%)</p><p> period</p><p> period</p><p> Longwu R&D</p><p> Center Construction</p><p> Project.</p><p> Mainly due to the</p><p> addition of an office</p><p>Right-of-use 6,410,634. Not</p><p>assets 25 applicable</p><p> of lease contracts in</p><p> the current period.</p><p>Long-term Mainly due to the</p><p>prepaid 0.33 0.64 -35.67 amortization of</p><p> .46 1</p><p>expenses renovation costs.</p><p> Mainly due to that</p><p> the trademark</p><p> amount of</p><p> RMB39.90 million</p><p> (SINGULADERM)</p><p> in the beginning</p><p>Other non- 5,554,726. 44,167,303.5</p><p>current assets 06 6</p><p> transferred to</p><p> intangible assets</p><p> since the trademark</p><p> transfer registration</p><p> is completed in the</p><p> current period.</p><p> Mainly due to the</p><p> increase of the</p><p>Contract 174,602,83 91,151,985.3</p><p>liabilities 3.91 2</p><p> and the point</p><p> conversion rate.</p><p> Mainly due to the</p><p> increased benefits</p><p> payable to</p><p> employees at the</p><p>Employee</p><p>compensation 2.16 1.70 58.86</p><p>payable</p><p> expanded operation</p><p> scale and continuous</p><p> staffing adjustment</p><p> in the current period.</p><p>Taxes 152,918,87 2.65 99,893,176.9 2.16 53.08 Mainly due to the</p><p> Annual Report 2022</p><p> Amount as</p><p> Amount as</p><p> of the end in total in total YOY</p><p> of the end of</p><p> Item of the assets assets change Description</p><p> the previous</p><p> current (%) (%) ratio (%)</p><p> period</p><p> period</p><p>payable 1.45 7 expanded sales scale</p><p> and the improved</p><p> profitability of the</p><p> Company.</p><p> Mainly due to</p><p> increased restricted</p><p>Other 216,392,18 62,162,153.5</p><p>payables 3.41 5</p><p> obligations at the</p><p> end of the period.</p><p>Non-current Mainly due to the</p><p>liabilities due 2,549,452. Not transfer of lease</p><p>within one 14 applicable liabilities due within</p><p>year one year.</p><p> Mainly due to the</p><p> addition of an office</p><p>Lease 3,718,119. Not</p><p>liabilities 41 applicable</p><p> of lease contracts in</p><p> the current period.</p><p> Mainly due to the</p><p> adjustment of</p><p> offline channels, the</p><p> intensified</p><p> adjustment of the</p><p> department store</p><p>Estimated 59,282,928 10,812,084.8</p><p>liabilities .68 8</p><p> optimization of</p><p> household</p><p> chemicals outlets,</p><p> and the shrinking of</p><p> the supermarket</p><p> channel.</p><p> Mainly due to the</p><p> increased deferred</p><p>Deferred income tax</p><p>income tax 0.33 8,408,158.81 0.18 126.20 liabilities accrued</p><p> .67</p><p>liabilities for one-time</p><p> depreciation of fixed</p><p> assets.</p><p>Share capital 4.91 4.34 41.05</p><p> Annual Report 2022</p><p> Amount as</p><p> Amount as</p><p> of the end in total in total YOY</p><p> of the end of</p><p> Item of the assets assets change Description</p><p> the previous</p><p> current (%) (%) ratio (%)</p><p> period</p><p> period</p><p> implemented the</p><p> plan for the</p><p> capitalization of</p><p> capital reserves and</p><p> the 2022 restricted</p><p> share incentive plan.</p><p> Mainly due to that</p><p> the Company</p><p> implemented the</p><p> incentive plan,</p><p>Treasury 164,976,00</p><p>stock 0.00</p><p> liabilities for</p><p> repurchase</p><p> obligations and</p><p> included them in the</p><p> treasury stock.</p><p> Mainly due to the</p><p> changes in</p><p>Other - translation</p><p> - Not</p><p>comprehensiv 1,918,603. -0.03 -0.03 difference of</p><p>e income 07 financial statements</p><p> denominated in</p><p> foreign currencies.</p><p> Mainly due to the</p><p> withdrawal of</p><p> statutory surplus</p><p> reserve according to</p><p> the net profit of the</p><p> parent company.</p><p>Surplus 141,759,73 100,634,780. The statutory</p><p>reserve 4.50 00 surplus reserve does</p><p> not need to be</p><p> withdrawn if the</p><p> cumulative amount</p><p> reaches fifty percent</p><p> or more of the</p><p> registered capital.</p><p>Retained 2,300,384, 1,696,978,06 Mainly due to</p><p>profits 763.19 4.52 increased net profit</p><p> Annual Report 2022</p><p> Amount as</p><p> Amount as</p><p> of the end in total in total YOY</p><p> of the end of</p><p> Item of the assets assets change Description</p><p> the previous</p><p> current (%) (%) ratio (%)</p><p> period</p><p> period</p><p> in the current period.</p><p>Other explanations</p><p>None</p><p>√ Applicable □ Not applicable</p><p>(1) Scale of assets</p><p>Including RMB216.10million of overseas assets, accounting for 3.74% of the total assets.</p><p>(2) Description of a high percentage of overseas assets</p><p>□ Applicable √ Not applicable</p><p>√ Applicable □ Not applicable</p><p> Unit: RMB</p><p> Item Ending book value Cause for restrictions</p><p> Cash and cash Including transformer deposit, Pinduoduo deposit,</p><p> equivalents L/C deposit, Tmall deposit, and Alipay deposit, etc.</p><p> Total 35,670,000.00</p><p>□ Applicable √ Not applicable</p><p>(IV) Analysis of industry operational information</p><p>√ Applicable □ Not applicable</p><p>Refer to the "Analysis of chemical operational information" below</p><p> Annual Report 2022</p><p>Analysis of chemical operational information</p><p>(1).Industry policies and changes</p><p>□ Applicable √ Not applicable</p><p>(2).Major sub-industries and industrial status of the Company</p><p>√ Applicable □ Not applicable</p><p>See the description in "(I) Industry pattern and trends", "VI. Discussion and Analysis of the Company"s</p><p>Future Development", "Section III Management Discussion and Analysis".</p><p>Industrial status of the Company:</p><p>According to comprehensive industry data analysis, the Company has gained some market share in the</p><p>domestic cosmetics market.</p><p>(1). Major business models</p><p>√ Applicable □ Not applicable</p><p>See the description of business models in "III. Business Activities Carried out by the Company during the</p><p>Reporting Period", "Section III Management Discussion and Analysis".</p><p>Adjusted business models during the Reporting Period</p><p>□ Applicable √ Not applicable</p><p>(2). Major products</p><p>√ Applicable □ Not applicable</p><p> Major upstream raw Major downstream Major price</p><p> Products Sub-industry</p><p> materials application areas influencing factors</p><p> Humectant, active</p><p> Personal income,</p><p>Skincare substance, grease</p><p> skin type, lifestyle</p><p>(including Skincare wax, emulsifier, Skincare, cleansing</p><p> habits, brand</p><p>cleansing) surfactant, essence,</p><p> preference</p><p> packaging</p><p> Grease wax, Personal income,</p><p>Make-up Make-up, beauty,</p><p> Make-up emulsifier, toner, living habits, brand</p><p>cosmetics contour</p><p> essence, packaging preference</p><p> Personal income,</p><p> Surfactant,</p><p> skin type, lifestyle</p><p>Body & hair Body & hair humectant, essence, Body & hair</p><p> habits, brand</p><p> packaging</p><p> preference</p><p>(3). R&D innovation</p><p>√ Applicable □ Not applicable</p><p>See "5. New R&D strategy", "V. Main Operations during the Reporting Period", "Section III Management</p><p>Discussion and Analysis".</p><p> Annual Report 2022</p><p>(4). Production technologies and process</p><p>√ Applicable □ Not applicable</p><p>The Company"s products are mainly divided into skincare (including cleansing) and make-up cosmetics.</p><p>Their production processes are shown as follows:</p><p> Skincare raw Functional</p><p> materials components</p><p> Heat</p><p> Heating to Homogeneous preservation Cooling Filtration and</p><p> dissolve emulsification and mixing discharge</p><p> Inspection</p><p> of semi-</p><p> finished</p><p> products</p><p> Warehousing Cartoning Packing Filling Storage</p><p> Inspection of</p><p> finished products</p><p> Cleansing</p><p> raw materials</p><p> Heat</p><p> Heating and preservation Cooling Filtration and</p><p> mixing and mixing discharge</p><p> Inspection</p><p> of semi-</p><p> finished</p><p> products</p><p> Warehousing Cartoning Packing Filling Storage</p><p> Inspection of</p><p> finished products</p><p> (1) Cosmetic powder blocks:</p><p> Annual Report 2022</p><p> Powder raw Functional Inspection of</p><p> materials components semi-finished</p><p> products</p><p> Mixing Toning Crushing and Discharge Powder storage</p><p> sieving</p><p> Warehousing Cartoning Packing Forming Filling</p><p> Aluminum plate</p><p> Inspection of Visual</p><p> finished inspection</p><p> products</p><p> (2) Lipstick cosmetics</p><p> Wax-based Functional</p><p> raw materials components</p><p> Heating to Toning Defoaming Filtration and</p><p> dissolve discharge</p><p> Inspection</p><p> of semi-</p><p> finished</p><p> products</p><p> Warehousing Cartoning Packing Molding Storage</p><p> Inspection of Visual</p><p> finished inspection</p><p> products</p><p> (3) Eyelashes and eyeliners</p><p> Basic raw Functional</p><p> materials components</p><p> Heating to Homogeneous Toning Cooling Discharge</p><p> dissolve emulsification Inspection</p><p> of semi-</p><p> finished</p><p> products</p><p> Warehousing Cartoning Packing Filling Storage</p><p> Inspection of</p><p> finished</p><p> products</p><p>(5). Production capacity and operation status</p><p>√ Applicable □ Not applicable</p><p> Unit: RMB ’0,000 Currency: RMB</p><p> Annual Report 2022</p><p> Amount of Estimated time</p><p> Capacity Capacity investment in of completion</p><p> Main plant or Designed</p><p> utilization under capacity of capacity</p><p> project capacity</p><p> ratio (%) construction under under</p><p> construction construction</p><p> Huzhou Skincare 300million 86.67 101.18 16,801.64 December 2024</p><p> Factory pcs million pcs</p><p> Huzhou 40 million pcs 25.06</p><p> Cosmetics</p><p> Factory</p><p>Change in production capacity</p><p>□ Applicable √ Not applicable</p><p>Adjustment of product line and optimization of capacity structure</p><p>□ Applicable √ Not applicable</p><p>Unexpected shutdown</p><p>□ Applicable √ Not applicable</p><p>(1). Basic information on major raw materials</p><p>√ Applicable □ Not applicable</p><p> YOY price</p><p> Major raw Settlement Purchase</p><p> Purchase model change ratio Consumption</p><p> materials method quantity</p><p> (%)</p><p> Mainly by</p><p> Settle</p><p> competitive</p><p> within the About 1,560</p><p> Packaging procurement, About 1,510</p><p> payment -14.77 million</p><p> materials except for some million pieces</p><p> period as pieces</p><p> strategic</p><p> agreed</p><p> suppliers</p><p> Mainly by</p><p> competitive</p><p> procurement,</p><p> while Settle</p><p> establishing within the</p><p> Raw About 2,052 About 1,953</p><p> long-term payment 5.31</p><p> material_humectant tons tons</p><p> strategic period as</p><p> cooperation agreed</p><p> with</p><p> advantageous</p><p> suppliers</p><p> Raw Mainly by price Settle About 754 About 720</p><p> material_active inquiry and within the tons tons</p><p> Annual Report 2022</p><p> substance comparison, payment</p><p> while period as</p><p> performing agreed</p><p> diversified</p><p> cultivation of</p><p> suppliers with a</p><p> single source of</p><p> supply</p><p> Mainly by</p><p> competitive</p><p> procurement,</p><p> while Settle</p><p> Raw establishing within the</p><p> About 850 About 810</p><p> material_grease long-term payment 24.62</p><p> tons tons</p><p> wax strategic period as</p><p> cooperation agreed</p><p> with</p><p> advantageous</p><p> suppliers</p><p> Mainly by</p><p> competitive</p><p> procurement,</p><p> Settle</p><p> while</p><p> within the</p><p> Raw cooperating About 160 About 150</p><p> payment 31.46</p><p> material_emulsifier with industry- tons tons</p><p> period as</p><p> leading</p><p> agreed</p><p> suppliers on</p><p> some raw</p><p> materials</p><p> Mainly by</p><p> competitive</p><p> procurement,</p><p> while Settle</p><p> establishing within the</p><p> Raw About 102</p><p> long-term payment 2.89 About 92 tons</p><p> material_sunscreen tons</p><p> strategic period as</p><p> cooperation agreed</p><p> with</p><p> advantageous</p><p> suppliers</p><p>Impact of changes in the prices of major raw materials on the Company"s operating costs: Rising prices of</p><p>raw materials increase operating costs.</p><p>(2). Basic information on major sources of energy</p><p>√ Applicable □ Not applicable</p><p> Annual Report 2022</p><p> YOY price</p><p> Purchase Settlement Purchase</p><p> Major energy change ratio Consumption</p><p> model method quantity</p><p> (%)</p><p> Prepayment and</p><p> monthly</p><p> Fixed settlement or</p><p> agreement with payment on</p><p> Water 0.00 201,279 tons 201,279 tons</p><p> the local water demand</p><p> company according to the</p><p> local</p><p> requirements</p><p> Prepayment and</p><p> monthly</p><p> Fixed</p><p> settlement or</p><p> agreement with</p><p> payment on 11.76 million 11.76 million</p><p> Electricity the local power 0.00</p><p> demand kwh kwh</p><p> supply</p><p> according to the</p><p> company</p><p> local</p><p> requirements</p><p> Prepayment and</p><p> monthly</p><p> Fixed</p><p> settlement or</p><p> agreement with</p><p> payment on</p><p> Gas the local gas 38.67 368,936 cbm 368,936 cbm</p><p> demand</p><p> supply</p><p> according to the</p><p> company</p><p> local</p><p> requirements</p><p>Impact of changes in the prices of major energy on the Company"s operating costs: The price of gas is</p><p>increased by 38.67%, resulting in a slight increase in operating cost since the consumption of gas only</p><p>takes up a small part in the energy structure.</p><p>(3). Countermeasures for risks of fluctuations in the prices of raw materials</p><p>Major financial products such as derivatives</p><p>□ Applicable √ Not applicable</p><p>(4). Basic information on other methods adopted such as staged reserves</p><p>□ Applicable √ Not applicable</p><p>(1). Basic information on the Company"s primary business activities by sub-industry</p><p>√ Applicable □ Not applicable</p><p> Unit: RMB ’0,000 Currency: RMB</p><p> Change Gross profit</p><p> Sub- Operating Operating Gross Change in Change in</p><p> in gross margin for</p><p> industry revenue cost profit operating operating</p><p> profit products in</p><p> Annual Report 2022</p><p> margin revenue cost YOY margin the same</p><p> (%) YOY (%) (%) YOY (%) industry and</p><p> field</p><p> Skincare No public</p><p> (including 70.51 38.56 29.68 2.02 information</p><p> cleansing) available</p><p> No public</p><p> Make-up</p><p> cosmetics</p><p> available</p><p> No public</p><p> Body &</p><p> hair</p><p> available</p><p> No public</p><p> Others 0.00 0.00 - -100.00 -100.00 - information</p><p> available</p><p>(2). Basic information on the Company"s primary business activities by sales channel</p><p>√ Applicable □ Not applicable</p><p> Unit: RMB ’0,000 Currency: RMB</p><p> Change in operating revenue</p><p> Sales channel Operating revenue</p><p> YOY (%)</p><p> Online 578,803.44 47.50</p><p> Offline 57,372.91 -17.62</p><p>Statement of accounting policies</p><p>□ Applicable √ Not applicable</p><p>(1). Basic information on major work safety accidents of the Company during the Reporting Period</p><p>□ Applicable √ Not applicable</p><p>(2). Major environmental violations</p><p>□ Applicable √ Not applicable</p><p> Annual Report 2022</p><p>(V) Analysis of investment</p><p>Overall analysis of external equity investments</p><p>√ Applicable □ Not applicable</p><p> Ending amount Beginning amount</p><p> Item Impairment Impairment</p><p> Carrying amount Book value Carrying amount Book value</p><p> provision provision</p><p> Other equity instrument</p><p> investments</p><p> Investment in joint</p><p> ventures</p><p> Investment in associates 216,906,642.52 81,442,213.22 135,464,429.30 181,555,246.18 14,670,468.59 166,884,777.59</p><p> Total 366,377,990.68 81,442,213.22 284,935,777.46 241,032,404.86 14,670,468.59 226,361,936.27</p><p>For details, see the description in "17. Long-term equity investments" and "18. Other equity instrument investments ", "VII. Notes to the Items in Consolidated</p><p>Financial Statements", "Section X Financial Report" of this report.</p><p>□ Applicable √ Not applicable</p><p>□ Applicable √ Not applicable</p><p>√ Applicable □ Not applicable</p><p> Unit: Yuan Currency: RMB</p><p> Profit and loss Impairment</p><p> Beginning Accumulated Amount of Amount of</p><p> Asset category from changes accrued for the Other changes Ending amount</p><p> amount change in fair purchase for sale/redemption</p><p> in fair value current period</p><p> Annual Report 2022</p><p> for the current value included the current for the current</p><p> period in equities period period</p><p> Other 56,402,400.00 90,000,000.00 146,402,400.00</p><p> Total 56,402,400.00 90,000,000.00 146,402,400.00</p><p>For details, refer to the particulars contained in "18. Description of other equity instrument investments" in "VII. Notes to the Items of Consolidated Financial</p><p>Statements", of "Section X Financial Report" of this report</p><p>Description of securities investment</p><p>□ Applicable √ Not applicable</p><p>Description of private equity investment</p><p>□ Applicable √ Not applicable</p><p>Description of derivatives investment</p><p>□ Applicable √ Not applicable</p><p> Annual Report 2022</p><p>□ Applicable √ Not applicable</p><p>(VI) Sale of major assets and equity</p><p>□ Applicable √ Not applicable</p><p>(VII) Analysis of major holding companies</p><p>√ Applicable □ Not applicable</p><p> Unit: RMB’0,000</p><p> Major</p><p> Major Nature of products Registered Total Net Holding or</p><p> Net assets</p><p> subsidiary business and capital assets profit shareholding</p><p> services</p><p>Zhejiang</p><p>Meiligu</p><p> Cosmetics</p><p>Electronic Cosmetics 1,000.00 62,360.91 25,376.57 8,238.00 Holding</p><p> sales</p><p>Commerce</p><p>Co., Ltd.</p><p>Hangzhou</p><p>Proya Cosmetics -</p><p> Cosmetics 5,000.00 27,637.31 5,554.91 Holding</p><p>Trade Co., sales 5,333.47</p><p>Ltd.</p><p>(VIII) Structured entities controlled by the Company</p><p>□ Applicable √ Not applicable</p><p>VI. Discussion and Analysis of the Company"s Future Development</p><p>(I) Industry pattern and trends</p><p>√ Applicable □ Not applicable</p><p>According to statistics from the National Bureau of Statistics, in 2022, the total retail sales of consumer</p><p>goods reached RMB43,973.3 billion, down by 0.2% YOY; the total retail sales of cosmetics reached</p><p>RMB393.6 billion, down by 4.5% YOY (covering consumer goods above designated units).</p><p>(II) Development strategy of the Company</p><p>√ Applicable □ Not applicable</p><p>Winning Now Winning Later, "6*N" strategy, enhanced core competence, and enriched brand matrix.</p><p>"6" represents new consumption, new marketing, new organization, new mechanism, new technology,</p><p>new intelligent manufacturing; "N" represents N brands created</p><p>(1) New consumption: Innovative services to meet more consumer needs and consumer value;</p><p>(2) New marketing: Digital marketing, fine omni-channel operation, and accurate and advanced consumer</p><p>insight. Focus on future marketing possibilities in new areas and make preparations;</p><p>(3) New organization: An efficient organization that is flat, platform-based, self-driven and collaborative;</p><p>(4) New mechanism: A flexible, diversified, business-oriented incentive mechanism to be established;</p><p> Annual Report 2022</p><p>(5) New technology: The focus on basic scientific research and the actions taken to establish the presence</p><p>of new raw materials and new R&D technologies, develop more R&D partners and resources in different</p><p>fields to form a global R&D landscape, provide technological guarantee for targeted product enhancement,</p><p>and create a sustainable and unique R&D technological competitiveness; measures taken to further</p><p>improve the intelligent operation management system and carry out targeted transformation toward digital</p><p>intelligence and informatization to improve operational refinement and management efficiency in business</p><p>and organization and achieve process transparency and accurate decision-making;</p><p>(6) New intelligent manufacturing: Creation of an agile and flexible supply chain to serve the hero product</p><p>matrix and the application of the digital management system to improve production quality, strengthen the</p><p>supply chain supervision, and guarantee product quality.</p><p>- The core connotation of "6*N" is to enable or incubate different brands that meet different needs of</p><p>different consumers based on the above six capabilities.</p><p>While Proya, as the main brand, maintains rapid and steady development, the Company creates, replicates,</p><p>enables and incubates different brands to meet the different needs of different consumers based on the</p><p>successful experience and core competence, enlarges the customer base, extends the demand coverage of</p><p>the life cycle of customers, gradually builds and improves the multi-brand matrix, and achieves long-term</p><p>sustainable growth.</p><p>(III) Business plan</p><p>√ Applicable □ Not applicable</p><p>I. Construction of a multi-category and multi-brand matrix</p><p>Proya:</p><p>(1) Brand: Better establish the brand awareness of "A Scientific Choice for Skin" by more scientific</p><p>product portfolios, better and more delicate product experiences, and the output of the reasonable concept</p><p>of skincare, thus taking the brand to a new level. Maintain outstanding products as the core driver of the</p><p>brand, and make satisfactory services and experiences consumers" reason for choice. Dig deeper into the</p><p>brand"s insistence on products and belief in scientific formula, communicate with consumers in an all-</p><p>around manner, deliver needed products and great experiences to consumers, and make Proya a leader in</p><p>the era of "home-made products".</p><p>(2) Product: Better upgrade the product in formula, efficacy, design, and use experiences around the core</p><p>mid-end product line, consolidate the status of hero products; better divide the needs of users with different</p><p>skin types, reserve richer and more detailed efficacy and categories, and expand the coverage to more</p><p>consumers to satisfy their needs for skin care.</p><p>(3) Marketing: 1) In 2023, Proya will keep carving the brand by taking "exploration and discovery" as</p><p>the core, continuously express our opinions in gender equality, family responsibility, intimate relationships,</p><p>young people"s growth, mental health, and other socially important issues, so as to expand the impact of</p><p>brand long-termism beyond brand incidents. 2) Based on the brand identity of the year, Proya will build</p><p>its own online public welfare platform to carry long-term public welfare actions and content under the</p><p>brand"s core projects and extend care of the brand.</p><p>(4) Channel:</p><p>products, penetrate into the market of the essence category as the core of the brand, enhance the penetration</p><p>of face cream, face mask, facial care kits, and other core categories, further improve the proportion of</p><p>high-value users, better refine the operation, improve services, and lift the brand mindset.</p><p> Annual Report 2022</p><p>achieve integrated operation of brand recommendation and purchase, improve the overall operation</p><p>efficiency, establish presence in the shelf e-commerce on TikTok, better work with high-quality KOLs,</p><p>and achieve diversified and healthy brand development in TikTok.</p><p>cooperation to realize resonance inside and outside the site; change to user-based operation for the</p><p>membership section with the focus on improving service level and user experiences and maintaining user</p><p>loyalty; continuously strengthen the refined operation of all traffic channels.</p><p>products and primarily aim at the direction of basic moisturizing and anti-aging products; beef up the</p><p>digitalization capability to empower offline sales, improve product turnover rate, and raise the satisfaction</p><p>of channel customers. Department stores: Focus on influential business district and large department store</p><p>groups, explore the new "online+offline" sales mode, and increase the repurchase rate and per customer</p><p>transaction.</p><p>Hapsode:</p><p>(1) Brand: Continuously consolidate the strategy of hero cleansing products, take the existing advantage</p><p>in the oil remover category, expand the customer base of Hapsode, and increase brand penetration in the</p><p>young population.</p><p>(2) Product: Complete the layout of the full cleansing product line based on Hapsode"s pyramid-typed</p><p>product system for oily skin. Keep improving the product efficacy of oil control in 2023 as the core</p><p>competitiveness of an oily skin care brand; create the product combo for oily and sensitive skin for the</p><p>soothing product line around the Ultra Soothing Facial Mask and the Ultra Soothing Serum.</p><p>(3) Marketing: Keep focusing on college students as the core target consumers and carry out serial brand</p><p>events to deliver Hapsode"s young and dynamic brand image.</p><p>(4) Channel: Focus on TikTok and Tmall and put more efforts on self live-streaming.</p><p>(1) Brand: Focus on building a professional brand of "Chinese make-up" around the brand core of</p><p>"Chinese make-up, original beauty" to deliver "original beauty" experiences to consumers. Consolidate</p><p>brand professionalism with marketing content, improve brand services by seeing through the target</p><p>customer group, and enhance the brand"s sense of value by innovating in brand peripherals and gifts.</p><p>(2) Product: Further expand the "Contour Line" advantages and keep increasing the brand penetration.</p><p>Continue to establish presence in the large make-up base category, reserve sub-categories such as liquid</p><p>foundation, cream foundation, cushion, and powder & pact, complete the make-up base mindset, and</p><p>create a "professional" brand image.</p><p>(3) Marketing: Carry out content marketing around new product launch, festival topics, and IP</p><p>cooperation.</p><p>(4) Channel: Focus on Tmall and TikTok.</p><p>(1) Brand: Establish the brand image of a scalp health expert from Japan, stabilize the product strength,</p><p>and strengthen the core brand efficacy as "a scalp health solution", allowing core consumers to recognize</p><p>the brand values of OR.</p><p>(2) Product: Further bring together international R&D capabilities and complete the global supply chain</p><p>system. Rely on Japan"s leading fundamental research and technological development advantages to erect</p><p> Annual Report 2022</p><p>a technological barrier and offer consumers a complete scalp health solution. Make further presence in the</p><p>scalp solution market, upgrade hair masks, hair care essence oil, and other hair care products, and create</p><p>a new flagship product line.</p><p>(3) Marketing: Output the brand personality and accumulate brand assets by communicating OR"s brand</p><p>trait as a "professional scalp health care expert". Launch product marketing based on the core mindset of</p><p>a top Japanese brand and a scalp health expert, allow consumers to better understand the conditions of</p><p>their scalp, and help them build up the basic scalp health knowledge base; continue with the "tiny but</p><p>beautiful" brand marketing, advocate a lifestyle from scalp health to mental and physical health, penetrate</p><p>into the core population, and enhance the brand likability among target consumers.</p><p>(4) Channel: Focus on Tmall (Tmall Global, Tmall Flagship Store) and TikTok in the Chinese Mainland;</p><p>make more breakthroughs in physical stores in Japan while increasing the online traffic.</p><p>II. R&D construction</p><p>In 2023, the Company will keep adopting the internationalization strategy, complete and upgrade the</p><p>research and development system, introduce high-level and cross-discipline talents with a global vision</p><p>covering chemistry, chemical engineering, pharmacology, dermatology, statistics, and computational</p><p>biology; establish research and development laboratories at home and abroad based on R&D advantages</p><p>in all regions across the globe. While completing the system of consumer and technology insight,</p><p>technology development, raw material development, formula, product development, and efficacy</p><p>evaluation, the Company also strengthens strategic partnerships with globally-leading research institutions</p><p>specializing in biotechnologies, life sciences, cytology, and dermatology.</p><p>(1) Fundamental research: Continue to plan for the development pipeline of new technologies and new</p><p>raw materials, and develop advanced enabling technologies in computational biology, genomics, and</p><p>proteomics.</p><p>(2) Applied research: Guided by market demand, develop skin care and make-up products of various levels</p><p>with obvious efficacy, great skin feel and favorable costs, and complete the technological layout for future</p><p>iterations of all hero products.</p><p>(3) Clinical research: Continue with the clinical research and verification of products, explore new</p><p>methods to verify the efficacy of raw materials and products, and develop new efficacy testing methods</p><p>by using advanced instruments and statistics.</p><p>(IV) Possible risks</p><p>√ Applicable □ Not applicable</p><p>(1) The Company"s brand strategy and channel strategy fail to come up to expectations due to intensified</p><p>competition from various brands in the industry;</p><p>(2) The control of digital and precise delivery costs fails to come up to expectations due to intensified</p><p>competition in marketing and ads delivery.</p><p>(1) New brand incubation risk: Performance fails to come up to expectations despite big investment in</p><p>marketing;</p><p>(2) New category cultivation risk: Performance fails to come up to expectations due to different operation</p><p>modes for different categories and the incompetent team.</p><p> Annual Report 2022</p><p>(V) Other</p><p>□ Applicable √ Not applicable</p><p>VII. Circumstances Where the Company Fails to Disclose Due to Non-applicability or Special</p><p> Reasons Such as State Secrets and Trade Secrets and Statement of Reasons</p><p>□ Applicable √ Not applicable</p><p> Section IVCorporate Governance</p><p>I. Description of Corporate Governance</p><p>√ Applicable □ Not applicable</p><p>During the Reporting Period, the Company continuously improved its standard operation and corporate</p><p>governance structure based on the actual situation pursuant to applicable laws and regulations, including</p><p>the Company Law, the Securities Law, the Listing Rules of the Shanghai Stock Exchange and the Code of</p><p>Corporate Governance of Listed Companies as well as the Articles of Association. The Company has set</p><p>up the general meeting of shareholders, Board of Directors, Board of Supervisors and special committees</p><p>under the Board of Directors as required and developed corresponding rules of procedure. Such rules</p><p>define the duties, powers, procedures and obligations of organizations at all levels in terms of decision-</p><p>making, supervision and implementation. They form a scientific and effective governance structure</p><p>featuring clear rights and responsibilities, mutual checks and balances, and mutual coordination. During</p><p>the Reporting Period, the Company consciously fulfilled the obligation for information disclosure,</p><p>managed investor relationships, and promoted the Company to continuously improve its standard</p><p>operation. The corporate governance status complies with the requirements of the normative documents</p><p>on the governance of listed companies issued by the CSRC.</p><p>Whether there are significant differences between the Company"s corporate governance and the</p><p>requirements of laws, administrative regulations and CSRC"s regulations on the governance of listed</p><p>companies; if so, explain the reasons.</p><p>□ Applicable √ Not applicable</p><p>II. Specific measures taken by the Company"s controlling shareholders and actual controllers to</p><p> ensure the Company"s independence in assets, personnel, finance, organization and business</p><p> activities as well as solutions, work progress and subsequent work plans taken due to influence</p><p> on the Company"s independence</p><p>□ Applicable √ Not applicable</p><p>Circumstances where any controlling shareholders, actual controllers and other entities under their control</p><p>engage in the same or similar business activities, as well as the impact of horizontal competition or major</p><p>changes in horizontal competition on the Company, resolutions taken, progress and follow-up resolutions</p><p>□ Applicable √ Not applicable</p><p> Annual Report 2022</p><p>III. Meetings of the General Meeting of Shareholders during the Reporting Period</p><p> Session Date Reference Date of release Resolution</p><p> The meeting approved proposals</p><p> including the Company"s Annual</p><p> Report 2021 and its Summary, and</p><p> the Plan for Annual Profit</p><p> Distribution and Capitalization of</p><p> Capital Reserves for 2021. For</p><p> General May 12, 2022-027 on SSE</p><p> May 13, 2022 details, see the Announcement on</p><p> Meeting of 2022 website</p><p> Resolutions of the 2021 Annual</p><p> Shareholders (www.sse.com.cn)</p><p> General Meeting of Shareholders</p><p> (No.: 2022-027) released on the</p><p> SSE website on May 13, 2022</p><p> (http://www.sse.com.cn) and</p><p> relevant media.</p><p> The meeting approved proposals</p><p> including the Proposal on 2022</p><p> Restricted Share Incentive Plan of</p><p> the Company (Draft) and Its</p><p> Summary, and the Proposal on</p><p> Extraordinary Announcement No. Management Method for the 2022</p><p> General July 25, 2022-041 on SSE Restricted Share Incentive Plan.</p><p> July 26, 2022</p><p> Meeting of 2022 website For details, see the Announcement</p><p> Shareholders (www.sse.com.cn) on Resolutions of the 2022 First</p><p> in 2022 Extraordinary General Meeting of</p><p> Shareholders (No.: 2022-041)</p><p> released on the SSE website on</p><p> July 26, 2022</p><p> (http://www.sse.com.cn) and</p><p> relevant media.</p><p>Request of preferred shareholders with restored voting rights for convening an extraordinary general</p><p>meeting</p><p>□ Applicable √ Not applicable</p><p>Description of the General Meeting of Shareholders</p><p>□ Applicable √ Not applicable</p><p> Annual Report 2022</p><p>IV. Directors, Supervisors and Senior Management</p><p>(I) Changes in shareholding and remuneration of current and resigned directors, supervisors and senior management during the Reporting Period</p><p>√ Applicable □ Not applicable</p><p> Unit: share</p><p> Total pre-tax</p><p> remuneration Any</p><p> Number of</p><p> Number of Change in received from remuneration</p><p> shares held</p><p> Position Term start Term end shares held shares Cause for the Company from the</p><p> Name Gender Age at the</p><p> (Note) date date at the end of during the change during the Company"s</p><p> beginning of</p><p> the year year Reporting related</p><p> the year</p><p> Period parties</p><p> (RMB’0,000)</p><p> Shares</p><p> Chairman of</p><p> HOU converted</p><p> the Board of Male 59 7/30/2015 9/8/2024 69,764,815 97,670,741 27,905,926 162.94 No</p><p>Juncheng from capital</p><p> Directors</p><p> reserve</p><p> Shares</p><p> converted</p><p> from capital</p><p> Director,</p><p> FANG reserve and</p><p> General Male 54 7/30/2015 9/8/2024 36,347,843 45,772,470 9,424,627 162.94 No</p><p> Yuyou shares</p><p> Manager</p><p> reduced for</p><p> personal</p><p> capital need</p><p> HOU</p><p> Director Male 35 9/9/2021 9/8/2024 0 0 0 48.06 No</p><p> Yameng</p><p> HOU Deputy</p><p> Male 35 9/15/2021 9/8/2024 0 0 0 0.00 No</p><p> Yameng General</p><p> Annual Report 2022</p><p> Manager</p><p> MA Independent</p><p> Male 53 5/13/2021 9/8/2024 0 0 0 15.00 No</p><p>Dongming Director</p><p> GE Independent</p><p> Male 48 9/9/2021 9/8/2024 0 0 0 15.00 No</p><p> Weijun Director</p><p> HOU</p><p> Supervisor Female 34 5/2/2018 9/8/2024 0 0 0 22.28 No</p><p> Luting</p><p> FANG</p><p> Supervisor Female 33 5/8/2018 9/8/2024 0 0 0 32.02 No</p><p> Qin</p><p> HU Lina Supervisor Female 35 9/9/2021 9/8/2024 0 0 0 17.19 No</p><p> Shares</p><p> converted</p><p> from capital</p><p> Deputy reserve and</p><p> JIN</p><p> General Male 61 4/16/2018 9/14/2024 54,981 216,973 161,992 grant of 70.79 No</p><p> Yanhua</p><p> Manager 2022</p><p> restricted</p><p> stock</p><p> incentive</p><p> Shares</p><p> converted</p><p> from capital</p><p> reserve and</p><p>WANG Li CFO Female 45 9/3/2018 9/14/2024 32,322 225,251 192,929 grant of 120.17 No</p><p> restricted</p><p> stock</p><p> incentive</p><p> Annual Report 2022</p><p> Deputy</p><p> General</p><p> Manager,</p><p>WANG Li Female 45 9/15/2021 9/14/2024 0 0 0 0.00 No</p><p> Secretary of</p><p> the Board of</p><p> Directors</p><p> Total / / / / / 106,199,961 143,885,435 37,685,474 / 666.40 /</p><p>Notes:</p><p>The total pre-tax remuneration received by the above directors, supervisors and the senior management from the Company during the Reporting Period is the total</p><p>pre-tax remuneration during their term of office in the Reporting Period.</p><p> Name Working experience</p><p> He once worked in Yiwu Liaoyuan Daily Chemical Co., Ltd., Hangzhou Proya Cosmetics Co., Ltd., and Hangzhou Proya Holding Co., Ltd. Since</p><p> August 2012, he has served as Chairman of the Company and its predecessor. As of the end of the Reporting Period, he concurrently served as</p><p> Executive Director and General Manager of Proya Trade, Executive Director of Meiligu, Executive Director of Chuangdai Electronics, Executive</p><p> Director of Yueqing Laiya, Inside Director and Representative Director of Korea Hanna, Executive Director and General Manager of Hapsode</p><p> HOU</p><p> (Hangzhou), Executive Director and General Manager of Huzhou Hapsode, Executive Director and General Manager of Danyang Hapsode,</p><p> Juncheng</p><p> Executive Director and General Manager of Mijing Siyu (Hangzhou), Executive Director and General Manager of Huzhou Younimi, Executive</p><p> Director of Proya (Hainan), Executive Director of Proya (Zhejiang), Chairman and General Manager of Hangzhou Kunyi Industrial Co., Ltd.,</p><p> Chairman of CBIC, Executive Director and General Manager of Huzhou Beauty Town Technology Incubation Park Co., Ltd., Director of Xinjiang</p><p> Huanyu New Silk Road Investment Development Co., Ltd., Director of Yongxinou (Ningbo) International Trading Co., Ltd., and Executive</p><p> Director of Zhejiang Zhujin Enterprise Management Co., Ltd.</p><p> He once worked in Shijiazhuang Liaoyuan Cosmetics Co., Ltd., Hangzhou Proya Cosmetics Co., Ltd., and Hangzhou Proya Holdings Co., Ltd.</p><p> Since 2007, he has been working in the Company and its predecessor. Since August 2012, he has served as Director and General Manager of the</p><p> FANG Company and its predecessor. As of the end of the Reporting Period, he concurrently served as General Manager of Meiligu, General Manager of</p><p> Yuyou Yueqing Laiya, Inside Director of Korea Hanna, Director of Hongkong Xinghuo, Executive Director and General Manager of Hangzhou Fangxiake</p><p> Investment Co., Ltd., Director of Hangzhou Kunyi Industrial Co., Ltd., Director of Hangzhou Tairentang Biotechnology Co., Ltd., Supervisor of</p><p> Zhejiang Boweihui Grapevine Technology Co., Ltd., and Director of Jiangsu Lenong Weimei Agricultural Technology Development Co., Ltd.</p><p> Annual Report 2022</p><p> He once worked in the E-commerce Department of Proya Cosmetics Co., Ltd., and has served as Director and Deputy General Manager of the</p><p> HOU</p><p> Company since September 2021. As of the end of the Reporting Period, he concurrently served as Executive Director and General Manager of</p><p> Yameng</p><p> Hainan Mengya Enterprise Consulting Co., Ltd. and Executive Director and General Manager of Hangzhou TIMAGE.</p><p> He used to be Deputy Director and Director of CSRC Zhejiang Branch, Director of the Commissioner"s Office of CSRC Shanghai Branch, and</p><p> MA Deputy General Manager and Secretary of the Board of Directors of Yongan Futures Co., Ltd. Since May 2021, he has served as Independent</p><p>Dongming Director of the Company. As of the end of the Reporting Period, he concurrently served as Independent Director of Transwarp Technology</p><p> (Shanghai) Co., Ltd., Independent Director of Zhejiang Shuangyuan Technology Co., Ltd., and Independent Director of Merit Interactive Co., Ltd.</p><p> He once worked in Zhejiang Xingyun Law Firm and Xingyun Law Firm Shanghai Branch. From February 2006 to December 2021, he served as</p><p> Professor, Doctoral Supervisor, and Legal Adviser of Shanghai University of Finance and Economics. Since January 2022, he has served as a full-</p><p> time teacher (professor) at the Law School of Fudan University. Since September 2021, he has served as Independent Director of the Company.</p><p> He also serves as Arbitrator at the China International Economic and Trade Arbitration Commission, Arbitrator at the Shanghai International</p><p> Economic and Trade Arbitration Commission, Arbitrator at Shanghai Arbitration Commission ,Arbitrator at Shenzhen Court of International</p><p>GE Weijun</p><p> Arbitration, Executive Officer of the China Commercial Law Society, Vice President of the Commercial Research Branch of the Shanghai Judicial</p><p> Think Tank, Vice President of the Commercial Law Research Association of the Shanghai Law Society, Vice President of the Cultural Law</p><p> Research Association of the Shanghai Law Society, Independent Director of Shanghai Huace Navigation Technology Ltd., Independent Director</p><p> of Changzhou ECTEK Automotive Electronics System Co., Ltd., Independent Director of Hangzhou EZVIZ Network Co., Ltd. and Independent</p><p> Director of Zheshang Development Group Co., Ltd.</p><p> From July 2013 to January 2014, she served as an expatriate financial specialist at Zhonghui Accounting Firm. From February 2014 to June 2017,</p><p> she served as a packaging material procurement specialist at the Purchasing Department of the Company. From June 2017 to April 2019, she served</p><p>HOU Luting as a raw material procurement specialist at the Purchasing Department of the Company. From April 2019 to March 2021, she served as a raw</p><p> material evaluation engineer. From March 2021 to December 2022, she served as a deputy price review manager. From December 2022 to present,</p><p> she has served as a price review manager. Since May 2018, she has served as Supervisor of the Company.</p><p> From November 2008 to January 2018, she served as Director of the Planning Department of the Company and its predecessor. From January 2018</p><p>FANG Qin to July 2022, she served as Planning Strategy Manager of the Company. Since July 2022, she has served as Senior Planning Strategy Manager of</p><p> the Company. Since May 2018, she has served as Supervisor of the Company.</p><p> She once worked in Pan-China Certified Public Accountants (Special General Partnership), and has served as Strategy Supervisor at the Company</p><p> HU Lina</p><p> since 2013, and has served as Supervisor of the Company since September 2021.</p><p>JIN Yanhua He once worked in Zhejiang Sanmen Fertilizer Factory, Zhejiang InBev Yandangshan Beer Co., Ltd., Zhejiang InBev Jinhua Beer Co., Ltd.,</p><p> Annual Report 2022</p><p> Hangzhou Proya Cosmetics Co., Ltd., and Hangzhou Proya Holding Co., Ltd. From 2007 to August 2012, he served as General Manager of the</p><p> Huzhou Factory under the Company and its predecessor. Since August 2012, he has served as General Manager of the Company"s Supply Chain</p><p> Management Center; since April 2018, he has served as Deputy General Manager of the Company. As of the end of the Reporting Period, he</p><p> concurrently served as Executive Director of Hanya (Huzhou), Executive Director of Huzhou UZERO, Manager of Chuangdai Electronics,</p><p> Executive Director and General Manager of Proya Commercial, Executive Director and General Manager of Huzhou Niuke, Executive Director</p><p> and General Manager of Hangzhou Wanyan, Executive Director and General Manager of Zhejiang Beute, Executive Director of Shanghai</p><p> Zhongwen, Executive Director and General Manager of Ningbo Proya, Chairman of Ningbo Keshi, Chairman of Ningbo TIMAGE, Director of</p><p> Hong Kong Keshi, Director of Hong Kong Wanyan, Director of Hong Kong Zhongwen, Executive Director of Zhejiang Qingya, Executive Director</p><p> of Luxiaotie, Executive Director and General Manager of Hangzhou Yizhuo, Executive Director and General Manager of Hangzhou Weiluoke,</p><p> Executive Director and General Manager of Hangzhou Oumisi, Director of Japan OR, Executive Director and General Manager of Guangzhou</p><p> Qianxi, Director of Ningbo Xiyou Interactive Entertainment Culture Media Co., Ltd., General Manager of Proya (Hainan), Director of Korea</p><p> Hapsode, Executive Director and General Manager of Xuzhou Laibo, Executive Director and General Manager of Shenggelan (Hangzhou),</p><p> Chairman and General Manager of Ningbo Tangyu, Manager of Proya (Zhejiang), Executive Director and General Manager of Hangzhou Boxin,</p><p> Executive Director and General Manager of Huzhou Keyan Trading Co., Ltd.</p><p> She once served as CFO of Guangzhou Yingtai Digital Power Technology Co., Ltd., Financial Representative of US CELLSTAR (Phonest Star),</p><p> Financial Manager of Shanghai Ruili Sports Co., Ltd., Financial Director of Vgrass Fashion Co., Ltd., Financial Director of Zhuoshang Clothing</p><p> WANG Li (Hangzhou) Co., Ltd., and Financial Director of Jiangsu Sunport Power Corp., Ltd. Since April 2023, she has served as Independent Director of</p><p> Zhejiang Wazam New Materials Co., Ltd. She is currently Deputy General Manager, Secretary of the Board of Directors, and CFO of Proya</p><p> Cosmetics Co., Ltd.</p><p>Other explanations</p><p>□ Applicable √ Not applicable</p><p> Annual Report 2022</p><p>(II) Positions of current and resigned directors, supervisors and senior management during the</p><p> Reporting Period</p><p>√ Applicable □ Not applicable</p><p> Name of Name of shareholder Position held in</p><p> Term start date Term end date</p><p> employee entity shareholder entity</p><p> Peixian Deyi Network</p><p> JIN Yanhua Technology Partnership Executive Partner August 2019 February 2022</p><p> (Limited Partnership)</p><p> Description of None</p><p> position held in</p><p> shareholder</p><p> entities</p><p>Notes: Peixian Deyi Network Technology Partnership (Limited Partnership) was deregistered in February</p><p>√ Applicable □ Not applicable</p><p> Name of Position held in</p><p> Name of another entity Term start date Term end date</p><p> employee shareholder entity</p><p> Executive Director and</p><p> Proya Trade June 2011</p><p> General Manager</p><p> November</p><p> Meiligu Executive Director</p><p> December</p><p> Chuangdai Electronics Executive Director</p><p> September</p><p> Yueqing Laiya Executive Director</p><p> Inside Director and November</p><p> Korea Hanna</p><p> Representative Director 2011</p><p> Executive Director and</p><p> Hapsode (Hangzhou) February 2018</p><p> General Manager</p><p> HOU</p><p> Executive Director and</p><p> Juncheng Huzhou Hapsode May 2016</p><p> General Manager</p><p> Executive Director and December</p><p> Danyang Hapsode</p><p> General Manager 2016</p><p> Executive Director and</p><p> Mijing Siyu (Hangzhou) February 2018</p><p> General Manager</p><p> Chairman of the Board of November</p><p> Huzhou Younimi March 2019</p><p> Directors 2022</p><p> Executive Director and November</p><p> Huzhou Younimi</p><p> General Manager 2022</p><p> Proya (Hainan) Executive Director January 2021</p><p> Proya (Zhejiang) Executive Director May 2022</p><p> Hangzhou Kunyi Chairman and General April 2014</p><p> Annual Report 2022</p><p>Name of Position held in</p><p> Name of another entity Term start date Term end date</p><p>employee shareholder entity</p><p> Industrial Co., Ltd. Manager</p><p> Cosmetics Industry</p><p> Chairman of the Board of December</p><p> (Huzhou) Investment</p><p> Directors 2018</p><p> Development Co., Ltd.</p><p> Huzhou Beauty Town</p><p> Executive Director and</p><p> Technology Incubation January 2019</p><p> General Manager</p><p> Park Co., Ltd.</p><p> Xinjiang Huanyu New</p><p> Silk Road Investment Director March 2021</p><p> Development Co., Ltd.</p><p> Yongxinou (Ningbo)</p><p> International Trading Director May 2022</p><p> Co., Ltd.</p><p> Zhejiang Zhujin</p><p> September</p><p> Enterprise Management Executive Director</p><p> Co., Ltd.</p><p> November</p><p> Meiligu General Manager</p><p> September</p><p> Yueqing Laiya General Manager</p><p> November</p><p> Korea Hanna Inside Director</p><p> Hongkong Xinghuo Director March 2019</p><p> November</p><p> Huzhou Younimi Director March 2019</p><p> Hangzhou Fangxiake Executive Director and</p><p> FANG May 2018</p><p> Investment Co., Ltd. General Manager</p><p> Yuyou</p><p> Hangzhou Kunyi</p><p> Director April 2014</p><p> Industrial Co., Ltd.</p><p> Hangzhou Tairentang December</p><p> Director</p><p> Biotechnology Co., Ltd. 2014</p><p> Zhejiang Boweihui</p><p> November</p><p> Grapevine Technology Supervisor</p><p> Co., Ltd.</p><p> Jiangsu Lenong Weimei</p><p> Agricultural Technology Director May 2022</p><p> Development Co., Ltd.</p><p> Hangzhou Yishan September</p><p> Supervisor January 2022</p><p> Design Co., Ltd. 2017</p><p> HOU Hainan Mengya</p><p> Executive Director and November</p><p>Yameng Enterprise Consulting</p><p> General Manager 2021</p><p> Co., Ltd.</p><p> Hangzhou TIMAGE Executive Director and March 2022</p><p> Annual Report 2022</p><p>Name of Position held in</p><p> Name of another entity Term start date Term end date</p><p>employee shareholder entity</p><p> General Manager</p><p> Particle Culture</p><p> Technology Group Independent Director October 2020 March 2022</p><p> (Hangzhou) Co., Ltd.</p><p> Transwarp Technology December</p><p> Independent Director</p><p> MA (Shanghai)Co., Ltd. 2020</p><p>Dongming Zhejiang Shuangyuan</p><p> December</p><p> Science & Technology Independent Director</p><p> Development Co., Ltd.</p><p> Merit Interactive Co.,</p><p> Independent Director May 2022</p><p> Ltd.</p><p> Wuxi Genecast</p><p> Independent Director January 2020 August 2022</p><p> Biotechnology Co., Ltd.</p><p> Shanghai Huace</p><p> December</p><p> Navigation Technology Independent Director</p><p> Ltd.</p><p> Changzhou ECTEK</p><p>GE Weijun September</p><p> Automotive Electronics Independent Director</p><p> System Co., Ltd.</p><p> Hangzhou EZVIZ</p><p> Independent Director March 2022</p><p> Network Co., Ltd.</p><p> Zheshang Development</p><p> Independent Director May 2022</p><p> Group Co., Ltd.</p><p> December</p><p> Anya (Huzhou) Executive Director</p><p> Huzhou UZERO Executive Director January 2018</p><p> Chuangdai Electronics Manager February 2018</p><p> Executive Director and September</p><p> Proya Commercial</p><p> General Manager 2018</p><p> Executive Director and December</p><p> Huzhou Niuke</p><p> General Manager 2018</p><p> Executive Director and</p><p> Hangzhou Wanyan January 2019</p><p> JIN General Manager</p><p> Yanhua Executive Director and</p><p> Zhejiang Beute March 2019</p><p> General Manager</p><p> Chairman of the Board of</p><p> Shanghai Zhongwen April 2019</p><p> Directors</p><p> Executive Director and December</p><p> Ningbo Proya</p><p> General Manager 2019</p><p> September</p><p> Ningbo Keshi Director</p><p> Ningbo TIMAGE Director July 2019</p><p> Peixian Deyi Network Executive Partner August 2019 February 2022</p><p> Annual Report 2022</p><p>Name of Position held in</p><p> Name of another entity Term start date Term end date</p><p>employee shareholder entity</p><p> Technology Partnership</p><p> (Limited Partnership)</p><p> Hong Kong Keshi Director March 2019</p><p> Hong Kong Wanyan Director October 2019</p><p> Hong Kong Zhongwen Director July 2019</p><p> Zhejiang Qingya Executive Director May 2020</p><p> Luxiaotie Executive Director August 2020</p><p> Executive Director and</p><p> Hangzhou Yizhuo July 2020</p><p> General Manager</p><p> Executive Director and</p><p> Hangzhou Weiluoke July 2020</p><p> General Manager</p><p> Executive Director and</p><p> Hangzhou Oumisi August 2020</p><p> General Manager</p><p> Japan OR Director August 2020</p><p> Executive Director and</p><p> Guangzhou Qianxi October 2020</p><p> General Manager</p><p> Ningbo Xiyou</p><p> Interactive September</p><p> Director</p><p> Entertainment Culture 2020</p><p> Media Co., Ltd.</p><p> Proya (Hainan) General Manager January 2021</p><p> Korea Hapsode Director of the Company June 2021</p><p> Executive Director and</p><p> Xuzhou Laibo January 2022</p><p> General Manager</p><p> Executive Director and September</p><p> Huzhou Boyun August 2022</p><p> General Manager 2020</p><p> Xuzhou Proya</p><p> Executive Director and</p><p> Information Technology January 2021 July 2022</p><p> General Manager</p><p> Co., Ltd.</p><p> Singuladerm Executive Director and</p><p> October 2021</p><p> (Hangzhou) General Manager</p><p> Chairman and General</p><p> Ningbo Tangyu October 2021</p><p> Manager</p><p> Proya (Zhejiang) Manager May 2022</p><p> Executive Director and December</p><p> Hangzhou Boxin</p><p> General Manager 2022</p><p> Huzhou Keyan Trading Executive Director and</p><p> March 2023</p><p> Co., Ltd. General Manager</p><p> Zhejiang Wazam New</p><p>WANG Li Independent Director April 2023</p><p> Materials Co., Ltd.</p><p>Description</p><p>of position None</p><p>held in</p><p> Annual Report 2022</p><p> Name of Position held in</p><p> Name of another entity Term start date Term end date</p><p> employee shareholder entity</p><p>other</p><p>entities</p><p>(III) Remuneration of directors, supervisors and senior management</p><p>√ Applicable □ Not applicable</p><p> The remuneration of directors and supervisors of the Company shall</p><p> be approved by the Remuneration and Appraisal Committee, the</p><p> Decision-making procedures for</p><p> Board of Directors and the Board of Supervisors respectively. Then,</p><p> remuneration of directors,</p><p> the remuneration plan shall be submitted to the general meeting of</p><p> supervisors and senior</p><p> shareholders for deliberation. The remuneration of senior</p><p> management</p><p> management shall be deliberated by the Remuneration and</p><p> Appraisal Committee and the Board of Directors.</p><p> Basis for determination of</p><p> The annual remuneration of the Company"s directors, supervisors</p><p> remuneration of directors,</p><p> and senior management shall be paid based on basic pay and</p><p> supervisors and senior</p><p> performance appraisal results.</p><p> management</p><p> Actual payment of remuneration</p><p> of directors, supervisors and Paid.</p><p> senior management</p><p> Total remuneration actually During the Reporting Period, the Company"s directors, supervisors</p><p> received by all directors, and senior management actually received a total remuneration of</p><p> supervisors and senior RMB6.6640 million from the Company (including current and</p><p> management as of the end of the resigned supervisors and senior management during the Reporting</p><p> Reporting Period Period).</p><p>(IV) Changes in the Company"s directors, supervisors and senior management</p><p>□ Applicable √ Not applicable</p><p>(V) Description of punishments by the CSRC in the past three years</p><p>□ Applicable √ Not applicable</p><p>(VI) Other</p><p>□ Applicable √ Not applicable</p><p>V. Meetings of the Board of Directors held during the Reporting Period</p><p> Session Date Resolution</p><p> The meeting approved proposals including the Proposal on</p><p> third session of January 12, 2022 Restrictions for the Third Release Period of the Restricted</p><p> Board of Directors Shares Granted for the First Time and with Reserve under</p><p> the 2018 Restricted Share Incentive Plan, the Proposal on the</p><p> Annual Report 2022</p><p> Use of Raised Funds to Replace Self-raised Funds Already</p><p> Invested in Fundraising Projects, and the Proposal on Using</p><p> Some Idle Raised Fund for Cash Management. For details,</p><p> see the Announcement on Resolutions of the 4th Meeting of</p><p> the Third Session of Board of Directors (No.: 2022-002)</p><p> disclosed by the Company on the SSE website</p><p> (http://www.sse.com.cn) and relevant media on January 13,</p><p> The meeting approved proposals including the Company"s</p><p> Annual Report 2021 and its Summary, the Company"s ESG</p><p> Report 2021, and the Company"s Plan for Profit Distribution</p><p>third session of April 20, 2022 see the Announcement on Resolutions of the 5th Meeting of</p><p>Board of Directors the Third Session of Board of Directors (No.: 2022-014)</p><p> disclosed by the Company on the SSE website</p><p> (http://www.sse.com.cn) and relevant media on April 22,</p><p> The meeting approved proposals including the Proposal on</p><p> and Its Summary, and the Proposal on Formulating the</p><p> Assessment Management Method for the 2022 Restricted</p><p>third session of July 8, 2022</p><p> Share Incentive Plan. For details, see the Announcement on</p><p>Board of Directors</p><p> Resolutions of the 6th Meeting of the Third Session of Board</p><p> of Directors (No.: 2022-033) released on the SSE website on</p><p> July 9, 2022 (http://www.sse.com.cn) and relevant media.</p><p> The meeting approved the Proposal on the Granting of</p><p>third session of July 25, 2022 Announcement on Granting of Restricted Shares to Incentive</p><p>Board of Directors Recipients (No.: 2022-044) released on the SSE website on</p><p> July 26, 2022 (http://www.sse.com.cn) and relevant media.</p><p> The meeting approved proposals including the Company"s</p><p> Special Report on the Semi-annual Storage and Actual Use</p><p> of Raised Fund. For details, see the Announcement on</p><p>third session of August 24, 2022</p><p> Resolutions of the 8th Meeting of the Third Session of Board</p><p>Board of Directors</p><p> of Directors (No.: 2022-045) disclosed by the Company on</p><p> the SSE website (http://www.sse.com.cn) and relevant media</p><p> on August 26, 2022.</p><p> The meeting approved the Company"s 2022 Third Quarter</p><p>third session of October 27, 2022 disclosed by the Company on the SSE website</p><p>Board of Directors (http://www.sse.com.cn) and relevant media on October 28,</p><p> Annual Report 2022</p><p>VI. Performance of Duties by Directors</p><p>(I) Directors attending meetings of the Board of Directors and general meetings of shareholders</p><p> Attendance at</p><p> general</p><p> Attendance at meetings of the Board of Directors</p><p> meetings of</p><p> shareholders</p><p> Number</p><p> Number Number Number</p><p> of Fail to attend</p><p> Director Independent of Number of of of</p><p> meetings two Number of</p><p> name director or not meetings meetings of the meetings meetings</p><p> of the consecutive general</p><p> of the Board of of the of the</p><p> Board of meetings of meetings of</p><p> Board of Directors Board of Board of</p><p> Directors the Board of shareholders</p><p> Directors attended by Directors Directors</p><p> to be Directors or attended</p><p> attended communication attended absent</p><p> attended not</p><p> in person by proxy from</p><p> this year</p><p> HOU</p><p> No 6 6 0 0 0 No 2</p><p> Juncheng</p><p> FANG</p><p> No 6 6 0 0 0 No 2</p><p> Yuyou</p><p> HOU</p><p> No 6 6 0 0 0 No 2</p><p> Yameng</p><p> MA</p><p> Yes 6 6 6 0 0 No 2</p><p> Dongming</p><p> GE</p><p> Yes 6 6 6 0 0 No 2</p><p> Weijun</p><p>Explanation on absence from two consecutive meetings of the Board of Directors</p><p>□ Applicable √ Not applicable</p><p> Number of meetings of the Board of Directors held</p><p> during the year</p><p> Including: number of on-site meetings 0</p><p> Number of meetings held by communication 0</p><p> Number of meetings held both on site and by</p><p> communication</p><p>(II) Circumstances where directors object to the Company"s relevant matters</p><p>□ Applicable √ Not applicable</p><p>(III) Other</p><p>□ Applicable √ Not applicable</p><p>VII. Special Committees under the Board of Directors</p><p>√ Applicable □ Not applicable</p><p>(1). Members of special committees under the Board of Directors</p><p> Category of special</p><p> Name of member</p><p> committee</p><p>Audit Committee HOU Yameng, MA Dongming, GE Weijun</p><p>Nomination Committee HOU Juncheng, MA Dongming, GE Weijun</p><p>Remuneration and</p><p> FANG Yuyou, MA Dongming, GE Weijun</p><p>Appraisal Committee</p><p> Annual Report 2022</p><p>Strategy Committee HOU Juncheng, MA Dongming, GE Weijun</p><p>(2). Four meetings held by the Audit Committee during the Reporting Period</p><p> Important</p><p> Other</p><p> comments</p><p> Date Description performance</p><p> and</p><p> of duties</p><p> suggestions</p><p> The 3rd meeting of the third session of the Audit</p><p> Committee was held to deliberate on and approve the</p><p> Company"s Annual Report 2021 and its Summary, the</p><p> Company"s 2022 Q1 Report, the Company"s Annual</p><p> Financial Final Report 2021, the Performance Report</p><p> Approve</p><p> these</p><p> of Directors, the Company"s Internal Control Evaluation</p><p> proposals and</p><p> Report 2021, the 2021 Special Report on the Annual</p><p> agree to</p><p> April 20, Storage and Actual Use of Raised Fund, the Company"s</p><p> submit them None</p><p> to the Board</p><p> Reserves for 2021, the Proposal on Payment of Audit</p><p> of Directors</p><p> Fees for 2021 and Further Employment of the Accounting</p><p> for</p><p> Firm for 2022, the Proposal on the Estimated Amount of</p><p> deliberation</p><p> Daily Related-party Transactions for 2022, the Proposal</p><p> on the Accrual of Asset Impairment Provision for 2021,</p><p> the Proposal on the Adjustment of the Conversion Price</p><p> of "Proya Convertible Bond", and the Company"s Annual</p><p> Internal Audit Work Report 2021.</p><p> Approve</p><p> these</p><p> proposals and</p><p> The 4th meeting of the third session of Audit Committee</p><p> agree to</p><p> July 8, was held to deliberate on and approve the Proposal on</p><p> submit them None</p><p> to the Board</p><p> (Draft) and Its Summary.</p><p> of Directors</p><p> for</p><p> deliberation</p><p> Approve</p><p> The 5th meeting of the third session of Audit Committee these</p><p> was held to deliberate on and approve the proposals and</p><p> Company"s 2022 Semi-annual Report and its Summary, agree to</p><p> August</p><p> the 2022 Special Report on the Semi-annual Storage and submit them None</p><p> Actual Use of Raised Fund, and the Proposal on the to the Board</p><p> Adjustment of the Conversion Price of "Proya of Directors</p><p> Convertible Bond". for</p><p> deliberation</p><p> Annual Report 2022</p><p> Approve</p><p> these</p><p> proposals and</p><p> The 6th meeting of the third session of Audit Committee agree to</p><p> October</p><p> was held to deliberate on and approve the Company"s submit them None</p><p> of Directors</p><p> for</p><p> deliberation</p><p>(3). Three meetings held by the Remuneration and Appraisal Committee during the Reporting</p><p> Period</p><p> Important</p><p> Other</p><p> comments</p><p> Date Description performance</p><p> and</p><p> of duties</p><p> suggestions</p><p> Approve</p><p> The 1st meeting of the third session of Remuneration and these</p><p> Appraisal Committee was held to deliberate on and proposals and</p><p> approve the Proposal on the Satisfaction of Conditions agree to</p><p> January</p><p> for Releasing the Sales Restrictions for the Third Release submit them None</p><p> Period of the Restricted Shares Granted for the First to the Board</p><p> Time and with Reserve under the 2018 Restricted Share of Directors</p><p> Incentive Plan. for</p><p> deliberation</p><p> Approve</p><p> these</p><p> The 2nd meeting of the third session of Remuneration and proposals and</p><p> Appraisal Committee was held to deliberate on and agree to</p><p> April 20,</p><p> approve the Proposal on Confirming the Remuneration of submit them None</p><p> Directors for 2021 and the Proposal on Confirming the to the Board</p><p> Remuneration of Senior Management for 2021. of Directors</p><p> for</p><p> deliberation</p><p> Approve</p><p> The 3rd meeting of the third session of Remuneration and</p><p> these</p><p> Appraisal Committee was held to deliberate on and</p><p> proposals and</p><p> approve the Proposal on 2022 Restricted Share Incentive</p><p> agree to</p><p> July 8, Plan of the Company (Draft) and Its Summary, the</p><p> submit them None</p><p> to the Board</p><p> Method for the 2022 Restricted Share Incentive Plan, and</p><p> of Directors</p><p> the Proposal on Verifying the List of Incentive Recipients</p><p> for</p><p> for the 2022 Restricted Share Incentive Plan.</p><p> deliberation</p><p>(4). One meeting held by the Strategy Committee during the Reporting Period</p><p> Annual Report 2022</p><p> Important</p><p> Other</p><p> comments</p><p> Date Description performance</p><p> and</p><p> of duties</p><p> suggestions</p><p> Approve</p><p> these</p><p> proposals and</p><p> The 2nd meeting of the third session of Strategy</p><p> agree to</p><p> April 20, Committee was held to deliberate on and approve the</p><p> submit them None</p><p> to the Board</p><p> of Directors</p><p> for</p><p> deliberation</p><p>(5). Dissenting matters</p><p>□ Applicable √ Not applicable</p><p>VIII. Explanation on the Company"s Risks Identified by the Board of Supervisors</p><p>□ Applicable √ Not applicable</p><p>The Board of Supervisors had no objection to matters supervised during the Reporting Period.</p><p>IX. Employees of the Parent Company and Major Subsidiaries as of the End of the Reporting</p><p> Period</p><p>(I) Employees</p><p> Number of current employees of the parent 1,129</p><p> company</p><p> Number of current employees of major 2,048</p><p> subsidiaries</p><p> Total number of employees 3,177</p><p> Number of retired employees to be supported by 4</p><p> the parent company and major subsidiaries</p><p> Specialty composition</p><p> Category Number of employees</p><p> Production workers 276</p><p> Sales specialists 2,370</p><p> Management 302</p><p> R&D personnel 229</p><p> Total 3,177</p><p> Educational background</p><p> Education level Number (persons)</p><p> Bachelor and above 1,217</p><p> Associate 724</p><p> High school and below 1,236</p><p> Total 3,177</p><p> Annual Report 2022</p><p>(II) Remuneration policy</p><p>√ Applicable □ Not applicable</p><p>Value creation is the Company"s basis for salary distribution. Performance is an intuitive reflection of</p><p>value. By establishing a comprehensive and objective performance evaluation system, the Company</p><p>combines salary distribution and performance evaluation of employees with an aim to fully guide and</p><p>motivate employees to create value.</p><p>(III) Training program</p><p>√ Applicable □ Not applicable</p><p>The Company adheres to the goal of gathering and training outstanding professionals by always</p><p>considering staff learning and growth as a primary task, and continuously innovating in and optimizing</p><p>training research, training topics, training forms, training implementation, training evaluation and</p><p>improvement, and trainer management. In terms of the form of learning, the Company combines internal</p><p>and external learning and fully improves the engagement of employees in training, thus making the</p><p>training more effective.</p><p>(IV) Labor outsourcing</p><p>√ Applicable □ Not applicable</p><p> Total man-hours for labor outsourcing</p><p> Total remuneration paid for labor outsourcing RMB53,644,979.66</p><p>Labor Service Co., Ltd. to outsource auxiliary services including canteen, greening, cleaning, and goods</p><p>handling, loading and unloading, and packaging to the latter and pay consideration for the agreed</p><p>quantities.</p><p>Enterprise Management Co., Ltd. to outsource services such as partial goods handling, loading and</p><p>unloading, combined packaging, and mask folding to the latter, and pay consideration for the agreed</p><p>quantities.</p><p>X. Profit Distribution or Capital Reserve Conversion Plan</p><p>(I) Development, implementation or adjustment of the cash dividend distribution policy</p><p>√ Applicable □ Not applicable</p><p>The Company held the 16th meeting of the second session of Board of Directors and the 3rd extraordinary</p><p>General Meeting of Shareholders on October 12, 2020 and October 28, 2020 respectively and approved</p><p>the Proposal on the Company"s Planning for Dividends to Shareholders for the Next Three Years (2020-</p><p>I. Factors considered in developing the planning for dividend distribution to shareholders</p><p>To promote the long-term and sustainable development, based on a comprehensive analysis of the</p><p>corporate development strategy, shareholder requirements and expectations, social capital costs, and</p><p>external financing environment, the Company has solicited and listened to the requirements and</p><p>expectations of shareholders, especially small and medium shareholders, fully considered the Company"s</p><p>current and future profitability, cash flow, development stage, project investment capital needs, and bank</p><p>credit, balanced the short-term and long-term interests of shareholders, and made institutional</p><p> Annual Report 2022</p><p>arrangements for profit distribution, so as to establish a sustainable and stable mechanism for dividend</p><p>distribution to investors to ensure the continuity and stability of the Company"s profit distribution policy.</p><p>II. Principles for planning for dividend distribution to shareholders</p><p>The Company implements a continuous and stable profit distribution policy, attaches importance to</p><p>reasonable investment returns to investors while considering sustainable development, and has established</p><p>a continuous and stable mechanism for returns to investors in combination with the Company"s</p><p>profitability and actual needs for the future development strategy. The Company shall make a profit</p><p>distribution plan in accordance with the Articles of Association. The Company"s Board of Directors, Board</p><p>of Supervisors and General Meeting of Shareholders shall fully consider the opinions of independent</p><p>directors, supervisors and public investors in deciding and demonstrating the profit distribution policy.</p><p>III. Planning for dividend distribution to shareholders (2020-2022)</p><p>reasonable investment returns to investors as well as the Company"s actual operating conditions and</p><p>sustainable development for the current year in profit distribution.</p><p>by laws and regulations. The distribution shall not exceed the accumulated distributable profits, and shall</p><p>not undermine the Company"s ability to continue as a going concern. When eligible for cash dividends,</p><p>the Company shall distribute profits first in cash.</p><p>When eligible for cash dividends under the Company"s Articles of Association, the Company shall, in</p><p>principle, distribute profits in cash on a yearly basis. The Company"s Board of Directors may propose that</p><p>the Company should distribute interim cash dividends according to the Company"s profitability and capital</p><p>needs. The Company shall maintain the continuity and stability of the profit distribution policy, and</p><p>distribute every year at least 20% of the distributable profits achieved for the current year. The Company"s</p><p>Board of Directors shall propose a differentiated cash dividend policy in line with the procedure under the</p><p>Company"s Articles of Association after a comprehensive analysis of factors such as industry</p><p>characteristics, development stage, its own business mode, profitability, and major spending arrangements.</p><p>(1) The Company shall evaluate the implemented plan for dividend distribution to shareholders once every</p><p>three years. According to applicable laws and regulations, the Company"s operating conditions, and the</p><p>opinions of shareholders (especially small and medium investors) and independent directors, the Company</p><p>may modify its current profit distribution policy when necessary and make a new plan for dividend</p><p>distribution to shareholders. Upon adjustment, the plan for dividend distribution to shareholders shall be</p><p>approved by voting at the General Meeting of Shareholders.</p><p>(2) The Company"s Board of Directors shall make an appropriate annual distribution plan or an interim</p><p>profit distribution plan as necessary for development after fully considering the Company"s profitability,</p><p>cash flow, development capital needs, financing costs, and the external financing environment, and</p><p>implement them upon the approval by the Company"s General Meeting of Shareholders.</p><p>During the Reporting Period, the Company approved the 2021 annual profit distribution plan at the 2021</p><p>Annual General Meeting of Shareholders, whereby distributing a cash dividend of RMB8.60 (tax inclusive)</p><p>for each 10 shares to all shareholders registered as of the record date on the basis of the total share capital</p><p>as of the record date for dividend distribution for a total of RMB172,868,570.76 (tax inclusive). The said</p><p>dividend distribution was completed on May 30, 2022.</p><p>(II) Special description of the cash dividend policy</p><p>√ Applicable □ Not applicable</p><p> Annual Report 2022</p><p> Is the cash dividend policy acceptable under the Company"s Articles of Association or</p><p> √Yes □No</p><p> as required by resolutions at the General Meeting of Shareholders?</p><p> Are dividend distribution standard and ratio clearly defined? √Yes □No</p><p> Are decision-making procedures and mechanisms complete? √Yes □No</p><p> Do independent directors fulfill their duties and play their roles diligently? √Yes □No</p><p> Do minority shareholders have the opportunity to fully express their opinions and</p><p> √Yes □No</p><p> demands, and are their legitimate rights and interests fully protected?</p><p>(III) Where the Company made profits and the parent company could provide positive profits</p><p> available to shareholders for distribution but did not propose a cash profit distribution plan</p><p> during the Reporting Period, the Company shall disclose the reasons in details and the purpose</p><p> and use of undistributed profits.</p><p>□ Applicable √ Not applicable</p><p>(IV) Profit distribution and capitalization of capital reserves during the Reporting Period</p><p>√ Applicable □ Not applicable</p><p> Unit: Yuan Currency: RMB</p><p> Number of bonus shares distributed per 10 shares</p><p> (shares)</p><p> Dividends per 10 shares (RMB) (tax included) 8.70</p><p> Conversions per 10 shares (shares) 4</p><p> Amount of cash dividends (tax included) 246,661,938.03</p><p> Net profit attributable to ordinary shareholders of</p><p> the Company in the annual consolidated statement 817,400,223.93</p><p> of dividends</p><p> Proportion in the net profit attributable to ordinary</p><p> shareholders of the Company in the consolidated 30.18</p><p> statement (%)</p><p> Amount of shares repurchased in cash included in</p><p> cash dividends</p><p> Total dividend amount (tax included) 246,661,938.03</p><p> Proportion of the dividend amount in the net profit</p><p> attributable to ordinary shareholders of the 30.18</p><p> Company in the consolidated statement (%)</p><p>XI. The Company"s Equity Incentive Plans, Employee Stock Ownership Plans or Other Employee</p><p> Incentives and Their Impact</p><p>(I) Relevant incentive matters disclosed in the temporary announcement and with no progress</p><p> or changes in subsequent implementation</p><p>√ Applicable □ Not applicable</p><p> Matter Reference</p><p> Announcement on the Satisfaction</p><p> SSE website, Shanghai Securities News, Securities Times on</p><p> of Conditions for Releasing the</p><p> January 13, 2022</p><p> Sales Restrictions for the Third</p><p> Annual Report 2022</p><p> Release Period of the Restricted</p><p> Shares Granted for the First Time</p><p> and with Reserve under the 2018</p><p> Restricted Share Incentive Plan</p><p> and Listing</p><p> Announcement on 2022</p><p> Restricted Share Incentive Plan of SSE website, Shanghai Securities News, Securities Times on July</p><p> the Company (Draft) and Its 9, 2022</p><p> Summary</p><p> Announcement on the Granting of</p><p> SSE website, Shanghai Securities News, Securities Times on July</p><p> Restricted Shares to Incentive</p><p> Recipients</p><p> Announcement on the Granting</p><p> SSE website, Shanghai Securities News, Securities Times on</p><p> Result of the 2022 Restricted</p><p> September 8, 2022</p><p> Stock Incentive Plan</p><p>(II) Incentives not disclosed in the interim announcement or with subsequent progress</p><p>Equity incentives</p><p>□ Applicable √ Not applicable</p><p>Other explanations</p><p>□ Applicable √ Not applicable</p><p>Employee stock ownership plans</p><p>□ Applicable √ Not applicable</p><p>Other incentives</p><p>□ Applicable √ Not applicable</p><p>(III) Equity incentives granted to directors and senior management during the Reporting Period</p><p>□ Applicable √ Not applicable</p><p>√ Applicable □ Not applicable</p><p> Unit: share</p><p> Number of Number</p><p> Number</p><p> newly of Market price</p><p> of Price of</p><p> granted restricted as of the end</p><p> restricted restricted Unloc</p><p> restricted Locked shares of the</p><p> Name Position shares shares ked</p><p> shares shares held at the Reporting</p><p> held at the granted shares</p><p> during the end of the Period</p><p> beginning (RMB)</p><p> Reporting Reporting (RMB)</p><p> of the year</p><p> Period Period</p><p> JIN Deputy 54,981 140,000 78.56 76,97 140,000 216,973 36,338,638.0</p><p> Yanhua General 3 4</p><p> Manager</p><p> WANG Deputy 32,322 180,000 78.56 45,25 180,000 225,251 37,725,037.4</p><p> Annual Report 2022</p><p> Li General 1 8</p><p> Manager,</p><p> Secretary</p><p> of the</p><p> Board of</p><p> Directors,</p><p> CFO</p><p> / 87,303 320,000 / 122,2 320,000 442,224 /</p><p> Total</p><p>Note: The Company implemented the 2021 Equity Distribution Plan on May 30, 2022, in which the</p><p>Company distributed to all shareholders a cash dividend of RMB8.60 (tax inclusive) per 10 shares based</p><p>on the total share capital as of the record date on which equity distribution is implemented and issued 4</p><p>shares for every 10 shares to all shareholders through capitalization of the capital reserve. The "unlocked</p><p>shares" and "number of restricted shares held at the end of the period" mentioned in the table above include</p><p>the shared converted through the capitalization of the capital reserve in 2021.</p><p>(IV) Evaluation mechanism for senior management as well as the establishment and</p><p> implementation of the incentive mechanism during the Reporting Period</p><p>√ Applicable □ Not applicable</p><p>During the Reporting Period, the Company"s General Manager and other senior management were</p><p>evaluated based on performance indicators and their annual performance remuneration was submitted by</p><p>the Remuneration and Appraisal Committee to the Board of Directors for deliberation.</p><p>XII. Construction and Implementation of the Internal Control System during the Reporting Period</p><p>√ Applicable □ Not applicable</p><p>The Company has developed relevant systems including the Internal Audit System, the External</p><p>Guarantee Decision-making Management System, the Related-party Transaction Management System,</p><p>the Raised Funds Management System, and the Information Disclosure Management System, and</p><p>established processes for company establishment/investment/change applications, entrusted wealth</p><p>management application, and guarantee application. The Company continuously improves the internal</p><p>control system and related processes, regulates the implementation of the internal control system,</p><p>strengthens the supervision and inspection of internal control, and promotes the healthy and sustainable</p><p>development of the Company.</p><p>Description on Material deficiencies in internal control during the Reporting Period</p><p>□ Applicable √ Not applicable</p><p>XIII. Management and Control of Subsidiaries during the Reporting Period</p><p>√ Applicable □ Not applicable</p><p>The Company has developed systems including the External Investment and Operation Decision-making</p><p>System and the Subsidiary Management System to implement centralized control over subsidiaries. The</p><p>Company HQ is responsible for its finance, asset operation and overall strategic planning while all</p><p>subsidiaries develop their strategic plans based on the Company"s overall strategic planning.</p><p>XIV. Description of the Internal Control Audit Report</p><p>√ Applicable □ Not applicable</p><p> Annual Report 2022</p><p>During the Reporting Period, Pan-China Certified Public Accountants (Special General Partnership), the</p><p>Company"s internal control auditing firm, issued the Internal Control Audit Report (Tian Jian Shen [2023]</p><p>No.3129), in which opinion the Company had maintained effective internal control over financial</p><p>reporting in all material aspects as of December 31, 2022 pursuant to the Basic Rules for Internal Control</p><p>and other applicable provisions.</p><p>Whether to disclose the internal control audit report: Yes</p><p>Type of opinion in the internal control audit report: standard unqualified opinion</p><p>XV. Correction of Problems Identified in the Special Campaign for Governance of Listed</p><p> Companies</p><p>None</p><p>XVI. Other</p><p>□ Applicable √ Not applicable</p><p> Section V Environmental and Social Responsibility</p><p>I. Environmental Information</p><p> Whether to establish the environmental protection</p><p> Yes</p><p> mechanism</p><p> Investment in environmental protection during the</p><p> Reporting Period (Unit: RMB’0,000)</p><p>(I) Environmental issues of the Company and major subsidiaries included in the list of primary</p><p> pollutant discharge entities announced by the environmental authority</p><p>□ Applicable √ Not applicable</p><p>(II) Environmental issues of the Company not included in the list of primary pollutant discharge</p><p> entities</p><p>√ Applicable □ Not applicable</p><p>□ Applicable √ Not applicable</p><p> entities</p><p>√ Applicable □ Not applicable</p><p>During the Reporting Period, the Company passed the ISO14001:2015 Environmental Management</p><p>System certification (valid until February 14, 2025). The emission of greenhouse gases and discharge of</p><p>industrial wastewater, air emissions, and residues mainly occur from product production.</p><p>The wastewater produced by the Company mainly comes from domestic sewage and production</p><p>wastewater and is discharged to landscape water pools or to the outside through a consolidated water pipe</p><p>after being treated by the sewage treatment station. The air emissions produced mainly comes from boilers.</p><p>The Company has formulated the Sewage Treatment Management System, the Boiler Management System,</p><p> Annual Report 2022</p><p>and other management documents to strictly control the discharge of wastewater and air emissions. During</p><p>the Reporting Period, the Company discharged wastewater and air emissions up to standards.</p><p>Main administrative measures taken during the Reporting Period include:</p><p>(1) Wastewater:</p><p>The Company installed the Multi Vision COD online automatic monitoring instrument, and monitored the</p><p>COD in treated water 24 hours a day to ensure class-A sewage discharge; constructed a sewage treatment</p><p>system to make sure treated sewage is highly purified and recycled; renovated environmental protection</p><p>technologies in the production park:</p><p>① Underground pipeline CCTV detection system: Consisting of crawlers, lenses, cable reels, and a</p><p>control system, the underground pipeline CCTV detection system is used to clear the blockage in the</p><p>pipeline inside the park and maintain and repair the pipeline network, so as to prevent the risk of sewage</p><p>leakage due to outdated pipeline and provide reliable technological support for zero sewage discharge;</p><p>② Perform technological transformation on the anaerobic tower of the sewage treatment station to</p><p>improve the biological anaerobic effect;</p><p>③ Increase the capacity and efficiency of the air flotation tank of the sewage treatment station to 10 tons;</p><p>improve the capability of treating gas explosion of sewage in the air flotation tank, and enhance the clean</p><p>water treatment capacity on the original basis.</p><p>(2) Air emissions:</p><p>① Huzhou production base (skincare factory): A air emissions treatment facility for the cream production</p><p>line was added to reduce the emission of dust and organic air emissions. After being use, the facility can</p><p>collect 99% dust and remove 75% organic air emissions. A highly-precise volatile organic chemical (VOC)</p><p>gas collection device was installed to effectively reduce unorganized gas emission;</p><p>② Huzhou production base (make-up factory): A Swiss-made VOC gas and dust treatment facility was</p><p>added.</p><p>(3) The Company properly disposes of solid waste generated in production and operations. The Company</p><p>manages solid wastes in a macroscopical manner and our factories can track the whole process data on</p><p>solid wastes and prevent risks by requesting to report the amount of generated hazardous waste on the</p><p>National Information System Platform for the Management of Solid Wastes and Chemicals every year,</p><p>selecting hazardous waste treatment service providers through open bidding on the platform, and</p><p>requesting for the treatment of hazardous wastes on the platform.</p><p>□ Applicable √ Not applicable</p><p>(III) The Company"s performance in helping protect the environment, prevent pollution and fulfill</p><p> environmental responsibilities</p><p>√ Applicable □ Not applicable</p><p>The emission of greenhouse gases and discharge of industrial wastewater, air emissions, and residues</p><p>mainly occur from product production. Moreover, the consumption of energy, raw materials, and other</p><p>resources principally occurs when products are made. Therefore, sustainable production can improve the</p><p>usage efficiency of resources and energy in production processes, reduce pollutants and greenhouse gas</p><p>emissions, and build a resource-saving and eco-friendly production system.</p><p>During the Reporting Period, the Company carried out a new round of audits on cleaner production in the</p><p>Huzhou Production Base (skincare factory). We investigated the current situation of pollutant emissions,</p><p> Annual Report 2022</p><p>energy management, and environmental protection, and also developed several cleaner production</p><p>implementation programs according to the investigation results.</p><p>During the Reporting Period, the Huzhou Production Base (skincare factory) planned and implemented</p><p>(1) Reduced waste water discharge by 4,400 tons;</p><p>(2) Reduced COD emission by 0.17 tons and ammonia nitrogen emission by 0.001 tons;</p><p>(3) Reduced the generation of hazardous waste by 3 tons;</p><p>(4) Reduced carbon dioxide emissions by 322.73 tons;</p><p>(5) Saved electricity by 565.9 MWh;</p><p>(6) Saved raw materials worth RMB108 thousand;</p><p>(7) Saved natural gas by 3,000 Nm³;</p><p>(8) Saved water by 4,600 m³.</p><p>(IV) Measures taken to reduce carbon emissions during the Reporting Period and their effects</p><p> Whether to take carbon emission</p><p> Yes</p><p> reduction measures</p><p> Carbon dioxide emission equivalent</p><p> reduced (unit: ton)</p><p> policies to suppliers, cooperate with them to reduce carbon</p><p> emissions in the stage of procurement, and prioritize</p><p> suppliers with low carbon emissions.</p><p> (1) Regularly collect carbon emissions data, invite</p><p> professional third parties to conduct data audits, and make</p><p> improvements to correct deviations inside the Company;</p><p> (2) Carry out energy-saving and technology upgrade</p><p> Type of carbon emission reduction</p><p> projects to improve energy efficiency;</p><p> measures (such as electricity generation</p><p> (3) Carry out clean energy replacement and increase the</p><p> with clean energy, carbon reduction</p><p> proportion of clean energy use through photovoltaic power</p><p> technologies used in production, or the</p><p> generation and the purchase of green electricity.</p><p> development and production of new</p><p> products that help reduce carbon</p><p> reduce carbon emissions after packaging disposal through</p><p> emissions)</p><p> packaging usage reduction, packaging recycling, and other</p><p> methods.</p><p> and logistics system to reduce energy consumption in the</p><p> process of warehousing and logistics by rationally arranging</p><p> warehouses and planning transportation routes.</p><p> sustainable consumption to consumers to provide them with</p><p> more sustainable choices.</p><p>Specific description</p><p>□ Applicable √ Not applicable</p><p> Annual Report 2022</p><p>II. Social Responsibility</p><p>(I) Whether to independently disclose social responsibility reports, sustainable development</p><p> reports, or ESG reports</p><p>√ Applicable □ Not applicable</p><p>For details, see the Proya Sustainable Development & Environmental, Social, and Governance (ESG)</p><p>Report 2022 disclosed by the Company on the SSE website (www.sse.com.cn) disclosed on the same day.</p><p>(II) Description of social responsibilities</p><p>√ Applicable □ Not applicable</p><p> External donation and charity</p><p> Quantity/content Description</p><p> projects</p><p> Include funds and materials donated by the</p><p> Total investment (RMB’0,000) 143.46 Company to various community philanthropy</p><p> and charitable activities</p><p> Shanghai Adream Foundation for the "One</p><p> County, One Dream" charity project.</p><p> Village, Jiulong County, Ganzi Prefecture,</p><p> Sichuan Province, and donated RMB100,000</p><p> Including: fund (RMB’0,000) 140.00</p><p> to village school so they could buy stationery</p><p> and books;</p><p> to the charity project jointly operated by the</p><p> Wuxing District Charity Federation of</p><p> Huzhou and Proya.</p><p> The Company donated anti-epidemic supplies</p><p> Cash value of materials</p><p> (RMB’0,000)</p><p> Hangzhou</p><p> Number of beneficiaries</p><p> (person)</p><p>Specific description</p><p>□ Applicable √ Not applicable</p><p>III. Poverty Alleviation and Rural Revitalization Progress</p><p>√ Applicable □ Not applicable</p><p> Poverty alleviation and rural</p><p> Quantity/content Description</p><p> revitalization project</p><p> to Shanghai Adream Foundation for the</p><p> Total investment (RMB’0,000) 110 "One County, One Dream" charity</p><p> project.</p><p> Annual Report 2022</p><p> Liwu Village, Jiulong County, Ganzi</p><p> Prefecture, Sichuan Province, and</p><p> donated RMB100,000 to village school</p><p> so they could buy stationery and books;</p><p> Including: fund (RMB’0,000) 110</p><p> Cash value of materials</p><p> (RMB’0,000)</p><p> Number of beneficiaries (person) 8,085</p><p> Form of support (such as</p><p> industrial support, employment Education support</p><p> support, education support, etc.)</p><p>Specific description</p><p>□ Applicable √ Not applicable</p><p> Annual Report 2022</p><p> Section VI Important Matters</p><p>I. Fulfillment of Commitments</p><p>(I) Commitments made by the Company"s actual controllers, shareholders, related parties, acquirers and the Company and other relevant parties during</p><p> the Reporting Period or continuing to the Reporting Period</p><p>√ Applicable □ Not applicable</p><p> The next</p><p> Whether the Cause for step in</p><p> Any commitment any the event</p><p> Date and</p><p> Background Type Promisor Description deadline for is timely failure to of failure</p><p> duration</p><p> performance and strictly perform to</p><p> performed in time perform</p><p> in time</p><p> Restrictions Directors, (1) During their terms as the Company"s Date: No Yes Not Not</p><p> on sales senior director/senior management, they shall not November applicable applicable</p><p> management transfer more than 25% of their total shares 15, 2017</p><p> HOU directly or indirectly held in the Company each Duration:</p><p> Juncheng, year. Within six months after leaving office, November</p><p> FANG they shall not transfer their shares directly or 15, 2017</p><p> Yuyou and indirectly held in the Company. (2) If their to long-</p><p> IPO-related CAO shares in the Company are sold within two term</p><p> commitments Liangguo years upon expiration of the lock-up period,</p><p> the selling price shall not be lower than the</p><p> offering price. If the closing price of the</p><p> Company"s shares is lower than the offering</p><p> price for 20 consecutive trading days within 6</p><p> months after the Company"s IPO, or the</p><p> closing price as of the end of the 6-month</p><p> period after the Company"s IPO is lower than</p><p> Annual Report 2022</p><p> the offering price, the lock-up period for their</p><p> shares in the Company will be automatically</p><p> extended for 6 months. Their commitments</p><p> above shall survive job change and</p><p> resignation. (3) Should any of them/their</p><p> partnership violate the said share lock-up</p><p> commitments, the lock-up period for</p><p> their/their partnership"s shares in the Company</p><p> will be automatically extended for 6 months.</p><p>Restrictions Senior (1) Within 12 months from the date of the Date: No Yes Not Not</p><p>on sales management Company"s IPO, they shall not transfer or April 16, applicable applicable</p><p> JIN Yanhua authorize any other to manage their shares 2018</p><p> directly or indirectly held in the Company or Duration:</p><p> have the Company repurchase such shares. (2) April 16,</p><p> During their terms as the Company"s senior 2018 to</p><p> management, they shall not transfer more than long-term</p><p> held in the Company each year. Within six</p><p> months after leaving office, they shall not</p><p> transfer their shares directly or indirectly held</p><p> in the Company. (3) If their shares in the</p><p> Company are sold within two years upon</p><p> expiration of the lock-up period, the selling</p><p> price shall not be lower than the offering price.</p><p> If the closing price of the Company"s shares is</p><p> lower than the offering price for 20</p><p> consecutive trading days within 6 months after</p><p> the Company"s IPO, or the closing price as of</p><p> the end of the 6-month period after the</p><p> Annual Report 2022</p><p> Company"s IPO is lower than the offering</p><p> price, the lock-up period for their shares in the</p><p> Company will be automatically extended for 6</p><p> months. Their commitments above shall</p><p> survive job change and resignation. (4) Should</p><p> any of them/their partnership violate the said</p><p> share lock-up commitments, the lock-up</p><p> period for their/their partnership"s shares in the</p><p> Company will be automatically extended for 6</p><p> months.</p><p>Restrictions Senior (1) Within 12 months from the date of the Date: No Yes Not Not</p><p>on sales management Company"s IPO, they shall not transfer or September applicable applicable</p><p> WANG Li authorize any other to manage their shares 3, 2018</p><p> directly or indirectly held in the Company or Duration:</p><p> have the Company repurchase such shares. (2) September</p><p> During their terms as the Company"s senior 3, 2018 to</p><p> management, they shall not transfer more than long-term</p><p> held in the Company each year. Within six</p><p> months after leaving office, they shall not</p><p> transfer their shares directly or indirectly held</p><p> in the Company. (3) If their shares in the</p><p> Company are sold within two years upon</p><p> expiration of the lock-up period, the selling</p><p> price shall not be lower than the offering price.</p><p> If the closing price of the Company"s shares is</p><p> lower than the offering price for 20</p><p> consecutive trading days within 6 months after</p><p> the Company"s IPO, or the closing price as of</p><p> Annual Report 2022</p><p> the end of the 6-month period after the</p><p> Company"s IPO is lower than the offering</p><p> price, the lock-up period for their shares in the</p><p> Company will be automatically extended for 6</p><p> months. Their commitments above shall</p><p> survive job change and resignation. (4) Should</p><p> any of them/their partnership violate the said</p><p> share lock-up commitments, the lock-up</p><p> period for their/their partnership"s shares in the</p><p> Company will be automatically extended for 6</p><p> months.</p><p>Restrictions Controlling (1) Within 24 months upon expiration of the Date: No Yes Not Not</p><p>on sales shareholder lock-up period, they shall not directly or November applicable applicable</p><p> and actual indirectly reduce their shares in the Issuer by 15, 2017</p><p> controller more than 6% of the total number of shares of Duration:</p><p> HOU the Issuer before such IPO. (2) They must sell November</p><p> Juncheng shares in the Company through methods 15, 2017</p><p> and FANG including but not limited to collective trading to long-</p><p> Aiqin through bidding, block trading, and transfer by term</p><p> agreement and transfer by agreement in line</p><p> with applicable laws, regulations and rules. (3)</p><p> Before selling the Company"s shares, they</p><p> shall announce the same three trading days in</p><p> advance, discharge the obligation to disclose</p><p> information in a timely and accurate manner as</p><p> per the rules of the securities exchange, except</p><p> to the extent that their shares in the Company</p><p> are less than 5%. (4) Should they fail to</p><p> perform the said intent of share reduction, they</p><p> Annual Report 2022</p><p> must explain the cause for failing to do so in</p><p> the Company"s General Meeting of</p><p> Shareholders and the media designated by the</p><p> CSRC and publicly apologize to the</p><p> Company"s shareholders and public investors.</p><p>Restrictions Shareholders (1) If they intend to reduce shares after the Date: No Yes Not Not</p><p>on sales FANG lock-up period expires, they will prudently November applicable applicable</p><p> Yuyou and make a share reduction plan as necessary for 15, 2017</p><p> LI Xiaolin the Company to stabilize the share price and Duration:</p><p> directly conduct operations and capital operations as November</p><p> holding required by the CSRC and the exchange on 15, 2017</p><p> more than shareholders for share reduction, whereby to long-</p><p> the the lock-up period. (2) They must sell shares</p><p> Company in the Company with methods including but</p><p> not limited to collective trading through</p><p> bidding, block trading, and transfer by</p><p> agreement in line with applicable laws,</p><p> regulations and rules. (3) Before selling the</p><p> Company"s shares, they shall announce the</p><p> same three trading days in advance, discharge</p><p> the obligation to disclose information in a</p><p> timely and accurate manner as per the rules of</p><p> the securities exchange except to the extent</p><p> that their shares in the Company are less than</p><p> intent of share reduction, they must explain the</p><p> cause for failing to do so in the Company"s</p><p> General Meeting of Shareholders and the</p><p> Annual Report 2022</p><p> media designated by the CSRC and publicly</p><p> apologize to the Company"s shareholders and</p><p> public investors.</p><p>Other The When the preconditions for enabling the share Date: No Yes Not Not</p><p> Company price stabilization plan are met, if the November applicable applicable</p><p> Company fails to take specific measures to 15, 2017</p><p> stabilize the share price, the Company must Duration:</p><p> explain the cause for failing to do so in the November</p><p> Company"s General Meeting of Shareholders 15, 2017</p><p> and the media designated by the CSRC and to long-</p><p> publicly apologize to the Company"s term</p><p> shareholders and public investors. In the event</p><p> of losses to investors not as a result of force</p><p> majeure, the Company will be liable for</p><p> compensation to investors by law, and be</p><p> liable otherwise as required by laws,</p><p> regulations and competent regulators; if the</p><p> losses are caused due to force majeure, the</p><p> Company shall work out a plan in the shortest</p><p> possible time to minimize losses to investors</p><p> and submit it to the General Meeting of</p><p> Shareholders for deliberation, so as to protect</p><p> the interests of the Company"s investors as</p><p> much as possible. Within three years from the</p><p> date of the Company"s IPO, if the Company</p><p> appoints new directors and senior</p><p> management, the Company will require such</p><p> new directors and senior management to fulfill</p><p> the commitments made by the directors and</p><p> Annual Report 2022</p><p> senior management at the time of the</p><p> Company"s IPO.</p><p>Other The When the preconditions for enabling the share Date: No Yes Not Not</p><p> Company"s price stabilization plan are met, if failing to November applicable applicable</p><p> controlling take specific measures to stabilize the share 15, 2017</p><p> shareholders price, they must explain the cause for failing to Duration:</p><p> and actual do so at the Issuer"s General Meeting of November</p><p> controllers Shareholders and the media designated by the 15, 2017</p><p> CSRC and publicly apologize to the Issuer"s to long-</p><p> shareholders and public investors. Where the term</p><p> commitment is not fulfilled, they will not</p><p> receive shareholder dividends from the Issuer</p><p> within 5 working days from the date when the</p><p> said incident occurs, and they will not be able</p><p> to transfer their shares until they take measures</p><p> to stabilize the share price as per the said plan</p><p> and achieve results.</p><p>Other The When the preconditions for enabling the share Date: No Yes Not Not</p><p> Company"s price stabilization plan are met, if failing to November applicable applicable</p><p> directors take specific measures to stabilize the share 15, 2017</p><p> (excluding price as per the plan to stabilize the share price, Duration:</p><p> independent they must explain the cause for failing to do so November</p><p> directors) at the Issuer"s General Meeting of 15, 2017</p><p> and senior Shareholders and the media designated by the to long-</p><p> management CSRC and publicly apologize to the Issuer"s term</p><p> shareholders and public investors. Where the</p><p> commitment is not fulfilled, they will not</p><p> receive remuneration and shareholder</p><p> dividends (if any) from the Issuer within 5</p><p> Annual Report 2022</p><p> working days from the date when the said</p><p> incident occurs, and they will not be able to</p><p> transfer their shares until they take measures to</p><p> stabilize the share price as per the said plan and</p><p> achieve results.</p><p>Other The If the Company"s prospectus contains false Date: No Yes Not Not</p><p> Company records, misleading statements or major November applicable applicable</p><p> omissions, which causes investors to suffer 15, 2017</p><p> losses in securities transactions, the Company Duration:</p><p> will compensate investors for such losses by November</p><p> law. After the illegal facts mentioned above 15, 2017</p><p> are identified by the CSRC or the stock to long-</p><p> exchange or the judicial authority where the term</p><p> Company is located, the Company will</p><p> actively compensate investors for direct</p><p> economic losses incurred therefrom by settling</p><p> with investors with respect to measurable</p><p> economic losses directly incurred to investors,</p><p> mediating with investors through a third party</p><p> and establishing an investor compensation</p><p> fund based on the principles of procedure</p><p> simplification, active negotiation,</p><p> compensation in advance, and effective</p><p> protection of investors" interests, especially</p><p> small and medium investors. If found to have</p><p> violated the said commitments, the Company</p><p> will publicly apologize to shareholders and</p><p> public investors for failing to perform the said</p><p> compensation measures at the General</p><p> Annual Report 2022</p><p> Meeting of Shareholders and the media</p><p> designated by the CSRC and compensate</p><p> investors for the actual losses identified by the</p><p> CSRC and the judicial authority.</p><p>Other The Issuer"s If the Issuer"s prospectus contains false Date: No Yes Not Not</p><p> controlling records, misleading statements or major November applicable applicable</p><p> shareholders omissions, which causes investors to suffer 15, 2017</p><p> and actual losses in securities transactions, they will Duration:</p><p> controllers compensate investors for such losses by law. November</p><p> After the illegal facts mentioned above are 15, 2017</p><p> identified by the CSRC or the stock exchange to long-</p><p> or the judicial authority where the Company is term</p><p> located, the Company will actively</p><p> compensate investors for direct economic</p><p> losses incurred therefrom by settling with</p><p> investors with respect to measurable economic</p><p> losses directly incurred to investors, mediating</p><p> with investors through a third party and</p><p> establishing an investor compensation fund</p><p> based on the principles of procedure</p><p> simplification, active negotiation,</p><p> compensation in advance, and effective</p><p> protection of investors" interests, especially</p><p> small and medium investors. If found to have</p><p> violated the said commitments, the Company"s</p><p> controlling shareholders and actual controllers</p><p> will publicly apologize to the Issuer"s</p><p> shareholders and public investors for failing to</p><p> perform the said compensation measures at the</p><p> Annual Report 2022</p><p> Issuer"s General Meeting of Shareholders and</p><p> the media designated by the CSRC and will not</p><p> receive shareholder dividends from the Issuer</p><p> within 5 working days from the date when the</p><p> said commitments are violated, and their</p><p> shares in the Issuer will not be transferred until</p><p> they take compensation measures as per the</p><p> said commitments and achieve results.</p><p>Other Directors, If the Issuer"s prospectus contains false Date: No Yes Not Not</p><p> supervisors records, misleading statements or major November applicable applicable</p><p> and senior omissions, which causes investors to suffer 15, 2017</p><p> management losses in securities transactions, they will Duration:</p><p> compensate investors for such losses by law. November</p><p> After the illegal facts mentioned above are 15, 2017</p><p> identified by the CSRC or the stock exchange to long-</p><p> or the judicial authority where the Company is term</p><p> located, the Company will actively</p><p> compensate investors for direct economic</p><p> losses incurred therefrom by settling with</p><p> investors with respect to measurable economic</p><p> losses directly incurred to investors, mediating</p><p> with investors through a third party and</p><p> establishing an investor compensation fund</p><p> based on the principles of procedure</p><p> simplification, active negotiation,</p><p> compensation in advance, and effective</p><p> protection of investors" interests, especially</p><p> small and medium investors. If found to have</p><p> violated the said commitments, the Company"s</p><p> Annual Report 2022</p><p> directors, supervisors and senior management</p><p> will publicly apologize to the Issuer"s</p><p> shareholders and public investors for failing to</p><p> perform the said compensation measures at the</p><p> Issuer"s General Meeting of Shareholders and</p><p> the media designated by the CSRC and will not</p><p> receive remuneration (or allowances) and</p><p> shareholder dividends (if any) from the Issuer</p><p> within 5 working days from the date when the</p><p> said commitments are violated, and their</p><p> shares in the Issuer will not be transferred until</p><p> they take compensation measures as per the</p><p> said commitments and achieve results.</p><p>Other The In order to ensure the effective use of the Date: No Yes Not Not</p><p> Company proceeds from the IPO, effectively prevent the November applicable applicable</p><p> risk of diluting immediate returns and improve 15, 2017</p><p> future returns, the Company intends to take Duration:</p><p> measures including tightening operation November</p><p> management and internal control, accelerating 15, 2017</p><p> the progress of fundraising projects, and to long-</p><p> strengthening the investor return mechanism, term</p><p> so as to improve asset quality, increase</p><p> operation revenue, raise future earnings, and</p><p> achieve sustainable development to fill the</p><p> diluted immediate returns. The Company</p><p> promises to continuously improve various</p><p> measures to fill the diluted spot returns in</p><p> accordance with the implementation rules</p><p> issued by the CSRC and Shanghai Stock</p><p> Annual Report 2022</p><p> Exchange. If found to have violated the said</p><p> commitments, the Company will promptly</p><p> announce the facts and cause of such violation,</p><p> except for force majeure or other reasons not</p><p> attributable to the Company, apologize to the</p><p> Company"s shareholders and public investors,</p><p> make supplementary commitments or</p><p> substitute commitments to investors to protect</p><p> the interests of investors as much as possible,</p><p> and implement such supplementary</p><p> commitments or substitute commitments</p><p> subject to the approval by the Company"s</p><p> General Meeting of Shareholders.</p><p>Other Controlling In order to ensure that the Company"s Date: No Yes Not Not</p><p> shareholder measures to fill the diluted immediate returns November applicable applicable</p><p> and actual can be effectively performed, they, as the 15, 2017</p><p> controller Company"s controlling shareholder and actual Duration:</p><p> HOU controller, promise that: (1) Under no November</p><p> Juncheng circumstances will they abuse the position as 15, 2017</p><p> and FANG the controlling shareholder and actual to long-</p><p> Aiqin controller by ultra vires interfering with the term</p><p> Company"s operation and management</p><p> activities or encroaching on the Company"s</p><p> interests; (2) After the CSRC and Shanghai</p><p> Stock Exchange have otherwise released</p><p> opinions and implementation rules on</p><p> measures to fill the diluted immediate returns</p><p> and relevant commitments, if the Company"s</p><p> relevant provisions and their commitments</p><p> Annual Report 2022</p><p> contradict such rules, they will immediately</p><p> make supplementary commitments in line with</p><p> such rules of the CSRC and Shanghai Stock</p><p> Exchange, and actively promote the Company</p><p> to issue new commitments or measures up to</p><p> the requirements of the CSRC and Shanghai</p><p> Stock Exchange; (3) They will fully,</p><p> completely and timely perform the Company"s</p><p> measures to fill the diluted immediate returns</p><p> and their commitments regarding the measures</p><p> to fill the diluted immediate returns. If found</p><p> to have violated such commitments, which</p><p> causes losses to the Company or shareholders,</p><p> they are willing to: ① state the cause and</p><p> apologize at the General Meeting of</p><p> Shareholders and the media designated by the</p><p> CSRC; ② be liable for compensation to the</p><p> Company and/or shareholders by law; ③</p><p> unconditionally accept the penalties or</p><p> regulatory measures taken by the CSRC and/or</p><p> Shanghai Stock Exchange and other securities</p><p> regulators as per their current rules. The said</p><p> measures to fill the diluted immediate returns</p><p> shall not be deemed to constitute a guarantee</p><p> for the Company"s future profits.</p><p>Other Directors, In order to ensure that the Company"s Date: No Yes Not Not</p><p> senior measures to fill the diluted immediate returns November applicable applicable</p><p> management can be effectively performed, they, as the 15, 2017</p><p> Annual Report 2022</p><p>Company"s directors and senior management, Duration:</p><p>promise that: (1) They will not offer benefits November</p><p>to other entities or individuals for free or on 15, 2017</p><p>unfair terms, or otherwise harm the Company"s to long-</p><p>interests; (2) They will strictly follow the term</p><p>Company"s budget management by limiting</p><p>their duty-related consumption to the extent</p><p>required, subject to the Company"s</p><p>supervision, and free from waste or</p><p>extravagance; (3) They will not use the</p><p>Company"s assets to engage in investment and</p><p>consumption activities unrelated to their</p><p>duties; (4) They will actively promote the</p><p>improvement of the Company"s compensation</p><p>system to better meet the requirements for</p><p>filling the diluted immediate returns; support</p><p>the Company"s Board of Directors or</p><p>Remuneration Committee to link the</p><p>development, revision, and supplementation of</p><p>the Company"s compensation system with the</p><p>implementation of the measures to fill the</p><p>diluted immediate returns; promise that the</p><p>vesting conditions for the Company"s equity</p><p>incentives will be linked to the implementation</p><p>of the Company"s measures to fill the diluted</p><p>immediate returns; (5) After the CSRC and</p><p>Shanghai Stock Exchange have otherwise</p><p>released the opinions and implementation</p><p>rules on the measures to fill the diluted</p><p> Annual Report 2022</p><p>immediate returns and relevant commitments,</p><p>if the Company"s relevant provisions and their</p><p>commitments contradict such rules, they will</p><p>immediately make supplementary</p><p>commitments in line with such rules of the</p><p>CSRC and Shanghai Stock Exchange, and</p><p>actively promote the Company to issue new</p><p>commitments or measures up to the</p><p>requirements of the CSRC and Shanghai Stock</p><p>Exchange; (6) They will fully, completely and</p><p>timely perform the Company"s measures to fill</p><p>the diluted immediate returns and their</p><p>commitments regarding the measures to fill the</p><p>diluted immediate returns. If found to have</p><p>violated such commitments, which causes</p><p>losses to the Company or shareholders, they</p><p>are willing to: ① state the cause and</p><p>apologize at the General Meeting of</p><p>Shareholders and the media designated by the</p><p>CSRC; ② be liable for compensation to the</p><p>Company and/or shareholders by law; ③</p><p>unconditionally accept the penalties or</p><p>regulatory measures taken by the CSRC and/or</p><p>Shanghai Stock Exchange and other securities</p><p>regulators as per their current rules. The said</p><p>measures to fill the diluted immediate returns</p><p>shall not be deemed to constitute a guarantee</p><p>for the Issuer"s future profits.</p><p> Annual Report 2022</p><p>Avoiding Controlling 1. They do not and will not directly or Date: No Yes Not Not</p><p>horizontal shareholder indirectly engage in any activities constituting November applicable applicable</p><p>competition and actual horizontal competition with the existing and 15, 2017</p><p> controller future businesses of the Company and its Duration:</p><p> HOU holding subsidiaries, including but not limited November</p><p> Juncheng to the R&D, production and sale of any 15, 2017</p><p> and FANG products same as or similar to those of the to long-</p><p> Aiqin Company and its holding subsidiaries. They term</p><p> shall be liable for the economic losses to the</p><p> Company caused by violation of the above</p><p> commitments. 2. For the enterprises under</p><p> their control, They will perform their</p><p> obligations under such commitments by</p><p> assigning agencies and personnel (including</p><p> but not limited to directors and managers), and</p><p> They shall be liable for the economic losses to</p><p> the Company caused by violation of the above</p><p> commitments. 3. From the date of signing this</p><p> letter of commitment, if the Company further</p><p> expands its product and business scope, the</p><p> enterprises under their control shall not</p><p> compete with the Company within the</p><p> expanded product or business scope, or will, in</p><p> case of any possible competition with the</p><p> Company within the expanded product or</p><p> business scope, withdraw from the</p><p> competition by: (1) stopping the production of</p><p> competing or potentially competing products;</p><p> (2) stopping the operation of competing or</p><p> Annual Report 2022</p><p> potentially competing business; (3)</p><p> transferring the competing business to the</p><p> Company; or (4) transferring the competing</p><p> business to an unrelated third party. 4. Their</p><p> shareholding companies, including Hangzhou</p><p> Huazhuang Industrial Investment Co., Ltd.,</p><p> Huzhou Mogan Wangshu Cosmetics Industry</p><p> Phase I Venture Capital Partnership (Limited</p><p> Partnership), and companies that they invest</p><p> in, engage in no cosmetics business or related</p><p> upstream and downstream business. If they</p><p> engage in such businesses in the future, They</p><p> commit that they will withdraw their</p><p> investment in those business through equity</p><p> transfer and other means, and that the</p><p> Company will be given priority to invest in the</p><p> said enterprises according to legal provisions</p><p> and the consent of other shareholders of those</p><p> enterprises.</p><p> Other Controlling Commitments on the effective fulfillment of Date: No Yes Not Not</p><p> shareholder the Company"s measures to fill the diluted April 21, applicable applicable</p><p> and actual immediate returns: 1. Under no circumstances 2021</p><p> controller will they interfere with the Company"s Duration:</p><p>Commitments</p><p> HOU operation and management activities or April 21,</p><p>on</p><p> Juncheng encroach on the company"s interests by ultra 2021 to</p><p>refinancing</p><p> and FANG vires; 2. From the date of the issuance of these long-term</p><p> Aiqin commitments to the date of the Company"s</p><p> public issuance of A-share convertible</p><p> corporate bonds, if the CSRC releases new</p><p> Annual Report 2022</p><p> regulatory rules on the measures to fill the</p><p> diluted immediate returns and relevant</p><p> commitments and the above-mentioned</p><p> commitments can no longer satisfy the new</p><p> regulatory rules, they will make</p><p> supplementary commitments in line with the</p><p> latest rules of the CSRC; 3. They will</p><p> practically fulfill the Company"s measures for</p><p> filling the diluted immediate returns and their</p><p> commitments regarding the measures to fill the</p><p> diluted immediate returns. Where they violate</p><p> those commitments, causing losses to the</p><p> Company or investors, they will assume the</p><p> compensation liability to the Company or</p><p> investors according to law. As one of the</p><p> parties responsible for the measures to fill the</p><p> immediate returns, should they violate or</p><p> refuse to fulfill the above commitments, they</p><p> shall be subject to the punishment or relevant</p><p> regulatory measures imposed on them by the</p><p> securities regulatory authorities such as the</p><p> CSRC and the SSE in accordance with the</p><p> relevant regulations and rules.</p><p>Other Directors, Commitments on the effective fulfillment of Date: No Yes Not Not</p><p> senior the Company"s measures to fill the diluted April 21, applicable applicable</p><p> management immediate returns: 1. They will not offer 2021</p><p> benefits to other entities or individuals for free Duration:</p><p> or on unfair terms, or otherwise harm the April 21,</p><p> Company"s interests; 2. They will limit their</p><p> Annual Report 2022</p><p>duty-related consumption; 3. They will not use 2021 to</p><p>the Company"s assets to engage in investment long-term</p><p>and consumption activities unrelated to their</p><p>duties; 4. The compensation system developed</p><p>by the Board of Directors and the</p><p>Remuneration and Appraisal Committee will</p><p>be linked to the implementation of the</p><p>measures for filling the diluted immediate</p><p>returns; 5. If the Company issues equity</p><p>incentives in the future, the vesting conditions</p><p>for the Company"s equity incentives will be</p><p>linked to the implementation of the Company"s</p><p>measures to fill the diluted immediate returns;</p><p>commitments to the date of the Company"s</p><p>public issuance of A-share convertible</p><p>corporate bonds, if the CSRC releases new</p><p>regulatory rules on the measures to fill the</p><p>diluted immediate returns and relevant</p><p>commitments and the above-mentioned</p><p>commitments can no longer satisfy the new</p><p>regulatory rules, they will make</p><p>supplementary commitments in line with the</p><p>latest rules of the CSRC. As one of the parties</p><p>responsible for the measures to fill the</p><p>immediate returns, should they violate or</p><p>refuse to fulfill the above commitments, they</p><p>shall be subject to the punishment or relevant</p><p>regulatory measures imposed on them by the</p><p> Annual Report 2022</p><p>securities regulatory authorities such as the</p><p>CSRC and the SSE in accordance with the</p><p>relevant regulations and rules.</p><p> Annual Report 2022</p><p>(II) Statement of whether the Company"s assets or projects fulfilled the original profit forecast</p><p> and its reason where the Company had profit forecasts on assets or projects and the Reporting</p><p> Period fell within the term of profit forecasts</p><p>□Fulfilled □Unfulfilled √Not applicable</p><p>(III) Execution of the performance undertakings and their impact on the goodwill impairment</p><p> testing</p><p>□ Applicable √ Not applicable</p><p> Annual Report 2022</p><p>II. Non-operating Occupation of Funds by the Controlling Shareholders and Other Related Parties during the Reporting Period</p><p>□ Applicable √ Not applicable</p><p>III. Illegal Guarantee</p><p>□ Applicable √ Not applicable</p><p> Annual Report 2022</p><p>IV. Explanation of the Company"s Board of Directors on the "Non-standard Audit Report" from</p><p> the Accounting Firm</p><p>□ Applicable √ Not applicable</p><p>V. Analysis and Explanation from the Company on the Reasons and Impact of Changes in</p><p> Accounting Policies, Accounting Estimates or Correction on Significant Accounting Errors</p><p>(I) Analysis and explanation from the Company on the reasons and impact of changes in</p><p> accounting policies or accounting estimates</p><p>√ Applicable □ Not applicable</p><p>For details, see the description in "44. Changes in significant accounting policies and accounting</p><p>estimates", "V. Significant Accounting Policies and Accounting Estimates", "Section X Financial Report".</p><p>(II) Analysis and explanation from the Company on the reasons and impact of the correction on</p><p> significant accounting errors</p><p>□ Applicable √ Not applicable</p><p>(III) Communication with the previous accounting firm</p><p>□ Applicable √ Not applicable</p><p>(IV) Other explanations</p><p>□ Applicable √ Not applicable</p><p>VI. Appointment and Dismissal of the Accounting Firm</p><p> Unit: Yuan Currency: RMB</p><p> Current accounting firm</p><p> Pan-China Certified Public Accountants</p><p> Name of the domestic accounting firm</p><p> (Special General Partnership)</p><p> Remuneration of the domestic accounting firm 1,400,000</p><p> Term of office of the domestic accounting firm 12</p><p> Names of CPAs from the domestic accounting firm YIN Zhibin, WANG Xiaokang</p><p> YIN Zhibin: 3 years of continual term of</p><p> Continual term of audit service provided by the CPAs audit service</p><p> from the in the domestic accounting firm WANG Xiaokang: 5 years of continual</p><p> term of audit service</p><p> Name Remuneration</p><p> Pan-China Certified Public</p><p> Accounting firm for internal</p><p> Accountants (Special General 200,000</p><p> control and audit</p><p> Partnership)</p><p>Explanation on appointment and dismissal of the accounting firm</p><p>□ Applicable √ Not applicable</p><p> Annual Report 2022</p><p>Explanation on the change of accounting firm during the Auditing Period</p><p>□ Applicable √ Not applicable</p><p>VII. Particulars on Risk of Delisting</p><p>(I) Reasons for the delisting risk warning</p><p>□ Applicable √ Not applicable</p><p>(II) Measures to be taken by the Company</p><p>□ Applicable √ Not applicable</p><p>(III) Situation and causes for termination of listing</p><p>□ Applicable √ Not applicable</p><p>VIII. Matters Related to Bankruptcy and Reorganization</p><p>□ Applicable √ Not applicable</p><p>IX. Material Litigations and Arbitrations</p><p>□ The Company had material litigations and arbitrations during the year √ The Company had no material</p><p>litigations and arbitrations during the year</p><p>X. Suspected Violations, Penalties and Rectifications of the Company and Its Directors,</p><p> Supervisors, Senior Management, Controlling Shareholders and Actual Controllers</p><p>□ Applicable √ Not applicable</p><p>XI. Integrity of the Company and Its Controlling Shareholders and Actual Controllers During the</p><p> Reporting Period</p><p>√ Applicable □ Not applicable</p><p> During the Reporting Period, the Company and its controlling shareholders and actual controllers</p><p>were in good faith.</p><p>XII. Significant Related-party Transactions</p><p>(I) Related-party transactions pertaining to daily operation</p><p> the follow-up implementation</p><p>□ Applicable √ Not applicable</p><p> follow-up implementation</p><p>√ Applicable □ Not applicable</p><p>The 5th meeting of the third session of Board of Directors and the 2021 annual General Meeting of</p><p>Shareholders were held by the Company on April 20, 2022 and May 12, 2022 respectively to deliberate</p><p> Annual Report 2022</p><p>on and approve the Proposal on the Estimated Amount of Daily Related-party Transactions for 2022. For</p><p>details, see the Announcement on the Estimated Amount of Daily Related-party Transactions for 2022</p><p>(No.: 2022-020) disclosed by the Company on the SSE website (www.sse.com.cn) on April 22, 2022. The</p><p>number of daily related-party transactions of the Company in 2022 does not exceed the estimated number</p><p>at the beginning of the year.</p><p>The estimated and actual amounts of the Company"s daily related-party transactions in 2022 are as follows:</p><p> Category of</p><p> Actual amount in</p><p> related-party Related party Estimated amount in 2022</p><p> transactions</p><p> Deposits in</p><p> Zhejiang Yueqing Rural No more than RMB150</p><p> bank accounts</p><p> Commercial Bank Co., million for daily amount RMB146.67million</p><p> opened with the</p><p> Ltd.</p><p> related party</p><p> Huzhou Beauteville</p><p> Information of</p><p> Technology Incubator RMB1.8 million RMB1.12million</p><p> related lease</p><p> Co., Ltd.</p><p>Note: The "actual amount in 2022" represents the balance in the accounts as of March 15, 2022 as Zhejiang</p><p>Yueqing Rural Commercial Bank Co., Ltd. has no longer been identified as an affiliated entity of the</p><p>Company since March 16, 2022. From January 1, 2022 to March 15, 2022, the Company obtained a deposit</p><p>interest of RMB1.44million from Zhejiang Yueqing Rural Commercial Bank Co., Ltd.</p><p>□ Applicable √ Not applicable</p><p>(II) Related-party transactions arising from acquisition and disposal of assets or equity</p><p> the follow-up implementation</p><p>□ Applicable √ Not applicable</p><p> follow-up implementation</p><p>□ Applicable √ Not applicable</p><p>□ Applicable √ Not applicable</p><p> performance</p><p>□ Applicable √ Not applicable</p><p>(III) Significant related-party transactions pertaining to joint external investment</p><p> the follow-up implementation</p><p>□ Applicable √ Not applicable</p><p> Annual Report 2022</p><p> follow-up implementation</p><p>□ Applicable √ Not applicable</p><p>□ Applicable √ Not applicable</p><p>(IV) Credits and debits with related parties</p><p> the follow-up implementation</p><p>□ Applicable √ Not applicable</p><p> follow-up implementation</p><p>□ Applicable √ Not applicable</p><p>□ Applicable √ Not applicable</p><p>(V) Financial business between the Company and related financial companies, holding financial</p><p>companies and related parties</p><p>□ Applicable √ Not applicable</p><p>(VI) Other</p><p>□ Applicable √ Not applicable</p><p>XIII. Significant Contracts and Their Performance</p><p>(I) Trusteeship, contracting and leasing</p><p>□ Applicable √ Not applicable</p><p>□ Applicable √ Not applicable</p><p>□ Applicable √ Not applicable</p><p> Annual Report 2022</p><p>(II) Guarantee</p><p>□ Applicable √ Not applicable</p><p> Annual Report 2022</p><p>(III) Entrusting others to manage cash assets</p><p>(1) Overall condition of entrusted wealth management</p><p>□ Applicable √ Not applicable</p><p>Others</p><p>□ Applicable √ Not applicable</p><p>(2) Individual entrusted wealth management</p><p>□ Applicable √ Not applicable</p><p>Others</p><p>□ Applicable √ Not applicable</p><p>(3) Impairment provisions of entrusted wealth management</p><p>□ Applicable √ Not applicable</p><p>(1) Overall condition of entrusted loans</p><p>□ Applicable √ Not applicable</p><p>Others</p><p>□ Applicable √ Not applicable</p><p>(2) Individual entrusted loans</p><p>□ Applicable √ Not applicable</p><p>Others</p><p>□ Applicable √ Not applicable</p><p>(3) Impairment provisions of entrusted loans</p><p>□ Applicable √ Not applicable</p><p>□ Applicable √ Not applicable</p><p>(IV) Other material contracts</p><p>□ Applicable √ Not applicable</p><p>XIV. Other Major Matters That Have A Significant Impact on Investors" Value Judgments and</p><p> Investment Decisions</p><p>□ Applicable √ Not applicable</p><p> Annual Report 2022</p><p> Section VII Shareholders and Changes in Shares</p><p> I. Changes in Share Capital</p><p> (I) Table of changes in shares</p><p> Unit: ’0,000 shares</p><p> Before this change Increase or decrease (+ or -) due to this change After this change</p><p> Shares</p><p> Issuance converted</p><p> Percent Bonus Percentage</p><p> Number of new from Other Subtotal Number</p><p> age (%) shares (%)</p><p> shares capital</p><p> reserve</p><p>I. Restricted</p><p>shares</p><p>by the state</p><p>by state-owned</p><p>legal persons</p><p>by other 34.7201 0.1727 210 -34.7201 175.2799 210 0.7407</p><p>domestic funds</p><p>Wherein: Shares</p><p>held by</p><p>domestic non-</p><p>state-owned</p><p>legal persons</p><p>Shares held by</p><p>domestic natural 34.7201 0.1727 210 -34.7201 175.2799 210 0.7407</p><p>persons</p><p>by foreign funds</p><p>Wherein: Shares</p><p>held by foreign</p><p>legal persons</p><p> Shares</p><p>held by foreign</p><p>natural persons</p><p>II. Unrestricted</p><p>outstanding 99.8273 8,040.3986 35.2718 99.2593</p><p>shares</p><p>Ordinary Shares 2765 04 469</p><p>funded shares</p><p>listed</p><p>domestically</p><p>funded shares</p><p>listed overseas</p><p> Annual Report 2022</p><p>III. Total shares 20,100. 8,250.95 28,351.9</p><p> √ Applicable □ Not applicable</p><p> On January 12, 2022, the 4th meeting of the third session of Board of Directors and the 4th meeting of the</p><p> third session of Board of Supervisors were held to deliberate on and approve the Proposal on the</p><p> Satisfaction of Conditions for Releasing the Sales Restrictions for the Third Release Period of the</p><p> Restricted Shares Granted for the First Time and with Reserve under the 2018 Restricted Share Incentive</p><p> Plan, agreeing that the Company may handle the release procedure for the incentive recipients who meet</p><p> the conditions for releasing the sales restrictions. A total of 347,201 restricted shares were released from</p><p> the sales restriction. The circulation date of released shares is January 20, 2022. The number of the</p><p> unrestricted circulating shares of the Company increased from 200,662,765 before the listing to</p><p> listing to 0.</p><p> On May 12, 2022, the 2021 annual General Meeting of Shareholders was held to deliberate on and approve</p><p> the Company"s Plan for Profit Distribution and Capitalization of Capital Reserves for 2021, in which the</p><p> Company distributed to all shareholders a cash dividend of RMB8.60 (tax inclusive) per 10 shares based</p><p> on the total share capital as of the record date on which equity distribution is implemented and issued 4</p><p> shares for every 10 shares to all shareholders through capitalization of the capital reserve, totaling</p><p> number of the unrestricted circulating shares of the Company increased from 201,009,966 before the</p><p> listing to 281,413,952.</p><p> On July 25, 2022, the 7th meeting of the third session of Board of Directors and the 7th meeting of the</p><p> third session of Board of Supervisors were held to deliberate on and approve the Proposal on the Granting</p><p> of Restricted Shares to Incentive Recipients, which considered that the granting conditions specified in the</p><p> restricted shares would be granted to 101 eligible incentive recipients at the consideration of</p><p> RMB78.56/share on July 25, 2022, which is considered the grant day. On September 6, 2022, the Company</p><p> completed the registration of the grant under the 2022 Restricted Share Incentive Plan at CSDC Shanghai</p><p> Branch. The number of the restricted circulating shares of the Company increased from 0 before the listing</p><p> to 2,100,000.</p><p> With the Approval of the CSRC, namely, the Reply on Approving Proya Cosmetics Co., Ltd."s Public</p><p> Issuance of Convertible Corporate Bonds (Zheng Jian Xu Ke [2021] No. 3408), on December 8, 2021,</p><p> the Company publicly issued 7,517,130 convertible bonds with a face value of RMB100 per share and a</p><p> total face value of RMB751,713,000, with a term of 6 years. With the approval of the SSE"s Self-</p><p> Regulatory Supervision Decision Letter [2021] No. 503, the convertible corporate bonds issued by the</p><p> Company amounting to RMB751,713,000 would be listed and traded on the Shanghai Stock Exchange</p><p> from January 4, 2022, with the short name of "Proya Convertible Bond" and the bond code of "113634".</p><p> The Proya Convertible Bond started conversion on June 14, 2022. As of December 31, 2022, RMB776,000</p><p> of Proya Convertible Bond had been converted to A-share stocks of the Company, generating 5,517 shares.</p><p> The number of the unrestricted circulating shares of the Company increased by 5,517.</p><p> Annual Report 2022</p><p> financial indicators in the last year and period (if any)</p><p>√ Applicable □ Not applicable</p><p>Implementation of the 2021 plan for capitalization of capital reserves: calculated based on the diluted total</p><p>share capital after the capitalization of capital reserves.</p><p>Changes in other shares: no material impact.</p><p> authority requires</p><p>□ Applicable √ Not applicable</p><p>(II) Changes in restricted shares</p><p>√ Applicable □ Not applicable</p><p> Unit: Share</p><p> Number of Number of Number of</p><p> Number of</p><p> restricted restricted restricted Date of</p><p> restricted Reason for</p><p> Name of shares at shares shares releasing</p><p> shares at the sales</p><p> shareholder the released increased the sales</p><p> end of the restriction</p><p> beginning during the during the restriction</p><p> year</p><p> of the year year year</p><p> Restricted</p><p> JIN Yanhua 39,320 39,320 140,000 140,000 -</p><p> Stock</p><p> Incentive Plan</p><p> Restricted</p><p> WANG Li 22,382 22,382 180,000 180,000 -</p><p> Stock</p><p> Incentive Plan</p><p> granted for The grant for</p><p> the first time the first time</p><p> under 2018 under 2018 January</p><p> Restricted Restricted 20, 2022</p><p> Stock Stock</p><p> Incentive Incentive Plan</p><p> Plan</p><p> granted with The grant with</p><p> reserve under reserve under</p><p> Restricted Restricted 20, 2022</p><p> Stock Stock</p><p> Incentive Incentive Plan</p><p> Plan</p><p> Annual Report 2022</p><p> granted under</p><p> Restricted</p><p> Restricted 0 0 1,780,000 1,780,000 -</p><p> Stock</p><p> Stock</p><p> Incentive Plan</p><p> Incentive</p><p> Plan</p><p> Total 347,201 347,201 2,100,000 2,100,000 / /</p><p>II. Issuance and Listing of Securities</p><p>(I) Issuance of securities as of the Reporting Period</p><p>√ Applicable □ Not applicable</p><p> Unit: Share Currency: RMB</p><p> Number of</p><p> Issue</p><p> Category of shares</p><p> price (or Issue Circulation Termination</p><p> shares and their Issue date available for</p><p> interest quantity date date</p><p> derivatives circulation</p><p> rate)</p><p> and trading</p><p> Convertible corporate bonds and warrant bonds</p><p> Convertible</p><p> corporate bonds</p><p>Issuance of securities in the Reporting Period (provide separate explanation on bonds with different</p><p>interest rates in their duration):</p><p>√ Applicable □ Not applicable</p><p>With the Approval of the CSRC, namely, the Reply on Approving Proya Cosmetics Co., Ltd."s Public</p><p>Issuance of Convertible Corporate Bonds (Zheng Jian Xu Ke [2021] No. 3408), on December 8, 2021,</p><p>the Company publicly issued 7,517,130 convertible bonds with a face value of RMB100 per share and a</p><p>total face value of RMB751,713,000. These convertible bonds were issued at face value with a term of 6</p><p>years.</p><p>With the approval of the SSE"s Self-Regulatory Supervision Decision Letter [2021] No. 503, the</p><p>convertible corporate bonds issued by the Company amounting to RMB751,713,000 would be listed and</p><p>traded on the Shanghai Stock Exchange from January 4, 2022, with the short name of "Proya Convertible</p><p>Bond" and the bond code of "113634". The nominal interest rate of the convertible corporate bonds issued</p><p>this time was as follows: 0.30% in the first year, 0.50% in the second year, 1.00% in the third year, 1.50%</p><p>in the fourth year, 1.80% in the fifth year, and 2.00% in the sixth year. The duration of the convertible</p><p>corporate bonds runs from December 8, 2021 to December 7, 2027.</p><p>According to relevant regulations and the Prospectus of Proya Cosmetics Co., Ltd. for the Public Offering</p><p>of A-Share Convertible Corporate Bonds, this “Proya Convertible Bond” issued by the Company can be</p><p>converted to the Company"s shares from June 14, 2022. The convertible period is from June 14, 2022 to</p><p>December 7, 2027. The initial conversion price is 195.98 RMB/share. The latest conversion price is 138.92</p><p>RMB/share. The historical adjustments to the conversion price are as follows:</p><p>“Proya Convertible Bond” was adjusted to RMB139.37/share on May 30, 2022. For details, see the</p><p>Announcement of Proya Cosmetics Co., Ltd. on Adjustment of Conversion Price due to 2021 Equity</p><p> Annual Report 2022</p><p>Distribution Plan (No.: 2022-029) released by the Company on the SSE website on May 24, 2022</p><p>(www.sse.com.cn).</p><p>Plan was completed, the conversion price of the “Proya Convertible Bond” has been adjusted to 138.92</p><p>RMB/share since September 9, 2022. For details, see the Announcement of Proya Cosmetics Co., Ltd. on</p><p>Adjustment of Conversion Price due to Additional Issuance from Granting of Restricted Shares (No.:</p><p>(II) Changes in the total number of shares and shareholder structure of the Company and changes</p><p> in the structure of assets and liabilities of the Company</p><p>√ Applicable □ Not applicable</p><p>The total number of the Company"s ordinary shares at the beginning and end of the Reporting Period was</p><p>The Company"s total assets and total liabilities at the beginning of the Reporting Period amounted to</p><p>RMB4,633,049,783.03 and RMB1,746,209,355.96 respectively, with the asset-liability ratio of 37.69%.</p><p>The Company"s total assets and total liabilities at the end of the Reporting Period amounted to</p><p>RMB5,778,071,824.19 and RMB2,240,848,493.90 respectively, with the asset-liability ratio of 38.78%.</p><p>(III) Existing internal employee shares</p><p>□ Applicable √ Not applicable</p><p>III. Shareholders and Actual Controllers</p><p>(I) Total number of shareholders</p><p> Total number of shareholders of ordinary shares as</p><p> of the end of the Reporting Period</p><p> Total number of shareholders of ordinary shares at</p><p> the end of last month prior to the disclosure date 13,080</p><p> of the Annual Report</p><p> Total number of shareholders of preferred shares</p><p> whose voting rights have been restored as of the 0</p><p> end of the Reporting Period</p><p> Total number of shareholders of preferred shares</p><p> whose voting rights have been restored at the end</p><p> of last month prior to the disclosure date of the</p><p> Annual Report</p><p>(II) Table of shareholdings of the top ten shareholders and the top ten shareholders of circulating</p><p> shares (or unrestricted shareholders) as of the end of the Reporting Period</p><p> Unit: share</p><p> Shareholdings of the top ten shareholders</p><p> Name of Number of Number Pledged,</p><p> Change Percentage Nature of</p><p> shareholder shares held of marked or</p><p> during the (%) shareholder</p><p> (full name) at the end restricted frozen</p><p> Annual Report 2022</p><p> Reporting of the shares Share</p><p> Number</p><p> Period period held status</p><p> Domestic</p><p>HOU</p><p>Juncheng</p><p> person</p><p>Hong Kong</p><p>Securities</p><p>Clearing 17,317,429 64,473,469 22.74 0 None Other</p><p>Company</p><p>Limited</p><p> Domestic</p><p>FANG Yuyou 9,424,627 45,772,470 16.14 0 None natural</p><p> person</p><p>China</p><p>Construction</p><p>Bank Co.,</p><p>Ltd. - Yinhua</p><p>Fuyu Theme 5,801,301 5,801,301 2.05 0 None Other</p><p>Hybrid</p><p>Securities</p><p>Investment</p><p>Fund</p><p>China</p><p>Construction</p><p>Bank Co.,</p><p>Ltd. - CUAM</p><p>Consumer</p><p>Industry</p><p>Hybrid</p><p>Securities</p><p>Investment</p><p>Fund</p><p>Aberdeen</p><p>Standard</p><p>Investment</p><p>Management</p><p>(Asia) Co.,</p><p>Ltd. -</p><p>Aberdeen</p><p>Standard -</p><p>China A-share</p><p>Equity Fund</p><p> Annual Report 2022</p><p>Industrial and</p><p>Commercial</p><p>Bank of China</p><p>Limited -</p><p>Jingshun</p><p>Changcheng</p><p>Emerging</p><p>Growth</p><p>Hybrid</p><p>Securities</p><p>Investment</p><p>Fund</p><p>Industrial and</p><p>Commercial</p><p>Bank of China</p><p>Limited -</p><p>CUAM</p><p>Consumption 300,002 1,500,089 0.53 0 None Other</p><p>Upgrade</p><p>Hybrid</p><p>Securities</p><p>Investment</p><p>Fund</p><p> Domestic</p><p>CAO</p><p> -2,407,401 1,362,537 0.48 0 None natural</p><p>Liangguo</p><p> person</p><p>J. P. Morgan</p><p>Securities</p><p>PLC - Self-</p><p>owned Capital</p><p> Shareholdings of the top ten unrestricted shareholders</p><p> Number of unrestricted Type and number of shares</p><p> Name of shareholder</p><p> circulating shares held Type Number</p><p>HOU Juncheng 97,670,741 RMB ordinary shares 97,670,741</p><p>Hong Kong Securities</p><p>Clearing Company Limited</p><p>FANG Yuyou 45,772,470 RMB ordinary shares 45,772,470</p><p>China Construction Bank</p><p>Co., Ltd. - Yinhua Fuyu</p><p>Theme Hybrid Securities</p><p>Investment Fund</p><p>China Construction Bank</p><p>Co., Ltd. - CUAM Consumer</p><p>Industry Hybrid Securities</p><p>Investment Fund</p><p> Annual Report 2022</p><p> Aberdeen Standard</p><p> Investment Management</p><p> (Asia) Co., Ltd. - Aberdeen 2,552,293 RMB ordinary shares 2,552,293</p><p> Standard - China A-share</p><p> Equity Fund</p><p> Industrial and Commercial</p><p> Bank of China Limited -</p><p> Jingshun Changcheng 2,380,000 RMB ordinary shares 2,380,000</p><p> Emerging Growth Hybrid</p><p> Securities Investment Fund</p><p> Industrial and Commercial</p><p> Bank of China Limited -</p><p> CUAM Consumption 1,500,089 RMB ordinary shares 1,500,089</p><p> Upgrade Hybrid Securities</p><p> Investment Fund</p><p> CAO Liangguo 1,362,537 RMB ordinary shares 1,362,537</p><p> J. P. Morgan Securities PLC</p><p> - Self-owned Capital</p><p> Explanation on the special</p><p> account for repurchase</p><p> None</p><p> among the top ten</p><p> shareholders</p><p> Explanation on the above-</p><p> mentioned shareholders"</p><p> entrusting voting rights, None</p><p> entrusted voting rights and</p><p> abstention from voting rights</p><p> Explanation on the related</p><p> relationship or parties acting FANG Yuyou is the younger brother of HOU Juncheng"s spouse FANG</p><p> in concert among the above Aiqin, so HOU Juncheng and FANG Yuyou are related.</p><p> shareholders</p><p> Explanation on the</p><p> shareholders of preferred</p><p> shares with voting rights None</p><p> restored and their</p><p> shareholdings</p><p>Shareholdings and sales restrictions of the top ten restricted shareholders</p><p>√ Applicable □ Not applicable</p><p> Unit: share</p><p> Number of Availability of restricted</p><p> Name of shareholder of Sales</p><p> Number restricted shares for circulation and</p><p> restricted shares restrictions</p><p> shares held trading</p><p> Annual Report 2022</p><p> Number of</p><p> Time of</p><p> new shares</p><p> availability</p><p> available</p><p> for</p><p> for</p><p> circulation</p><p> circulation</p><p> and trading</p><p> and trading</p><p> See the</p><p> explanation</p><p> below for</p><p> details</p><p> Explanation on the related relationship or</p><p> parties acting in concert among the above None</p><p> shareholders</p><p>Note: The restricted shares held by equity incentive recipients are those granted under the 2022 Restricted</p><p>Stock Incentive Plan. The restricted period was 12 months, 24 months, and 36 months from the completion</p><p>of their registration with CSDC Shanghai Branch (September 6, 2022).</p><p>(III) Strategic investors or general legal persons becoming the top ten shareholders because of</p><p> placing of new shares</p><p>□ Applicable √ Not applicable</p><p>IV. Controlling shareholders and Actual Controllers</p><p>(I) Controlling shareholders</p><p>□ Applicable √ Not applicable</p><p>√ Applicable □ Not applicable</p><p> Name HOU Juncheng and Fang Aiqin</p><p> Nationality Chinese</p><p> Acquire residence permits in other</p><p> No</p><p> countries or regions or not</p><p> HOU Juncheng and Fang Aiqin are husband and wife. HOU</p><p> Juncheng serves as the Chairman of the Company, and Fang</p><p> Main job and title</p><p> Aiqin serves as the Senior Purchasing Consultant of the</p><p> Company.</p><p>□ Applicable √ Not applicable</p><p>□ Applicable √ Not applicable</p><p> Annual Report 2022</p><p> controlling shareholders</p><p>√ Applicable □ Not applicable</p><p>(II) Actual controllers</p><p>□ Applicable √ Not applicable</p><p>√ Applicable □ Not applicable</p><p> Name HOU Juncheng and Fang Aiqin</p><p> Nationality Chinese</p><p> Acquire residence permits in other</p><p> No</p><p> countries or regions or not</p><p> HOU Juncheng and Fang Aiqin are husband and wife. HOU</p><p> Juncheng serves as the Chairman of the Company, and Fang</p><p> Main job and title</p><p> Aiqin serves as the Senior Purchasing Consultant of the</p><p> Company.</p><p> Shareholdings in other domestic or</p><p> overseas listed companies over the None</p><p> past 10 years</p><p>□ Applicable √ Not applicable</p><p>□ Applicable √ Not applicable</p><p> controllers</p><p>√ Applicable □ Not applicable</p><p> Annual Report 2022</p><p> management</p><p>□ Applicable √ Not applicable</p><p>(III) Other explanations on controlling shareholders and actual controllers</p><p>□ Applicable √ Not applicable</p><p>V. The accumulative number of pledged shares of the Company"s controlling shareholders or the</p><p> largest shareholder and its persons acting in concert accounted for more than 80% of the</p><p> Company"s shares held by them</p><p>□ Applicable √ Not applicable</p><p>VI. Other Legal Person Shareholders with More Than 10% Shareholdings</p><p>□ Applicable √ Not applicable</p><p>VII. Explanation on Limitation on Reduction of Shareholding</p><p>□ Applicable √ Not applicable</p><p>VIII.Specific Implementation of Share Repurchase During the Reporting Period</p><p>□ Applicable √ Not applicable</p><p> Section VIII Information on Preferred Shares</p><p>□ Applicable √ Not applicable</p><p> Annual Report 2022</p><p> Section IX Information on Bonds</p><p>I. Enterprise Bonds, Corporate Bonds and Non-financial Corporate Debt Financing Instruments</p><p>□ Applicable √ Not applicable</p><p>II. Convertible Corporate Bonds</p><p>√ Applicable □ Not applicable</p><p>(I) Issuance of convertible bonds</p><p>√ Applicable □ Not applicable</p><p>With the Approval of the CSRC, namely, the Reply on Approving Proya Cosmetics Co., Ltd."s Public</p><p>Issuance of Convertible Corporate Bonds (Zheng Jian Xu Ke [2021] No. 3408), on December 8, 2021,</p><p>the Company publicly issued 7,517,130 convertible bonds with a face value of RMB100 per share and a</p><p>total face value of RMB751,713,000. These convertible bonds were issued at face value with a term of 6</p><p>years.</p><p>With the approval of the SSE"s Self-Regulatory Supervision Decision Letter [2021] No. 503, the</p><p>convertible corporate bonds issued by the Company amounting to RMB751,713,000 would be listed and</p><p>traded on the Shanghai Stock Exchange from January 4, 2022, with the short name of "Proya Convertible</p><p>Bond" and the bond code of "113634". The nominal interest rate of the convertible corporate bonds issued</p><p>this time was as follows: 0.30% in the first year, 0.50% in the second year, 1.00% in the third year, 1.50%</p><p>in the fourth year, 1.80% in the fifth year, and 2.00% in the sixth year. The duration of the convertible</p><p>corporate bonds runs from December 8, 2021 to December 7, 2027.</p><p>According to relevant regulations and the Prospectus of Proya Cosmetics Co., Ltd. for the Public Offering</p><p>of A-Share Convertible Corporate Bonds, this “Proya Convertible Bond” issued by the Company can be</p><p>converted to the Company"s shares from June 14, 2022. The convertible period is from June 14, 2022 to</p><p>December 7, 2027. The initial conversion price is 195.98 RMB/share. The latest conversion price is 138.92</p><p>RMB/share. The historical adjustments to the conversion price are as follows:</p><p>Proya Convertible Bond was adjusted to RMB139.37/share on May 30, 2022. For details, see the</p><p>Announcement of Proya Cosmetics Co., Ltd. on Adjustment of Conversion Price due to 2021 Equity</p><p>Distribution Plan (No.: 2022-029) released by the Company on the SSE website on May 24, 2022</p><p>(www.sse.com.cn).</p><p>Plan was completed, the conversion price of the Proya Convertible Bond has been adjusted to 138.92</p><p>RMB/share since September 9, 2022. For details, see the Announcement of Proya Cosmetics Co., Ltd. on</p><p>Adjustment of Conversion Price due to Additional Issuance from Granting of Restricted Shares (No.:</p><p>(II) Holders and guarantors of convertible bonds during the Reporting Period</p><p>√ Applicable □ Not applicable</p><p> Name of the convertible corporate</p><p> Proya Convertible Bond</p><p> bond</p><p> Number of holders of the convertible</p><p> corporate bond at the end of the</p><p> Annual Report 2022</p><p>Reporting Period</p><p>Guarantors of the convertible bond of</p><p> None</p><p>the Company</p><p>The top ten holders of the convertible bond are as follows:</p><p> Number of bonds held at</p><p> Name of holders of the convertible</p><p> the end of the Reporting Holding ratio (%)</p><p> corporate bond</p><p> Period (RMB)</p><p>Dajia Assets - Minsheng Bank - Dajia</p><p>Assets - Selected Conservative</p><p>Portfolio No.5 (Issue 2) Collective</p><p>Asset Management Product</p><p>China Merchants Bank Co., Ltd. -</p><p>Huabao Convertible Bond Securities 40,233,000 5.36</p><p>Investment Fund</p><p>ICBC Credit Suisse Ruixi Fixed-</p><p>income Pension Product - Bank of 26,647,000 3.55</p><p>China Limited</p><p>Industrial and Commercial Bank of</p><p>China Limited - Southern Profitable</p><p>Return Bond Securities Investment</p><p>Fund</p><p>Dajia Assets - China Merchants Bank -</p><p>Dajia Assets - Selected Conservative</p><p>Portfolio No.1 (Issue 1) Collective</p><p>Asset Management Product</p><p>Industrial and Commercial Bank of</p><p>China Limited - Yinhua Convertible 21,487,000 2.86</p><p>Bond Securities Investment Fund</p><p>Dajia Assets - China CITIC Bank -</p><p>Dajia Assets Houkun No.40 Collective 20,481,000 2.73</p><p>Asset Management Product</p><p>Generali Asset Management -</p><p>Industrial and Commercial Bank of</p><p>China - Generali Asset Management - 19,000,000 2.53</p><p>Selected Bond Asset Management</p><p>Product</p><p>Dajia Assets - Postal Savings Bank of</p><p>China - Dajia Assets - Selected</p><p>Conservative Portfolio No.6 (Issue 2)</p><p>Collective Asset Management Product</p><p>China Merchants Bank Co., Ltd. -</p><p>Oriental Juli Bond Securities 12,500,000 1.66</p><p>Investment Fund</p><p> Annual Report 2022</p><p>(III) Changes in convertible bonds during the Reporting Period</p><p>√ Applicable □ Not applicable</p><p> Unit: Yuan Currency: RMB</p><p> Name of the Increase or decrease due to this change</p><p> convertible Before this After this</p><p> Share</p><p> corporate change Redemption Sell-back change</p><p> conversion</p><p> bond</p><p> Proya</p><p> Convertible 751,713,000 776,000 0 0 750,937,000</p><p> Bond</p><p>Cumulative conversion of convertible bonds during the Reporting Period</p><p>√ Applicable □ Not applicable</p><p> Name of the convertible corporate bond Proya Convertible Bond</p><p> Amount of shares converted from bonds in the</p><p> Reporting Period (RMB)</p><p> Number of shares converted from bonds in the</p><p> Reporting Period (share)</p><p> Accumulated number of shares converted from</p><p> bonds (share)</p><p> Proportion of the accumulated number of</p><p> converted shares in the total number of issued 0.0020</p><p> shares of the Company before conversion (%)</p><p> Amount of bonds not converted into shares</p><p> (RMB)</p><p> Proportion of unconverted convertible bonds in</p><p> the total amount of convertible bonds issued (%)</p><p>(IV) Historical adjustments to the conversion price</p><p>√ Applicable □ Not applicable</p><p> Unit: Yuan Currency: RMB</p><p> Name of the convertible</p><p> Proya Convertible Bond</p><p> corporate bond</p><p> Date of Adjusted Time of Media of Explanation on adjustments to</p><p> adjustment conversion price disclosure disclosure the conversion price</p><p> Since the 2021 Equity</p><p> SSE website,</p><p> Distribution Plan was</p><p> Shanghai</p><p> implemented by the Company,</p><p> May 30, 139.37 May 24, Securities</p><p> the conversion price of the Proya</p><p> Convertible Bond was adjusted</p><p> Securities</p><p> to 139.37 RMB/share on May</p><p> Times</p><p> Annual Report 2022</p><p> Announcement of Proya</p><p> Cosmetics Co., Ltd. on</p><p> Adjustment of Conversion Price</p><p> due to 2021 Equity Distribution</p><p> Plan (No.: 2022-029) released</p><p> by the Company on the SSE</p><p> website on May 24, 2022</p><p> (www.sse.com.cn).</p><p> Since the registration of</p><p> restricted shares involved in the</p><p> grant under the 2022 Restricted</p><p> Stock Incentive Plan was</p><p> completed, the conversion price</p><p> of the Proya Convertible Bond</p><p> SSE website, has been adjusted to 138.92</p><p> Shanghai RMB/share since September 9,</p><p> September 138.92 September Securities 2022. For details, see the</p><p> Securities Cosmetics Co., Ltd. on</p><p> Times Adjustment of Conversion Price</p><p> due to Additional Issuance from</p><p> Granting of Restricted Shares</p><p> (No.: 2022-052) released by the</p><p> Company on the SSE website on</p><p> September 8, 2022</p><p> (www.sse.com.cn).</p><p> Latest conversion price as of the</p><p> end of the Reporting Period</p><p>(V) The Company"s liabilities, changes in credit, and cash arrangements for debt repayment in</p><p> future years</p><p>□ Applicable √ Not applicable</p><p>(VI) Other explanations on convertible bonds</p><p>□ Applicable √ Not applicable</p><p> Section X Financial Report</p><p>I. Audit Report</p><p>√ Applicable □ Not applicable</p><p> Audit Report</p><p> Tian Jian Shen [2023] No.3128</p><p>To all shareholders of Proya Cosmetics Co., Ltd.:</p><p> Annual Report 2022</p><p>I. Audit Opinion</p><p>We have audited the financial statements of Proya Cosmetics Co., Ltd. (hereinafter referred to as "Proya"),</p><p>which comprise the consolidated and parent company"s balance sheets as at December 31, 2022, the</p><p>consolidated and parent company"s income statements, the consolidated and parent company"s cash flow</p><p>statements, and the consolidated and parent company"s statements of changes in shareholders" equity for</p><p>the year of 2022, as well as notes to financial statements.</p><p>In our opinion, the accompanying financial statements were prepared in accordance with the Accounting</p><p>Standards for Business Enterprises in all material aspects and give a true and fair view of the consolidated</p><p>and parent company"s financial position of Proya as at December 31, 2022 and of its consolidated and</p><p>parent company"s operating results and cash flows for the year of 2022.</p><p>II. Basis of Audit Opinion</p><p>We have conducted our audit in accordance with the Chinese Auditing Standards for Certified Public</p><p>Accountants. The "Responsibilities of CPAs for the Audit of the Financial Statements" herein further</p><p>illustrate our responsibilities under those standards. In accordance with the Code of Professional Ethics of</p><p>Chinese Certified Public Accountants, we are independent of Proya and have performed other</p><p>responsibilities in respect of professional ethics. We believe that the audit evidence we have obtained is</p><p>sufficient and appropriate to provide a basis for our opinion.</p><p>III. Key Audit Matters</p><p>Key audit matters are, in our professional judgment, most significant in our audit of the financial</p><p>statements for the current period. These matters were addressed in the context of our audit of the financial</p><p>statements as a whole, and in forming our opinion thereon, we do not provide a separate opinion on these</p><p>matters.</p><p>(I) Recognition of revenue</p><p>For relevant information disclosure, refer to "38. Revenue" in "V. Significant Accounting Policies and</p><p>Estimates", "61. Operating revenue and operating costs" in "VII. Notes to the Items of Consolidated</p><p>Financial Statements", and "6. Segment information" in "XVI. Other Significant Matters" of "Section X</p><p>Financial Report" herein.</p><p>The operating revenue of Proya primarily comes from the sale of cosmetics. The operating revenue for</p><p>Pursuant to the sales contract between Proya and its customer, under the distribution model, the sales</p><p>revenue is recognized by Proya when its products are delivered to and accepted by the buyers. Under the</p><p>agency sales model, the sales revenue is recognized by Proya when its products are delivered to the agent</p><p>and the agent completes the sales and issues the sales list for goods. Under the direct sales model, the sales</p><p>revenue is recognized by Proya when its products are delivered to its consumer and the consumer confirms</p><p>the receipt and makes the payment.</p><p>Since operating revenue is one of the key performance indicators of Proya, there is an inherent risk that</p><p>the management of Proya (hereinafter referred to as the "management") achieves specific goals or</p><p>expectations through inappropriate recognition of revenue. Therefore, we identify the recognition of</p><p>revenue as a key audit matter.</p><p>For recognition of revenue, we primarily implemented the following audit procedures:</p><p> Annual Report 2022</p><p>(1) To obtain an understanding of key internal controls related to the recognition of revenue, evaluate the</p><p>design of these controls, determine whether these controls were implemented, and test the operational</p><p>effectiveness of these controls;</p><p>(2) To issue letters to the main customers to confirm the sales amount in 2022 and the balance of accounts</p><p>receivable as at the end of 2022;</p><p>(3) To test details and make a spot-check on supporting documents for recognition of revenue (including</p><p>sales contracts, delivery documents, receipts, agency sales lists, and sales invoices), understand major</p><p>contract terms or conditions, and evaluate the appropriateness of the method for recognition of revenue;</p><p>(4) To implement analysis procedures, including analysis on fluctuations in revenue of each month of</p><p>(5) To obtain the rebate and subsidy policies, rebate and subsidy calculation sheets and other information,</p><p>and check whether the withholding amount of rebate and subsidy as at the end of 2022 was sufficient; to</p><p>analyze whether the amount of rebate and subsidy and the withholding amount were reasonable based on</p><p>the rebate and subsidy policy as well as the revenue in 2022; and to check the settlement after the rebate</p><p>and subsidy withholding period as at the end of 2022;</p><p>(6) To obtain the return and exchange policy, calculation sheet of provisions and other information, and</p><p>check whether the estimated future return and exchange rate is reasonable; to check the subsequent return</p><p>and exchange situation and compare it with the estimated return and exchange data;</p><p>(7) To learn about the inventory and stock age of each major dealer as at the end of 2022 and check whether</p><p>the inventory amount and structure of the dealer were reasonable;</p><p>(8) To analyze the sales data of main online chain stores by calculating the consumption per capita,</p><p>consumption per time, purchase times and repurchase information of customers of online chain stores and</p><p>comparing them with the selling prices and normal use days of Proya products, so as to judge the rationality</p><p>of the above data in combination with normal consumption habits and analyze the authenticity and</p><p>rationality of the income of online chain stores;</p><p>(9) To compare the background transaction data, Alipay receipt data and sales revenue data on financial</p><p>accounts of online chain stores, and analyze the matching attribute of data, so as to check the authenticity</p><p>of sales from the online chain stores;</p><p>(10) To check whether the information related to the operating revenue is properly presented in the</p><p>financial statements.</p><p>(II) Net realizable value of inventories</p><p>For relevant information disclosure, refer to "15. Inventories" in "V. Significant Accounting Policies and</p><p>Estimates" and "9. Inventories" in "VII. Notes to the Items of Consolidated Financial Statements" of</p><p>"Section X Financial Report" herein.</p><p>As of December 31, 2022, the book balance of inventories of Proya amounted to RMB710.13million, the</p><p>provision for devaluation of inventories amounted to RMB41.08million, and the carrying value of</p><p>inventories amounted to RMB669.05million.</p><p>At the balance sheet date, inventories are measured at the lower of cost and net realizable value, and</p><p>provision for devaluation of inventories is made if the cost of a single inventory is higher than its net</p><p>realizable value. On the basis of considering the purpose of holding inventories, the management</p><p>determines the estimated selling price based on the historical selling price, actual selling price, and future</p><p>market trends, and also determines the net realizable value based on the amount after deducting the</p><p>estimated cost of completion, estimated sale expense and relevant taxes from the estimated sale price of</p><p>inventories.</p><p> Annual Report 2022</p><p>Since the amount of inventories is significant and the determination of the net realizable value of</p><p>inventories involves significant judgment by the management, we identified the net realizable value of</p><p>inventories as a key audit matter.</p><p>For net realizable value of inventories, we primarily implemented the following audit procedures:</p><p>(1) To obtain an understanding of key internal controls related to the net realizable value of inventories,</p><p>evaluate the design of these controls, determine whether these controls were implemented, and test the</p><p>operational effectiveness of these controls;</p><p>(2) To obtain the accrual policy and calculation process for provision for devaluation of inventories, and</p><p>re-check the calculation process;</p><p>(3) To obtain the list of products that are no longer sold, count the products rolling off the production lines</p><p>in the inventories and the corresponding raw material inventories, and verify whether the provision for</p><p>devaluation of inventories was accrued for the raw material inventories;</p><p>(4) To check whether the inventories as at the end of the period had long inventory ages, outdated models</p><p>and changes in market demand in combination with the inventory monitoring, and evaluate whether the</p><p>management reasonably estimated the net realizable value;</p><p>(5) To check whether the information related to the net realizable value of inventories was properly</p><p>presented in the financial statements.</p><p>IV. Other Information</p><p>The management is responsible for the other information, which comprises all the information covered in</p><p>the Annual Report other than the financial statements and this audit report.</p><p>Our audit opinion on the financial statements does not cover the other information and we do not express</p><p>any form of assurance conclusion thereon.</p><p>In connection with our audit of the financial statements, our responsibility is to read the other information</p><p>and, in doing so, consider whether the other information is materially inconsistent with the financial</p><p>statements or our knowledge obtained in the audit or otherwise appears to be materially misstated.</p><p>If, based on the work we have performed, we conclude that there is a material misstatement of this other</p><p>information, we are required to report that fact. We have nothing to report in this regard.</p><p>V. Responsibilities of the Management and Those Charged With Governance for the Financial</p><p>Statements</p><p>The management is responsible for the preparation of financial statements that give a true and fair view in</p><p>accordance with the Accounting Standards for Business Enterprises, and for the design, implementation</p><p>and maintenance of necessary internal control to enable the preparation of financial statements that are</p><p>free from material misstatement, whether due to fraud or error.</p><p>In preparing the financial statements, the management is responsible for assessing Proya"s ability to</p><p>continue as a going concern, disclosing, as applicable, matters related to going concern and using the going</p><p>concern basis of accounting unless the management either intends to liquidate the Company or to cease</p><p>operations, or has no realistic alternative but to do so.</p><p>The governance of Proya (hereinafter referred to as "governance") is responsible for overseeing the</p><p>financial reporting process of Proya.</p><p>VI. Responsibilities of CPAs for the Audit of the Financial Statements</p><p>Our objective is to obtain reasonable assurance of whether there is a material misstatement in the financial</p><p>statements as a whole due to fraud or error and to issue an audit report containing audit opinion.</p><p> Annual Report 2022</p><p>Reasonable assurance is a highly reliable assurance, but is not a guarantee that an audit conducted in</p><p>accordance with China Standards on Auditing will always identify a material misstatement when it exists.</p><p>Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate,</p><p>they could reasonably be expected to influence the economic decisions of users taken on the basis of these</p><p>financial statements.</p><p>As part of an audit in accordance with the auditing standards, we exercise professional judgment and</p><p>maintained professional skepticism throughout the audit. We also:</p><p>(I) Identify and assess the risks of material misstatement of the financial statements, whether due to fraud</p><p>or error, design and perform audit procedures responsive to those risks, and obtain audit evidence that is</p><p>sufficient and appropriate to provide a basis for our opinion. The risk of not identifying a material</p><p>misstatement resulting from fraud is higher than that of failing to detect one resulting from error, as fraud</p><p>may involve collusion, forgery, intentional omissions, misrepresentations, or the override of internal</p><p>control.</p><p>(II) Obtain an understanding of internal control related to the audit to design the appropriate audit</p><p>procedures.</p><p>(III) Evaluate the appropriateness of accounting policies used and the reasonableness of accounting</p><p>estimates and related disclosures made by the management.</p><p>(IV) Conclude on the appropriateness of the management"s use of the going concern basis of accounting</p><p>and, based on the audit evidence obtained, determined whether a material uncertainty exists related to</p><p>events or conditions that may significantly affect Proya"s ability to continue as a going concern. If we</p><p>conclude that a material uncertainty exists, we are required to draw attention in our audit report to the</p><p>related disclosures in the financial statements or, if such disclosures are inadequate, to modify our opinion.</p><p>Our conclusions are based on the audit evidence obtained up to the date of our audit report. However,</p><p>future events or conditions may cause Proya to cease to continue as a going concern.</p><p>(V) Evaluate the overall presentation, structure and content of the financial statements, and determine</p><p>whether the financial statements reflect the related transactions and events fairly.</p><p>(VI) Obtain sufficient and appropriate audit evidence of the financial information of the entity or business</p><p>activity of Proya in order to express an opinion on the financial statements. We are responsible for</p><p>directing, supervising and performing group audits. We take full responsibility for the audit opinion.</p><p>We communicate with the governance regarding, among other matters, the planned scope and timing of</p><p>the audit and significant audit findings, including any significant deficiencies in internal control that we</p><p>identify during the audit.</p><p>We also provide a statement to those charged with governance on compliance with ethical requirements</p><p>related to independence, and communicate with them all relationships and other matters that may be</p><p>reasonably considered to affect our independence, as well as related precautions (if applicable).</p><p>From the matters we discussed with the those charged with governance, we determine those matters were</p><p>of most significance in the audit of the financial statements for the current period and are therefore the key</p><p>audit matters. We describe these matters in the audit report unless laws or regulations preclude public</p><p>disclosure about these matters or when, in extremely rare circumstances, we determine that a matter should</p><p>not be communicated in our audit report because the adverse consequences of doing so would reasonably</p><p>be expected to outweigh the public interest benefits of such communication.</p><p>Pan-China Certified Public Accountants LLP Chinese CPA: YIN Zhibin</p><p>(Project Partner)</p><p>Hangzhou, China Chinese CPA: WANG Xiaokang</p><p> Annual Report 2022</p><p> April 19, 2023</p><p>II. Financial Statements</p><p> Consolidated Balance Sheet</p><p> As at December 31, 2022</p><p>Prepared by: Proya Cosmetics Co., Ltd.</p><p> Unit: Yuan Currency: RMB</p><p> Item Notes As at December 31, 2022 As at December 31, 2021</p><p> Current assets:</p><p> Cash and cash equivalents VII. 1 3,161,003,085.05 2,391,048,249.81</p><p> Clearing settlement funds</p><p> Loans to banks and other</p><p> financial institutions</p><p> Held-for-trading financial</p><p> assets</p><p> Derivative financial assets</p><p> Notes receivable</p><p> Accounts receivable VII. 5 102,157,898.41 138,626,627.90</p><p> Receivable financing VII. 6 3,242,000.00</p><p> Prepayments VII. 7 91,483,523.15 58,406,647.11</p><p> Premiums receivable</p><p> Reinsurance premium</p><p> receivable</p><p> Reserves for reinsurance</p><p> contract receivable</p><p> Other receivables VII. 8 73,564,083.63 66,043,707.81</p><p> Including: Interest receivable</p><p> Dividends receivable</p><p> Financial assets purchased</p><p> under resale agreements</p><p> Inventories VII. 9 669,051,326.73 447,938,758.29</p><p> Contract assets</p><p> Held-for-sale assets</p><p> Non-current assets due</p><p> within one year</p><p> Other current assets VII. 13 49,735,996.57 53,534,962.39</p><p> Total current assets 4,146,995,913.54 3,158,840,953.31</p><p> Non-current assets:</p><p> Loans and advances to</p><p> customers</p><p> Debt investments</p><p> Annual Report 2022</p><p> Other debt investments</p><p> Long-term receivables</p><p> Long-term equity VII. 17</p><p>investments</p><p> Other equity instrument VII. 18</p><p>investments</p><p> Other non-current financial</p><p>assets</p><p> Investment real estate VII. 20 68,654,700.81 70,321,868.00</p><p> Fixed assets VII. 21 570,376,309.67 558,981,209.20</p><p> Construction in progress VII. 22 207,378,935.86 108,678,896.27</p><p> Bearer biological assets</p><p> Oil and gas assets</p><p> Right-of-use assets VII. 25 6,410,634.25</p><p> Intangible assets VII. 26 420,316,883.26 397,145,124.29</p><p> Development expenditure</p><p> Goodwill</p><p> Long-term prepaid expenses VII. 29 19,142,604.46 29,756,474.11</p><p> Deferred income tax assets VII. 30 48,305,338.82 38,796,018.02</p><p> Other non-current Assets VII. 31 5,554,726.06 44,167,303.56</p><p> Total non-current assets 1,631,075,910.65 1,474,208,829.72</p><p> Total assets 5,778,071,824.19 4,633,049,783.03</p><p>Current liabilities:</p><p> Short-term borrowings VII. 32 200,195,890.41 200,251,506.85</p><p> Loans from the central bank</p><p> Placements from banks and</p><p>other financial institutions</p><p> Held-for-trading financial</p><p>liabilities</p><p> Derivative financial</p><p>liabilities</p><p> Notes payable VII. 35 69,626,352.12 79,156,771.40</p><p> Accounts payable VII. 36 475,427,484.23 404,026,241.16</p><p> Advance from customers VII. 37 464,328.26 173,769.85</p><p> Contract liabilities VII. 38 174,602,833.91 91,151,985.32</p><p> Financial assets sold under</p><p>repurchase agreements</p><p> Customer deposits and</p><p>deposits from banks and other</p><p>financial institutions</p><p> Funds from securities trading</p><p>agencies</p><p> Funds from underwriting</p><p>securities agencies</p><p> Annual Report 2022</p><p> Employee compensation VII. 39</p><p>payable</p><p> Taxes payable VII. 40 152,918,871.45 99,893,176.97</p><p> Other payables VII. 41 216,392,183.41 62,162,153.55</p><p> Including: Interest payable</p><p> Dividends payable</p><p> Fees and commissions</p><p>payable</p><p> Amounts payable under</p><p>reinsurance contracts</p><p> Held-for-sale liabilities</p><p> Non-current liabilities due VII. 43</p><p>within one year</p><p> Other current liabilities VII. 44 10,820,499.59 9,521,415.32</p><p> Total current liabilities 1,427,936,644.88 1,024,986,070.14</p><p>Non-current liabilities:</p><p> Insurance contract reserves</p><p> Long-term borrowings</p><p> Bonds payable VII. 46 724,491,557.93 695,586,778.80</p><p> Including: Preferred stock</p><p> Perpetual bonds</p><p> Lease liabilities VII. 47 3,718,119.41</p><p> Long-term payables</p><p> Long-term employee</p><p>compensation payable</p><p> Povisions VII. 50 59,282,928.68 10,812,084.88</p><p> Deferred income VII. 51 6,399,811.33 6,416,263.33</p><p> Deferred income tax VII. 30</p><p>liabilities</p><p> Other non-current liabilities</p><p> Total non-current</p><p>liabilities</p><p> Total liabilities 2,240,848,493.90 1,746,209,355.96</p><p>Owners" equity (or shareholders" equity):</p><p> Paid-in capital (or share VII. 53</p><p>capital)</p><p> Other equity instruments VII. 54 50,903,510.12 50,956,622.11</p><p> Including: Preferred stock</p><p> Perpetual bonds</p><p> Capital reserve VII. 55 914,815,786.22 834,272,205.66</p><p> Less: Treasury shares VII. 56 164,976,000.00 5,628,128.21</p><p> Other comprehensive VII. 57</p><p> -1,918,603.07 -1,247,674.10</p><p>income</p><p> Special reserve</p><p> Annual Report 2022</p><p> Surplus reserve VII. 59 141,759,734.50 100,634,780.00</p><p> General risk reserve</p><p> Retained profits VII. 60 2,300,384,763.19 1,696,978,064.52</p><p> Total owners" equity (or 3,524,488,659.96 2,876,975,835.98</p><p> shareholders" equity)</p><p> attributable to equity holders of</p><p> the parent company</p><p> Minority interests 12,734,670.33 9,864,591.09</p><p> Total owners" equity (or</p><p> shareholders" equity)</p><p> Total liabilities and</p><p> owners" equity (or shareholders" 5,778,071,824.19 4,633,049,783.03</p><p> equity)</p><p> Person in charge of</p><p> The chairman of the CFO of the Company:</p><p> Accounting Department:</p><p> Company: HOU Juncheng WANG Li</p><p> WANG Li</p><p> Parent Company"s Balance Sheet</p><p> As at December 31, 2022</p><p>Prepared by: Proya Cosmetics Co., Ltd.</p><p> Unit: Yuan Currency: RMB</p><p> As at December 31,</p><p> Item Notes As at December 31, 2022</p><p> Current assets:</p><p> Cash and cash equivalents 2,169,179,716.12 1,691,858,730.42</p><p> Held-for-trading financial</p><p> assets</p><p> Derivative financial assets</p><p> Notes receivable</p><p> Accounts receivable XVII. 1 289,883,063.24 354,196,955.99</p><p> Receivable financing 3,092,000.00</p><p> Prepayments 34,908,418.05 24,580,460.37</p><p> Other receivables XVII. 2 141,574,549.59 222,452,930.42</p><p> Including: Interest receivable</p><p> Dividends receivable</p><p> Inventories 458,341,886.37 271,436,146.45</p><p> Contract assets</p><p> Held-for-sale assets</p><p> Non-current assets due</p><p> within one year</p><p> Other current assets 32,667,616.71 33,270,945.69</p><p> Total current assets 3,126,555,250.08 2,600,888,169.34</p><p> Non-current assets:</p><p> Debt investments</p><p> Annual Report 2022</p><p> Other debt investments</p><p> Long-term receivables</p><p> Long-term equity XVII. 3 394,321,950.41 350,003,540.49</p><p>investments</p><p> Other equity instrument 110,580,000.00 20,580,000.00</p><p>investments</p><p> Other non-current financial</p><p>assets</p><p> Investment real estate 348,408,309.83 362,657,495.17</p><p> Fixed assets 278,011,361.35 253,209,471.02</p><p> Construction in progress 206,756,324.14 105,012,647.89</p><p> Bearer biological assets</p><p> Oil and gas assets</p><p> Right-of-use assets 5,707,540.03</p><p> Intangible assets 382,584,698.57 395,609,113.72</p><p> Development expenditure</p><p> Goodwill</p><p> Long-term prepaid expenses 13,494,337.73 20,075,870.93</p><p> Deferred income tax assets 11,372,733.52 22,968,793.93</p><p> Other non-current Assets 4,916,417.58 4,493,322.95</p><p> Total non-current assets 1,756,153,673.16 1,534,610,256.10</p><p> Total assets 4,882,708,923.24 4,135,498,425.44</p><p>Current liabilities:</p><p> Short-term borrowings 200,195,890.41 200,251,506.85</p><p> Held-for-trading financial</p><p>liabilities</p><p> Derivative financial</p><p>liabilities</p><p> Notes payable 69,626,352.12 79,156,771.40</p><p> Accounts payable 217,330,371.42 282,934,452.33</p><p> Advance from customers</p><p> Contract liabilities 68,099,041.17 28,108,787.35</p><p> Employee compensation 58,246,111.22 33,926,736.55</p><p>payable</p><p> Taxes payable 69,952,710.78 66,893,331.24</p><p> Other payables 167,125,433.78 8,546,397.66</p><p> Including: Interest payable</p><p> Dividends payable</p><p> Held-for-sale liabilities</p><p> Non-current liabilities due 2,210,449.03</p><p>within one year</p><p> Other current liabilities</p><p> Total current liabilities 852,786,359.93 699,817,983.38</p><p>Non-current liabilities:</p><p> Annual Report 2022</p><p> Long-term borrowings</p><p> Bonds payable 724,491,557.93 695,586,778.80</p><p> Including: Preferred stock</p><p> Perpetual bonds</p><p> Lease liabilities 3,354,028.30</p><p> Long-term payables</p><p> Long-term employee</p><p>compensation payable</p><p> Provisions</p><p> Deferred income 6,399,811.33 6,416,263.33</p><p> Deferred income tax 18,758,960.23 8,395,198.23</p><p>liabilities</p><p> Other non-current liabilities</p><p> Total non-current 753,004,357.79 710,398,240.36</p><p>liabilities</p><p> Total liabilities 1,605,790,717.72 1,410,216,223.74</p><p>Owners" equity (or shareholders" equity):</p><p> Paid-in capital (or share 283,519,469.00 201,009,966.00</p><p>capital)</p><p> Other equity instruments 50,903,510.12 50,956,622.11</p><p> Including: Preferred stock</p><p> Perpetual bonds</p><p> Capital reserve 964,613,342.84 834,563,920.32</p><p> Less: Treasury shares 164,976,000.00 5,628,128.21</p><p> Other comprehensive</p><p>income</p><p> Special reserve</p><p> Surplus reserve 141,759,734.50 100,634,780.00</p><p> Retained profits 2,001,098,149.06 1,543,745,041.48</p><p> Total owners" equity (or 3,276,918,205.52 2,725,282,201.70</p><p>shareholders" equity)</p><p> Total liabilities and 4,882,708,923.24 4,135,498,425.44</p><p>owners" equity (or shareholders"</p><p>equity)</p><p> Person in charge of</p><p> The chairman of the CFO of the Company:</p><p> Accounting Department:</p><p> Company: HOU Juncheng WANG Li</p><p> WANG Li</p><p> Consolidated Income Statement</p><p> January - December 2022</p><p> Unit: Yuan Currency: RMB</p><p> Item Notes 2022 2021</p><p>I. Total operating revenue VII. 61 6,385,451,424.00 4,633,150,538.43</p><p>Including: Operating revenue VII. 61 6,385,451,424.00 4,633,150,538.43</p><p> Annual Report 2022</p><p> Interest income</p><p> Premiums earned</p><p> Fee and commission income</p><p>II. Total operating costs 5,191,391,396.39 3,892,457,794.07</p><p>Including: Operating costs VII. 61 1,934,850,203.65 1,554,155,646.61</p><p> Interest expenses</p><p> Fee and commission</p><p>expenses</p><p> Surrenders</p><p> Claims and policyholder</p><p>benefits (net of amounts recoverable</p><p>from reinsurers)</p><p> Net provision for insurance</p><p>liability reserves</p><p> Insurance policyholder</p><p>dividends</p><p> Expenses for reinsurance</p><p>accepted</p><p> Taxes and surcharges VII. 62 56,394,508.94 40,680,295.80</p><p> Selling expenses VII. 63 2,785,837,352.95 1,991,534,076.73</p><p> General and administrative VII. 64</p><p>expenses</p><p> Research and development VII. 65</p><p>expenses</p><p> Financial expenses VII. 66 -40,996,523.01 -7,484,395.13</p><p> Including: Interest expenses 13,019,503.91 9,759,260.83</p><p> Interest income 51,707,124.62 28,096,157.42</p><p> Add: Other income VII. 67 39,065,105.62 16,458,269.45</p><p> Investment income ("-" VII. 68</p><p> -5,658,023.28 -7,337,735.84</p><p>refers to loss)</p><p> Including: Income from</p><p>investments in associates and joint -5,658,023.28 -7,337,735.84</p><p>ventures</p><p> Income from</p><p>derecognition of financial assets</p><p>measured at amortized cost</p><p> Foreign exchange gains ("-"</p><p>refers to loss)</p><p> Net gain on exposure</p><p>hedging ("-" refers to loss)</p><p> Gains on changes in fair</p><p>value ("-" refers to loss)</p><p> Credit impairment loss ("-" VII. 71</p><p> -5,057,425.43 -24,834,947.18</p><p>refers to loss)</p><p> Annual Report 2022</p><p> Asset impairment losses ("-" VII. 72</p><p> -164,884,555.28 -53,513,590.04</p><p>refers to losses)</p><p> Gains from disposal of assets VII. 73</p><p>("-" refers to loss)</p><p>III. Operating profit ("-" refers to</p><p>loss)</p><p> Add: Non-operating revenue VII. 74 1,178,886.33 249,852.89</p><p> Less: Non-operating expenses VII. 75 4,613,645.24 3,801,835.06</p><p>IV. Total profits ("-" refers to total</p><p>losses)</p><p> Less: Income tax expenses VII. 76 222,866,719.56 110,746,888.31</p><p>V. Net profits ("-" refers to net</p><p>losses)</p><p>(I) Classified by the nature of continuing operations</p><p>operations ("-" refers to net losses)</p><p>discontinued operations ("-" refers</p><p>to net losses)</p><p>(II) Classified by ownership</p><p>shareholders of the parent company 817,400,223.93 576,119,025.56</p><p>("-" refers to net losses)</p><p>to minority interests ("-" refers to net 13,883,582.44 -19,065,338.53</p><p>losses)</p><p>VI. Other comprehensive income,</p><p> -670,928.97 -978,607.97</p><p>net of tax</p><p> (I) Other comprehensive income</p><p>attributable to owners of the parent -670,928.97 -978,607.97</p><p>company, net of tax</p><p>income that cannot be reclassified to</p><p>profit or loss</p><p> (1) Changes arising from the re-</p><p>measurement of net liabilities or net</p><p>assets of defined benefit plans</p><p> (2) Other comprehensive income</p><p>that cannot be reclassified to profit</p><p>or loss under the equity method</p><p> (3) Changes in fair value of other</p><p>equity instrument investments</p><p> (4) Changes in fair value of</p><p>enterprises" own credit risks</p><p> Annual Report 2022</p><p> income that will be reclassified into -670,928.97 -978,607.97</p><p> profit or loss</p><p> (1) Other comprehensive income</p><p> that will be reclassified to profit or</p><p> loss under the equity method</p><p> (2) Changes in fair value of other</p><p> debt investments</p><p> (3) Amounts of financial assets</p><p> reclassified into other</p><p> comprehensive income</p><p> (4) Provision for credit</p><p> impairment of other debt</p><p> investments</p><p> (5) Reserve for cash flow hedges</p><p> (6) Translation differences of</p><p> financial statements denominated in -670,928.97 -978,607.97</p><p> foreign currencies</p><p> (7) Others</p><p> (II) Other comprehensive income</p><p> attributable to minority interests, net</p><p> of tax</p><p> VII. Total comprehensive income 830,612,877.40 556,075,079.06</p><p> (I) Total comprehensive income</p><p> attributable to owners of the parent 816,729,294.96 575,140,417.59</p><p> company</p><p> (II) Total comprehensive income</p><p> attributable to minority interests</p><p> VIII. Earnings per share</p><p> (I) Basic earnings per share</p><p> (RMB/share)</p><p> (II) Diluted earnings per share</p><p> (RMB/share)</p><p>In case of business combination under common control, net profit realized by the combined party before</p><p>the combination in the current period was RMB0.00; net profit realized by the combined in the previous</p><p>period was RMB0.00.</p><p> The chairman of the Company: CFO of the Company: WANG Person in charge of Accounting</p><p> HOU Juncheng Li Department: WANG Li</p><p> Parent Company"s Income Statement</p><p> January - December 2022</p><p> Unit: Yuan Currency: RMB</p><p> Item Notes 2022 2021</p><p> I. Operating revenue XVII. 4 3,081,136,936.75 2,273,848,366.50</p><p> Annual Report 2022</p><p> Less: Operating cost XVII. 4 1,424,725,111.00 1,076,826,259.92</p><p> Taxes and surcharges 24,372,917.75 19,398,763.14</p><p> Selling expenses 472,193,858.89 284,076,298.04</p><p> General and administrative</p><p>expenses</p><p> Research and development</p><p>expenses</p><p> Financial expenses -41,965,768.21 -9,534,296.78</p><p> Including: Interest expenses 13,019,503.91 7,909,483.79</p><p> Interest income 42,503,905.91 23,839,106.03</p><p> Add: Other income 15,650,274.95 7,273,692.73</p><p> Investment income ("-" refers XVII. 5</p><p> -4,161,437.71 -18,567,432.77</p><p>to loss)</p><p> Including: Income from</p><p>investments in associates and joint -5,149,438.13 -7,608,313.87</p><p>ventures</p><p> Income from</p><p>derecognition of financial assets</p><p>measured at amortized cost</p><p> Net gain on exposure hedging</p><p>("-" refers to loss)</p><p> Gains on changes in fair value</p><p>("-" refers to loss)</p><p> Credit impairment loss ("-"</p><p>refers to loss)</p><p> Asset impairment losses ("-"</p><p> -126,987,703.77 -25,486,816.12</p><p>refers to losses)</p><p> Gains from disposal of assets</p><p>("-" refers to loss)</p><p>II. Operating profit ("-" refers to loss) 788,849,771.00 629,736,591.27</p><p> Add: Non-operating revenue 22,010.99 25,856.69</p><p> Less: Non-operating expenses 1,516,181.13 3,739,409.87</p><p>III. Total profits ("-" refers to total</p><p>losses)</p><p> Less: Income tax expenses 116,008,968.02 72,463,653.90</p><p>IV. Net profits ("-" refers to net losses) 671,346,632.84 553,559,384.19</p><p> (I) Net profits from continuing</p><p>activities ("-" refers to net losses)</p><p> (II) Net profits from discontinuing</p><p>activities ("-" refers to net losses)</p><p>V. Net amount of other comprehensive</p><p>income after tax</p><p> (I) Other comprehensive income</p><p>that cannot be reclassified into profit</p><p>or loss</p><p> Annual Report 2022</p><p>measurement of defined benefit plans</p><p>that cannot be reclassified to profit or</p><p>loss under the equity method</p><p>other equity instrument investments</p><p>enterprise"s own credit risk</p><p> (II) Other comprehensive income to</p><p>be reclassified into profit or loss</p><p>that may be reclassified to profit or</p><p>loss under equity method</p><p>debt investments</p><p>comprehensive income on</p><p>reclassification of financial assets</p><p>of other debt investments</p><p>translation of financial statements</p><p>VI. Total comprehensive income 671,346,632.84 553,559,384.19</p><p>VII. Earnings per share:</p><p> (I) Basic earnings per share</p><p>(RMB/share)</p><p> (II) Diluted earnings per share</p><p>(RMB/share)</p><p> The chairman of the Company: HOU CFO of the Company: Person in charge of</p><p> Juncheng WANG Li Accounting Department:</p><p> WANG Li</p><p> Consolidated Cash Flow Statement</p><p> January - December 2022</p><p> Unit: Yuan Currency: RMB</p><p> Item Notes 2022 2021</p><p>I. Cash flows from operating activities:</p><p> Cash received from the sale of goods</p><p>and the rendering of services</p><p> Net increase in customer deposits and</p><p>deposits from banks and other financial</p><p>institutions</p><p> Annual Report 2022</p><p> Net increase in loans from the central</p><p>bank</p><p> Net increase in taking from other</p><p>financial institutions</p><p> Cash received from premiums under</p><p>original insurance contract</p><p> Net cash received from reinsurance</p><p>business</p><p> Net cash received from policyholders"</p><p>deposits and investment contract</p><p>liabilities</p><p> Cash received from interest, fees and</p><p>commissions</p><p> Net increase in taking from banks and</p><p>other financial institutions</p><p> Net increase in financial assets sold</p><p>under repurchase arrangements</p><p> Net cash received from securities</p><p>trading agency</p><p> Receipts of tax refunds 80,005.56</p><p> Other cash received related to VII. 78 (1)</p><p>operating activities</p><p> Sub-total of cash inflows from</p><p>operating activities</p><p> Cash paid for goods purchased and</p><p>services received</p><p> Net increase in loans and advances to</p><p>customers</p><p> Net increase in balance with the central</p><p>bank and due from banks and other</p><p>financial institution</p><p> Cash paid for compensation payments</p><p>under original insurance contract</p><p> Net increase in loans to banks and</p><p>other financial institutions</p><p> Cash paid for interest, fees and</p><p>commissions</p><p> Cash paid for insurance policyholder</p><p>dividends</p><p> Cash paid to and on behalf of</p><p>employees</p><p> Payments of various types of taxes 660,096,624.31 432,668,333.55</p><p> Other cash paid related to operating VII. 78 (2)</p><p>activities</p><p> Annual Report 2022</p><p> Sub-total of cash outflows from</p><p>operating activities</p><p> Net cash flow from operating</p><p>activities</p><p>II. Cash flows from investing activities:</p><p> Cash received from disposal and</p><p>recovery of investments</p><p> Cash received from investment income</p><p> Net cash received from disposal of</p><p>fixed assets, intangible assets and other 3,751,463.96 47,622.98</p><p>long-term assets</p><p> Net cash received from disposal of</p><p>subsidiaries and other business entities</p><p> Other cash received related to</p><p>investing activities</p><p> Sub-total of cash inflows from</p><p>investing activities</p><p> Cash paid for acquisition or</p><p>construction of fixed assets, intangible 170,963,405.43 194,102,666.70</p><p>assets and other long-term assets</p><p> Cash paid for investments 131,003,609.10 70,029,200.00</p><p> Net increase in pledged loans</p><p>receivables</p><p> Net cash paid for acquiring</p><p>subsidiaries and other operating entities</p><p> Other cash paid related to investing VII. 78 (4)</p><p>activities</p><p> Sub-total of cash outflows from</p><p>investing activities</p><p> Net cash flow from investing</p><p> -298,215,550.57 -341,823,618.60</p><p>activities</p><p>III. Cash flows from financing activities:</p><p> Cash received from capital</p><p>contributions</p><p> Including: Cash received from capital</p><p>contributions from minority shareholders 700,000.00 700,000.00</p><p>of subsidiaries</p><p> Cash received from borrowings 300,000,000.00 946,996,018.87</p><p> Other cash received related to</p><p>financing activities</p><p> Sub-total of cash inflows from</p><p>financing activities</p><p> Cash repayments of borrowings 300,000,000.00 299,000,000.00</p><p> Annual Report 2022</p><p> Cash paid for distribution of dividends</p><p>or profits or settlement of interest 182,663,748.85 154,245,329.79</p><p>expenses</p><p> Including: Payments for distribution of</p><p>dividends or profits to minority owners of</p><p>subsidiaries</p><p> Other cash paid related to financing VII. 78 (6)</p><p>activities</p><p> Sub-total of cash outflows from</p><p>financing activities</p><p> Net cash flow from financing</p><p> -65,251,320.73 489,615,295.96</p><p>activities</p><p>IV. Impact of foreign exchange rate</p><p> -670,928.97 -978,607.97</p><p>changes on cash and cash equivalents</p><p>V. Net increase in cash and cash</p><p>equivalents</p><p> Add: Opening balance of cash and cash</p><p>equivalents</p><p>VI. Closing balance of cash and cash</p><p>equivalents</p><p> Person in charge of</p><p> The chairman of the Company: HOU CFO of the Company:</p><p> Accounting Department:</p><p> Juncheng WANG Li</p><p> WANG Li</p><p> Parent Company"s Cash Flow Statement</p><p> January - December 2022</p><p> Unit: Yuan Currency: RMB</p><p> Item Notes 2022 2021</p><p>I. Cash flows from operating activities:</p><p> Cash received from the sale of goods and the</p><p>rendering of services</p><p> Receipts of tax refunds</p><p> Other cash received related to operating</p><p>activities</p><p> Sub-total of cash inflows from operating</p><p>activities</p><p> Cash paid for goods purchased and services</p><p>received</p><p> Cash paid to and on behalf of employees 265,940,955.35 180,867,131.86</p><p> Payments of various types of taxes 276,743,971.90 197,049,919.18</p><p> Other cash paid related to operating</p><p>activities</p><p> Sub-total of cash outflows from operating</p><p>activities</p><p> Net cash flow from operating activities 1,790,129,321.03 644,827,094.22</p><p> Annual Report 2022</p><p>II. Cash flows from investing activities:</p><p> Cash received from disposal and recovery of</p><p>investments</p><p> Cash received from investment income</p><p> Net cash received from disposal of fixed</p><p>assets, intangible assets and other long-term 1,057,300.53</p><p>assets</p><p> Net cash received from disposal of</p><p>subsidiaries and other business entities</p><p> Other cash received related to investing</p><p>activities</p><p> Sub-total of cash inflows from investing</p><p>activities</p><p> Cash paid for acquisition or construction of</p><p>fixed assets, intangible assets and other long- 163,990,474.83 135,132,853.40</p><p>term assets</p><p> Cash paid for investments 179,238,922.10 36,338,783.21</p><p> Net cash paid for acquisition of subsidiaries</p><p>and other business units</p><p> Other cash paid related to investing</p><p>activities</p><p> Sub-total of cash outflows from investing</p><p>activities</p><p> Net cash flow from investing activities -340,472,096.40 -34,093,079.88</p><p>III. Cash flows from financing activities:</p><p> Cash received from capital contributions 164,976,000.00</p><p> Cash received from borrowings 300,000,000.00 946,996,018.87</p><p> Other cash received related to financing</p><p>activities</p><p> Sub-total of cash inflows from financing</p><p>activities</p><p> Cash repayments of borrowings 300,000,000.00 200,000,000.00</p><p> Cash paid for distribution of dividends or</p><p>profits or settlement of interest expenses</p><p> Other cash paid related to financing</p><p>activities</p><p> Sub-total of cash outflows from financing</p><p>activities</p><p> Net cash flow from financing activities -18,454,612.37 589,812,011.86</p><p>IV. Impact of foreign exchange rate changes</p><p>on cash and cash equivalents</p><p>V. Net increase in cash and cash equivalents 1,431,202,612.26 1,200,546,026.20</p><p> Add: Opening balance of cash and cash</p><p>equivalents</p><p> Annual Report 2022</p><p>VI. Closing balance of cash and cash</p><p>equivalents</p><p> Person in charge of</p><p> The chairman of the Company: CFO of the Company:</p><p> Accounting Department:</p><p> HOU Juncheng WANG Li</p><p> WANG Li</p><p> Annual Report 2022</p><p> Consolidated Statements of Changes in Owners" Equity</p><p> January - December 2022</p><p> Unit: Yuan Currency: RMB</p><p> Equity attributable to owners of the parent company</p><p> Total equity</p><p> Item Minority</p><p> Paid-in capital Other equity instruments Other General attributable to</p><p> Less: Treasury Special interests</p><p> (or share Capital reserve comprehensive Surplus reserve risk Retained profits Other Subtotal owners</p><p> Preference Perpetual shares reserve</p><p> capital) Other income reserve</p><p> shares bonds</p><p>I. Balance at</p><p>the end of the 201,009,966.00 50,956,622.11 834,272,205.66 5,628,128.21 -1,247,674.10 100,634,780.00 1,696,978,064.52 2,876,975,835.98 9,864,591.09 2,886,840,427.07</p><p>previous year</p><p>Add: Changes</p><p>in accounting</p><p>policies</p><p> Correction</p><p>for previous</p><p>errors</p><p> Business</p><p>combination</p><p>under common</p><p>control</p><p> Other</p><p>II. Balance at</p><p>the beginning</p><p>of the current</p><p>year</p><p>III. Increase of</p><p>the current</p><p>period ("-" 82,509,503.00 -53,111.99 80,543,580.56 159,347,871.79 -670,928.97 41,124,954.50 603,406,698.67 647,512,823.98 2,870,079.24 650,382,903.22</p><p>refers to</p><p>decrease)</p><p>(I) Total</p><p>comprehensive -670,928.97 817,400,223.93 816,729,294.96 13,883,582.44 830,612,877.40</p><p>income</p><p> Annual Report 2022</p><p>(II) Owners"</p><p>contribution</p><p>and capital</p><p>reduction</p><p>shares</p><p>contributed by</p><p>the owners</p><p>contributions</p><p>by other equity</p><p>instrument</p><p>holders</p><p>share-based</p><p>payments 47,357,121.25 47,357,121.25 47,357,121.24</p><p>credited to</p><p>owners" equity</p><p>(III) Profit</p><p>distribution</p><p>of surplus 41,124,954.50 -41,124,954.50</p><p>reserve</p><p>of general risk</p><p>provision</p><p>to owners (or -172,868,570.76 -172,868,570.76 -172,868,570.76</p><p>shareholders)</p><p>(IV) Internal</p><p>carry-forward</p><p>of owners"</p><p>equity</p><p>capital reserve</p><p>to capital (or</p><p>share capital)</p><p> Annual Report 2022</p><p>surplus reserve</p><p>to capital (or</p><p>share capital)</p><p>reserve to cover</p><p>loss</p><p>defined benefit</p><p>scheme carried</p><p>forward to</p><p>retained</p><p>earnings</p><p>forward of</p><p>other</p><p>comprehensive</p><p>income to</p><p>retained</p><p>earnings</p><p>(V) Special</p><p>reserve</p><p>for the period</p><p>for the period</p><p>(VI) Others -</p><p> -50,040,368.19 -50,040,368.19 -61,753,871.38</p><p>IV. Balance at 283,519,469.00 2,300,384,763.19</p><p>the end of the 50,903,510.12 914,815,786.22 164,976,000.00 -1,918,603.07 141,759,734.50 3,524,488,659.96 12,734,670.33 3,537,223,330.29</p><p>period</p><p> Equity attributable to owners of the parent company Total equity</p><p> Item Minority</p><p> attributable to</p><p> interests</p><p> Other equity instruments Capital reserve Surplus reserve Retained profits Other Subtotal owners</p><p> Annual Report 2022</p><p> Paid-in capital Less: Other Special General</p><p> Preference Perpetual</p><p> (or share Other Treasury comprehensive reserve risk</p><p> shares bonds</p><p> capital) shares income reserve</p><p>I. Balance at</p><p>the end of the 201,116,925.00 837,034,836.69 12,653,905.25 -269,066.13 100,634,780.00 1,265,671,865.63 2,391,535,435.94 90,326,830.19 2,481,862,266.13</p><p>previous year</p><p>Add: Changes</p><p>in accounting</p><p>policies</p><p> Correction</p><p>for previous</p><p>errors</p><p> Business</p><p>combination</p><p>under common</p><p>control</p><p> Other</p><p>II. Balance at</p><p>the beginning 201,116,925.00 837,034,836.69 12,653,905.25 -269,066.13 100,634,780.00 1,265,671,865.63 2,391,535,435.94 90,326,830.19 2,481,862,266.13</p><p>of the year</p><p>III. Increase of</p><p>the current</p><p>period ("-" -106,959.00 50,956,622.11 -2,762,631.03 -7,025,777.04 -978,607.97 431,306,198.89 485,440,400.04 404,978,160.94</p><p>refers to</p><p>decrease)</p><p>(I) Total</p><p>comprehensive -978,607.97 576,119,025.56 575,140,417.59 556,075,079.06</p><p>income</p><p>(II) Owners"</p><p>contribution</p><p> -106,959.00 -1,999,494.15 -7,025,777.04 4,919,323.89 700,000.00 5,619,323.89</p><p>and capital</p><p>reduction</p><p>shares</p><p> -106,959.00 -1,626,846.39 -7,025,777.04 5,291,971.65 700,000.00 5,991,971.65</p><p>contributed by</p><p>the owners</p><p>contributions</p><p>by other equity</p><p> Annual Report 2022</p><p>instrument</p><p>holders</p><p>share-based</p><p>payments -372,647.76 -372,647.76 -372,647.76</p><p>credited to</p><p>owners" equity</p><p>(III) Profit</p><p> -144,804,186.00 -144,804,186.00 -144,804,186.00</p><p>distribution</p><p>of surplus</p><p>reserve</p><p>of general risk</p><p>provision</p><p>to owners (or -144,804,186.00 -144,804,186.00 -144,804,186.00</p><p>shareholders)</p><p>(IV) Internal</p><p>carry-forward</p><p>of owners"</p><p>equity</p><p>capital reserve</p><p>to capital (or</p><p>share capital)</p><p>surplus reserve</p><p>to capital (or</p><p>share capital)</p><p>reserve to cover</p><p>loss</p><p>defined benefit</p><p>scheme carried</p><p>forward to</p><p>retained</p><p> Annual Report 2022</p><p>earnings</p><p>forward of</p><p>other</p><p>comprehensive</p><p>income to</p><p>retained</p><p>earnings</p><p>(V) Special</p><p>reserve</p><p>for the period</p><p>for the period</p><p>(VI) Others -</p><p>IV. Balance at</p><p>the end of the 201,009,966.00 50,956,622.11 834,272,205.66 5,628,128.21 -1,247,674.10 100,634,780.00 1,696,978,064.52 2,876,975,835.98 9,864,591.09 2,886,840,427.07</p><p>period</p><p> The chairman of the Company: HOU Juncheng CFO of the Company: WANG Li Person in charge of Accounting Department: WANG Li</p><p> Parent Company"s Statement of Changes in Owners" Equity</p><p> January - December 2022</p><p> Unit: Yuan Currency: RMB</p><p> Paid-in Other equity instruments Other</p><p> Item capital (or Less: Treasury compre Special Total equity</p><p> Preference Perpetual Capital reserve Surplus reserve Retained profits</p><p> share Other shares hensive reserve attributable to owners</p><p> shares bonds</p><p> capital) income</p><p> I. Balance at the</p><p> end of the 834,563,920.32 5,628,128.21 100,634,780.00 1,543,745,041.48 2,725,282,201.70</p><p> previous year</p><p> Add: Changes</p><p> in accounting</p><p> policies</p><p> Annual Report 2022</p><p> Correction</p><p>for previous</p><p>errors</p><p> Other</p><p>II. Balance at</p><p>the beginning of 834,563,920.32 5,628,128.21 100,634,780.00 1,543,745,041.48 2,725,282,201.70</p><p>the year</p><p>III. Increase of</p><p>the current</p><p>period ("-" -53,111.99 130,049,422.52 159,347,871.79 41,124,954.50 457,353,107.58 551,636,003.82</p><p>refers to</p><p>decrease)</p><p>(I) Total</p><p>comprehensive 671,346,632.84 671,346,632.84</p><p>income</p><p>(II) Owners"</p><p>contribution and</p><p>capital</p><p>reduction</p><p>shares</p><p>contributed by</p><p>the owners</p><p>contributions by</p><p>other equity</p><p>instrument</p><p>holders</p><p>share-based</p><p>payments 47,357,121.24 47,357,121.24</p><p>credited to</p><p>owners" equity</p><p> Annual Report 2022</p><p>(III) Profit</p><p>distribution</p><p>of surplus 41,124,954.50 -41,124,954.50</p><p>reserve</p><p>to owners (or -172,868,570.76 -172,868,570.76</p><p>shareholders)</p><p>(IV) Internal</p><p>carry-forward 80,403,986.0</p><p> -80,403,986.00</p><p>of owners" 0</p><p>equity</p><p>capital reserve 80,403,986.0</p><p> -80,403,986.00</p><p>to capital (or 0</p><p>share capital)</p><p>surplus reserve</p><p>to capital (or</p><p>share capital)</p><p>reserve to cover</p><p>loss</p><p>defined benefit</p><p>scheme carried</p><p>forward to</p><p>retained</p><p>earnings</p><p>forward of other</p><p> Annual Report 2022</p><p>comprehensive</p><p>income to</p><p>retained</p><p>earnings</p><p>(V) Special</p><p>reserve</p><p>for the period</p><p>for the period</p><p>(VI) Others -534,526.22 -534,526.22</p><p>IV. Balance at</p><p>the end of the 964,613,342.84 164,976,000.00 141,759,734.50 2,001,098,149.06 3,276,918,205.52</p><p>period</p><p> Paid-up Other equity instruments Other</p><p> Item capital (or Less: Treasury compre Special Total equity</p><p> Preference Perpetual Capital reserve Surplus reserve Retained profits</p><p> share Other shares hensive reserve attributable to owners</p><p> shares bonds</p><p> capital) income</p><p>I. Balance at the</p><p>end of the 837,075,425.32 12,653,905.25 100,634,780.00 1,134,989,843.29 2,261,163,068.36</p><p> .00</p><p>previous year</p><p>Add: Changes</p><p>in accounting</p><p>policies</p><p> Correction</p><p>for previous</p><p>errors</p><p> Other</p><p> Annual Report 2022</p><p>II. Balance at</p><p>the beginning of 837,075,425.32 12,653,905.25 100,634,780.00 1,134,989,843.29 2,261,163,068.36</p><p> .00</p><p>the current year</p><p>III. Increase of</p><p>the current</p><p>period ("-" -106,959.00 -2,511,505.00 -7,025,777.04 408,755,198.19 464,119,133.34</p><p>refers to</p><p>decrease)</p><p>(I) Total</p><p>comprehensive 553,559,384.19 553,559,384.19</p><p>income</p><p>(II) Owners"</p><p>contribution and</p><p> -106,959.00 -1,999,494.15 -7,025,777.04 4,919,323.89</p><p>capital</p><p>reduction</p><p>shares</p><p> -106,959.00 -1,626,846.39 -7,025,777.04 5,291,971.65</p><p>contributed by</p><p>the owners</p><p>contributions by</p><p>other equity</p><p>instrument</p><p>holders</p><p>share-based</p><p>payments -372,647.76 -372,647.76</p><p>credited to</p><p>owners" equity</p><p>(III) Profit</p><p> -144,804,186.00 -144,804,186.00</p><p>distribution</p><p> Annual Report 2022</p><p>of surplus</p><p>reserve</p><p>to owners (or -144,804,186.00 -144,804,186.00</p><p>shareholders)</p><p>(IV) Internal</p><p>carry-forward</p><p>of owners"</p><p>equity</p><p>capital reserve</p><p>to capital (or</p><p>share capital)</p><p>surplus reserve</p><p>to capital (or</p><p>share capital)</p><p>reserve to cover</p><p>loss</p><p>defined benefit</p><p>scheme carried</p><p>forward to</p><p>retained</p><p>earnings</p><p>forward of other</p><p>comprehensive</p><p>income to</p><p> Annual Report 2022</p><p>retained</p><p>earnings</p><p>(V) Special</p><p>reserve</p><p>for the period</p><p>for the period</p><p>(VI) Others 50,956,622.</p><p> -512,010.85 50,444,611.26</p><p>IV. Balance at</p><p>the end of the 834,563,920.32 5,628,128.21 100,634,780.00 1,543,745,041.48 2,725,282,201.70</p><p> .00 11</p><p>period</p><p> The chairman of the Company: HOU Juncheng CFO of the Company: WANG Li Person in charge of Accounting Department: WANG Li</p><p> Annual Report 2022</p><p>III. General Information about the Company</p><p>√ Applicable □ Not applicable</p><p>Proya Cosmetics Co., Ltd. (hereinafter referred to as "Company" or the "Company"), formerly known as</p><p>Proya (Huzhou) Cosmetics Co., Ltd., was registered in Wuxing Branch of Huzhou Municipal</p><p>Administration for Industry and Commerce on May 24, 2006. Headquartered in Hangzhou, Zhejiang, the</p><p>Company now holds the business license with the unified social credit code of 91330100789665033F.</p><p>Currently, the Company"s registered capital is RMB283,513,952.00, and the paid-in capital is</p><p>RMB283,519,469.00 (the paid-in capital is RMB5,517.00 higher than the registered capital due to the</p><p>conversion of convertible bonds without industrial and commercial change registration). The total number</p><p>of shares converted is 283,519,469 (with a par value of 1.00 RMB/per share), including 2,100,000</p><p>restricted circulating A shares and 281,419,469 unrestricted circulating A shares. which were listed for</p><p>trading on SSE on November 15, 2017.</p><p>The Company is a beauty and personal care company mainly engaged in cosmetics research and</p><p>development, production, and sales. The Company"s main products are cosmetics.</p><p>The financial statements were approved for external disclosure by the 11th meeting of the third session of</p><p>the Board of Directors of the Company on April 19, 2023.</p><p>√ Applicable □ Not applicable</p><p>The Company has incorporated 47 subsidiaries, including Hangzhou Proya Trade Co., Ltd., Anya (Huzhou)</p><p>Cosmetics Co., Ltd., Zhejiang Meiligu Electronic Commerce Co., Ltd., Huzhou Chuangdai E-commerce</p><p>Co., Ltd., Yueqing Laiya Trading Co., Ltd. and Hapsode (Hangzhou) Cosmetics Co., Ltd., into the</p><p>consolidated financial statements of the reporting period. For details, refer to the particulars contained in</p><p>notes "VIII. Change of Consolidation Scope" and "IX. Equity in Other Entities" in this report.</p><p>IV. Preparation Basis of Financial Statements</p><p>The financial statements of the Company are prepared based on going concern.</p><p>√ Applicable □ Not applicable</p><p>There are no matters or situations that may substantially affect the Company"s ability to continue as a</p><p>going concern within 12 months since the end of the Reporting Period.</p><p>V. Significant Accounting Policies and Estimates</p><p>Notes to specific accounting policies and accounting estimates:</p><p>√ Applicable □ Not applicable</p><p>Refer to "44. Changes in Significant Accounting Policies and Estimates" in "V. Significant Accounting</p><p>Policies and Estimates" of "Section X Financial Report" for details.</p><p>The financial statements have been prepared by the Company in conformity with the China Accounting</p><p> Annual Report 2022</p><p>Standards for Business Enterprises, and present truly and completely the Company"s financial position,</p><p>operating performance, changes in shareholders" equity, cash flow and other related information.</p><p>The accounting period of the Company is from January 1 to December 31 of each calendar year.</p><p>√ Applicable □ Not applicable</p><p>The operating cycle of the Company"s businesses is short; the Company adopts 12 months as the liquidity</p><p>classification criteria for assets and liabilities.</p><p>The functional currency of the Company is RMB. Overseas subsidiaries including Hapsode Co., Ltd.,</p><p>Hanna Cosmetics Co., Ltd., Korea Younimi Cosmetics Co., Ltd. and O&R Co., Ltd. adopt the currency in</p><p>their major econonmic environment of operation as their function currency.</p><p>√ Applicable □ Not applicable</p><p>The assets and liabilities acquired by the Company through business combination are measured at the</p><p>carrying value of the combined party in the consolidated financial statements of the ultimate controlling</p><p>party at the combination date. The Company adjusts the capital reserve in accordance with the difference</p><p>between the carrying value share of the owners" equity of the combined party in the consolidated financial</p><p>statements of the ultimate controlling party and the carrying value of the consideration paid for the</p><p>business combination or the total nominal value of the issued shares. If the capital reserve is not sufficient</p><p>to offset the difference, the retained earnings will be adjusted.</p><p>The difference by which the cost of combination is greater than the fair value of the net identifiable assets</p><p>of the acquiree is recognized by the Company as goodwill on the acquisition date; the difference by which</p><p>the combination cost is less than the fair value share of the net identifiable assets of the acquiree is recorded</p><p>into the profit or loss after the re-check of the measurement of the fair value of identifiable assets, liabilities</p><p>or contingent liabilities acquired from the acquiree, and the combination cost.</p><p>√ Applicable □ Not applicable</p><p>statements. The consolidated financial statements are based on the financial statements of the parent</p><p>company and its subsidiaries, and prepared by the parent company in accordance with the Accounting</p><p>Standards for Business Enterprises No. 33 - Consolidated Financial Statements.</p><p>same subsidiary in two consecutive fiscal years</p><p>The acquisition of the equity of the acquiree is to control its operating and financial policies and to obtain</p><p>long-term benefits from its operating activities. After the right to control the acquiree is acquired, the</p><p>acquiree is included in the consolidation scope of the consolidated financial statements. Due to changes</p><p> Annual Report 2022</p><p>in the Company"s business plans and arrangements, if the equity of the acquiree is disposed of in the second</p><p>fiscal year to the point of losing control over it, the acquiree will be excluded from the consolidation scope</p><p>of the consolidated financial statements when the control is lost.</p><p>√ Applicable □ Not applicable</p><p>related to the share of interests in the joint operation:</p><p>(1) Assets solely held, and assets jointly held on proportion;</p><p>(2) Liabilities solely undertaken, and liabilities jointly undertaken on proportion;</p><p>(3) Income generated from selling the Company"s output share of the joint operation;</p><p>(4) Income of the joint operation generated from selling assets according to the Company"s holding share;</p><p>(5) Cost incurred alone, and cost incurred from the joint operation on proportion;</p><p>Cash presented in the cash flow statement refers to cash on hand and deposits that can be used for payment</p><p>at any time. Cash equivalents refer to the short-term (generally the expiration is within three months from</p><p>the date of purchase) and highly liquid investments that are readily convertible to known amounts of cash</p><p>and subject to an insignificant risk of change in value.</p><p>√ Applicable □ Not applicable</p><p>Foreign currency transactions are translated into RMB at the approximate rate of spot rate on the</p><p>transaction date during initial recognition. On the balance sheet date, the foreign-currency monetary items</p><p>are calculated based on the spot rate on the same date. The exchange difference arising from the different</p><p>exchange rates is included in the current profit or loss, except the exchange difference between the</p><p>principal and interest of the foreign currency loans specially borrowed for the purchase and construction</p><p>of assets eligible for capitalization. The foreign currency non-monetary items measured at historical cost</p><p>are still translated based on the approximate rate of the spot rate on the transaction date, and the RMB</p><p>amount is not changed. The foreign currency non-monetary items measured at fair value are translated</p><p>based on the spot rate on the determination date of the fair value, and the difference is included in the</p><p>current profit or loss or other comprehensive income.</p><p>Assets and liabilities items in the balance sheet are translated at the spot rates prevailing at the balance</p><p>sheet date. Owners" equity items other than "undistributed profits" are translated at the spot rates on the</p><p>transaction dates. Income and expense items in the income statement are translated at the approximate</p><p>rates of the spot rates on the transaction dates. Any balance incurred from the translation of foreign-</p><p>currency financial statements by the above method is included in other comprehensive income.</p><p>√ Applicable □ Not applicable</p><p> Annual Report 2022</p><p>Financial assets are classified into the following three categories at initial recognition: (1) financial assets</p><p>measured at amortized cost; (2) financial assets measured at fair value through other comprehensive</p><p>income; (3) financial assets measured at fair value through profit or loss.</p><p>Financial liabilities are classified into the following four categories at initial recognition: (1) financial</p><p>liabilities measured at fair value through profit or loss; (2) financial liabilities arise when a transfer of a</p><p>financial asset does not qualify for derecognition or that are accounted for using the continuing-</p><p>involvement method; (3) loan commitments not belonging to the financial guarantee contracts mentioned</p><p>in item (1) or (2) above and those not belonging to item (1) above and given at a rate lower than market</p><p>interest rate; (4) financial liabilities measured at amortized cost.</p><p>(1) Recognition basis and initial measurement method for financial assets and liabilities</p><p>A financial asset or liability is recognized when the Company becomes a party to a financial instrument</p><p>contract. Financial assets and liabilities are measured at the fair value at initial recognition. For financial</p><p>assets and liabilities measured at fair value through profit or loss, relevant transaction expenses are directly</p><p>included in the current profit or loss; for other categories of financial assets or liabilities, relevant</p><p>transaction costs are recognized as expenses at initial recognition. However, where the accounts receivable</p><p>initially recognized by the Company do not contain a significant financing component or the Company</p><p>does not consider the financing component in the contract of less than one year, the initial measurement</p><p>is made according to the transaction price defined in the Accounting Standards for Business Enterprises</p><p>No. 14 – Revenue.</p><p>(2) Subsequent measurement of financial assets</p><p>Such financial assets are subsequently measured at amortized cost using the effective interest method. The</p><p>gains and losses incurred by the financial assets measured at amortized cost but not belonging to any</p><p>hedging relationship are included in the current profit or loss during derecognition, reclassification,</p><p>amortization according to the effective interest method or impairment recognition.</p><p>They are subsequently measured at fair value. The interest, impairment losses or gains and exchange gains</p><p>or losses calculated with the effective interest method are included in the current profit or loss, and other</p><p>gains or losses are included in other comprehensive income. At derecognition, the gains or losses</p><p>accumulated previously through comprehensive income are transferred from other comprehensive income</p><p>and included into the current profit or loss.</p><p>They are subsequently measured at fair value. The dividends obtained (except for the part from investment</p><p>cost recovery) are included in the current profit or loss, and other gains or losses are included in other</p><p>comprehensive income. At derecognition, the gains or losses accumulated previously through other</p><p>comprehensive income are transferred from other comprehensive income and included into retained</p><p>earnings.</p><p>They are subsequently measured at fair value. The generated gains or losses (including interest and</p><p>dividend income) are included in the current profit or loss, unless the financial assets belong to part of the</p><p>hedging relationship.</p><p>(3) Subsequent measurement of financial liabilities</p><p>Such financial liabilities include held-for-trading financial liabilities (including derivative instruments</p><p>belonging to financial liabilities) and those designated as financial liabilities measured at fair value through</p><p> Annual Report 2022</p><p>profit or loss. Such financial liabilities are subsequently measured at fair value. Changes in the fair value</p><p>of financial liabilities measured at fair value through profit or loss due to changes in the Company"s own</p><p>credit risk are included in other comprehensive income, unless the treatment will cause or enlarge the</p><p>accounting mismatch in the profit or loss. Other gains or losses (including interest, except changes in the</p><p>fair value arising from the Company"s own credit risk) are included in the current profit or loss, unless the</p><p>financial liabilities belong to part of the hedging relationship. At derecognition, the gains or losses</p><p>accumulated previously through other comprehensive income are transferred from other comprehensive</p><p>income and included into retained earnings.</p><p>continued involvement in transferred financial assets</p><p>They are measured in accordance with the Accounting Standards for Business Enterprises No. 23 -</p><p>Transfer of Financial Assets.</p><p>and those not belonging to item 1) above and given at a rate lower than market interest rate</p><p>They are subsequently measured at the higher one of the following two amounts, after initial recognition:</p><p>① loss provisions determined according to regulations on impairment of financial instruments; ②</p><p>balance of the initially recognized amount after deducting cumulative amortization recognized in</p><p>accordance with the regulations set out in the Accounting Standards for Business Enterprises No. 14 –</p><p>Revenue.</p><p>They are measured at amortized cost using the effective interest method. The gains and losses incurred by</p><p>the financial liabilities measured at amortized cost but not belonging to any hedging relationship are</p><p>included in the current profit or loss during derecognition or amortization according to the effective interest</p><p>method.</p><p>(4) Derecognition of financial assets and liabilities</p><p>① The contract right to collect cash flow from the financial assets has terminated;</p><p>② The financial assets have been transferred and such transfer satisfies the provisions for derecognition</p><p>of financial assets in the Accounting Standards for Business Enterprises No. 23 - Transfer of Financial</p><p>Assets.</p><p>liabilities (or that part thereof) are derecognized.</p><p>If the Company has transferred almost all the risks and rewards related to the ownership of financial assets,</p><p>the financial assets are derecognized, and the rights and obligations resulting from or retained in the</p><p>transfer are separately recognized as the assets or liabilities. In case that almost all the risks and rewards</p><p>related to the ownership of the financial assets are retained, the recognition of the transferred financial</p><p>assets is continued. In case that almost all the risks and rewards related to the ownership of the financial</p><p>assets are neither transferred nor retained, disposal shall apply depending on the following circumstances:</p><p>(1) if the control over the financial assets is not retained, the financial assets shall be derecognized, and</p><p>the rights and obligations resulting from or retained in the transfer are separately recognized as the assets</p><p>or liabilities; (2) if the control over the financial assets is retained, the relevant financial assets are</p><p>recognized according to the degree of continued involvement in the transferred financial assets, and the</p><p>relevant liabilities are recognized accordingly.</p><p>If the transfer of an entire financial asset satisfies the conditions for derecognition, the difference between</p><p> Annual Report 2022</p><p>the two amounts below shall be included in the current profit or loss: (1) Carrying value of the transferred</p><p>financial assets at the date of derecognition; (2) The sum of consideration received for the transfer of</p><p>financial asset, plus the corresponding derecognized portion of accumulated change in fair value</p><p>previously included in other comprehensive income (in cases where the transferred financial asset is debt</p><p>instrument investment measured at fair value with changes included in other comprehensive income). If</p><p>part of the financial assets is transferred and the transfer satisfies the conditions for derecognition, the</p><p>overall carrying value before the transfer of financial assets is apportioned according to their respective</p><p>relative fair value at the transfer date between the portion of derecognized part and the remaining part, and</p><p>the difference between the two amounts below is included in the current profit or loss: (1) carrying value</p><p>of the derecognized part; (2) the sum of consideration for the derecognized part, plus the corresponding</p><p>derecognized part of accumulated change in fair value previously included in other comprehensive income</p><p>(in cases where the transferred financial assets are debt instrument investment measured at fair value with</p><p>changes included in other comprehensive income).</p><p>The Company adopts valuation techniques appropriate to the prevailing circumstances with the support of</p><p>sufficient data and other information available, to determine the fair value of relevant financial assets and</p><p>liabilities. The Company divides the inputs for the estimation technique into the following levels and uses</p><p>them in turn:</p><p>(1) Level 1 inputs are quoted prices (unadjusted) in active markets for identical assets or liabilities that the</p><p>Company can access at the measurement date.</p><p>(2) Level 2 inputs are inputs other than quoted prices included within Level 1 that are observable, either</p><p>directly or indirectly, including: the quotation of similar assets or liabilities in an active market; the</p><p>quotation of the identical or similar assets or liabilities in an inactive market; other observable inputs other</p><p>than the quotation, such as the interest rate and yield curves that can be observed during the normal</p><p>quotation intervals; and the market validation inputs;</p><p>(3) Level 3 inputs are unobservable inputs of related assets or liabilities, including the interest rate, stock</p><p>volatility, future cash flow of retirement obligations borne during the business combination, and financial</p><p>forecasts made based on its own data, which cannot be observed directly or cannot be verified according</p><p>to observable market data.</p><p>(1) Impairment measurement and accounting treatment of financial instruments</p><p>Based on the expected credit loss, the Company carries out accounting treatment for impairment and</p><p>recognizes the loss provision for the financial assets measured at amortized cost, the debt instrument</p><p>investment measured at fair value through other comprehensive income, contract assets, lease receivables,</p><p>the loan commitment other than financial liabilities measured at fair value through profit or loss, and the</p><p>financial guarantee contracts of financial liabilities not measured at fair value through profit or loss or</p><p>financial liabilities not from failure of transfer of financial assets to meet the derecognition conditions or</p><p>continued involvement in transferred financial assets.</p><p>Expected credit loss refers to the weighted average of credit losses of financial instruments weighted by</p><p>the risk of default. Credit loss refers to the balance between all contractual cash flows discounted according</p><p>to the original effective interest rate and receivable under the contract by the Company and all cash flows</p><p>as expected, i.e. the present value of all cash shortages. The purchased or underlying financial assets of</p><p>the Company with credit impairment incurred are discounted according to their effective interest rates</p><p>upon credit adjustment.</p><p> Annual Report 2022</p><p>For the purchased or underlying financial assets with credit impairment incurred, only the accumulative</p><p>changes in the expected credit loss in the whole duration after initial recognition are recognized by the</p><p>Company as loss provisions on the balance sheet date.</p><p>For the receivables and contract assets from transactions in accordance with the Accounting Standards for</p><p>Business Enterprises No. 14 – Revenue, excluding significant financing components or without</p><p>consideration, by the Company, to the financing components in the contract of no more than one year, the</p><p>Company measures the loss provision according to the amount equal to the expected credit loss in the</p><p>whole duration by applying simplified measurement method.</p><p>For the lease receivables as well as receivables and contract assets from transactions in accordance with</p><p>the Accounting Standards for Business Enterprises No. 14 – Revenue, including significant financing</p><p>components, the Company measures the loss provision according to the amount equal to the expected</p><p>credit loss in the whole duration by applying simplified measurement method.</p><p>For financial assets other than the above measurement methods, the Company shall, on each balance sheet</p><p>date, assess whether their credit risk has increased significantly since initial recognition. If the credit risk</p><p>has increased significantly since the initial recognition, the Company will measure the loss provision based</p><p>on the amount of expected credit loss in the whole duration; if the credit risk has not significantly increased</p><p>since the initial recognition, the Company will measure the loss provision based on the amount of expected</p><p>credit loss for the financial instruments in the next 12 months.</p><p>The Company determines whether the credit risk of financial instruments has increased significantly since</p><p>initial recognition by utilizing the available, reasonable and well-grounded information, including</p><p>forward-looking information, and comparing the default risks of the financial instruments on the balance</p><p>sheet date and on the initial recognition date.</p><p>If the Company determines that the financial instruments bear a low credit risk on the balance sheet date,</p><p>it assumes that the credit risk of the financial instruments has not increased significantly since initial</p><p>recognition.</p><p>The Company evaluates the expected credit risk and measures the expected credit loss based on single</p><p>financial instrument or portfolio of financial instruments. When based on the portfolio of financial</p><p>instruments, the Company divides financial instruments into different portfolios on the basis of the</p><p>common risk characteristics.</p><p>The Company re-measures the expected credit loss on each balance sheet date, and the increased or</p><p>reversed amount of the loss provision arising therefrom, as losses or gains from impairment, shall be</p><p>included in the current profit or loss. For financial assets measured at amortized cost, the loss provision</p><p>deducts the carrying value of the financial assets listed in the balance sheet; for the debt investment</p><p>measured at fair value with changes included in other comprehensive income, the Company recognizes its</p><p>loss provision in other comprehensive income without deducting the carrying value of the financial assets.</p><p>(2) Financial instruments of which expected credit risks are assessed by portfolio and expected credit</p><p>losses are measured with a three-stage model</p><p> Basis for determining the Method for measuring the</p><p> Item</p><p> portfolio expected credit loss</p><p> Calculating the expected credit</p><p> loss by the default risk exposure</p><p> Other receivables - account age and the expected credit loss rate</p><p> Account age</p><p> portfolio in next 12 months or in the</p><p> whole duration by referring to</p><p> historical experience in credit</p><p> Annual Report 2022</p><p> loss and according to the</p><p> current situation and the</p><p> forecast on future economic</p><p> conditions.</p><p>(3) Receivables and contract assets with expected credit losses measured by portfolio with a simplified</p><p>measurement method</p><p> Basis for determining the Method for measuring the</p><p> Item</p><p> portfolio expected credit loss</p><p> Calculating the expected credit</p><p> loss by the default risk exposure</p><p> and the expected credit loss rate</p><p> in the whole duration by</p><p> Receivables financing - bank</p><p> Bill type referring to historical</p><p> acceptance note</p><p> experience in credit loss and</p><p> according to the current</p><p> situation and the forecast on</p><p> future economic conditions</p><p> Calculating the expected credit</p><p> loss by preparing the</p><p> comparison table between</p><p> account age of accounts</p><p> receivable and expected credit</p><p> Accounts receivable - account</p><p> Account age loss rate in the whole duration</p><p> age portfolio</p><p> by referring to historical</p><p> experience in credit loss and</p><p> according to the current</p><p> situation and the forecast on</p><p> future economic conditions</p><p>loss rate in the whole duration</p><p> Accounts receivable</p><p> Account age</p><p> Expected credit loss rate (%)</p><p> Within 1 year (inclusive, same for below) 5</p><p> Above 3 years 100</p><p>Financial assets and liabilities are resented in the balance sheet respectively without offsetting. However,</p><p>when the following conditions are met, the financial assets and liabilities are presented at the net amount</p><p>after mutual offset in the balance sheet: (1) the Company has the legal right of offsetting the recognized</p><p>amount and such legal right is currently executable; (2) the Company plans to settle by net amount or</p><p>simultaneously realize the financial assets and clear off the financial liabilities.</p><p>When the financial assets that do not meet the derecognition conditions are transferred, the Company does</p><p>not offset the transferred financial assets with the relevant liabilities.</p><p> Annual Report 2022</p><p>Determination and accounting treatment of the expected credit loss of notes receivable</p><p>□ Applicable √ Not applicable</p><p>Determination and accounting treatment of the expected credit loss of accounts receivable</p><p>√ Applicable □ Not applicable</p><p>Refer to "10. Financial instruments" in "V. Significant Accounting Policies and Estimates" of "Section X</p><p>Financial Report" of this report.</p><p>√ Applicable □ Not applicable</p><p>Refer to "10. Financial instruments" in "V. Significant Accounting Policies and Estimates" of "Section X</p><p>Financial Report" of this report.</p><p>Determination and accounting treatment of the expected credit loss of other receivables</p><p>√ Applicable □ Not applicable</p><p>Refer to "10. Financial instruments" in "V. Significant Accounting Policies and Estimates" of "Section X</p><p>Financial Report" of this report.</p><p>√ Applicable □ Not applicable</p><p>Inventories include finished goods or commodities for sale in daily operations, goods in process during</p><p>the production, materials consumed during production or rendering of service.</p><p>Moving weighted average method is adopted for delivered inventories.</p><p>At the balance sheet date, inventories are measured at the lower of cost and net realizable value, and</p><p>provision for devaluation of inventories is made if the cost of a single inventory is higher than its net</p><p>realizable value. The net realizable value of inventories directly for sale is determined by the amount of</p><p>the estimated selling price after subtracting the estimated sales expenses and relevant taxes during the</p><p>normal production and operation; the net realizable value of inventories required to be processed is</p><p>determined by the amount of the estimated selling price of the finished products after subtracting the</p><p>estimated cost by the end of processing, the estimated sales expenses and relevant taxes during the normal</p><p>production and operation. On the balance sheet date, the net realizable value is determined separately for</p><p>the two parts of the same inventory with or without contract price, and is compared with the relevant costs</p><p>to separately determine the amount withdrawn or reversed for inventory falling price reserve.</p><p>The Company adopts a perpetual inventory system.</p><p> Annual Report 2022</p><p>(1) Low-value consumables</p><p>Amortization is performed by the immediate write-off method.</p><p>(2) Packaging</p><p>Amortization is performed by the immediate write-off method.</p><p>(1). Recognition methods and standards of contract assets</p><p>√ Applicable □ Not applicable</p><p>The rights of the Company to collect consideration from the customer unconditionally (i.e. only depending</p><p>on time) are presented as receivables; the rights (depend on other factors than time) to collect consideration</p><p>for transferring goods to the customer are presented as contract assets.</p><p>(2). Determination and accounting treatment of the expected credit loss of contract assets</p><p>□ Applicable √ Not applicable</p><p>□ Applicable √ Not applicable</p><p>(1). Determination and accounting treatment of the expected credit loss of debt investments</p><p>□ Applicable √ Not applicable</p><p>(1). Determination and accounting treatment of the expected credit loss of other debt investments</p><p>□ Applicable √ Not applicable</p><p>(1). Determination and accounting treatment of the expected credit loss of long-term receivables</p><p>□ Applicable √ Not applicable</p><p>√ Applicable □ Not applicable</p><p>Joint control is the contractually agreed sharing of control of an arrangement. It exists only when decisions</p><p>about the relevant activities of the arrangement require the unanimous consent of the parties sharing</p><p>control. Significant influence refers to the power to participate in the decision-making process on the</p><p>financial and operating policies of the investee, but not to control or impose joint control together with</p><p>other parties over the formulation of these policies.</p><p>(1) For a long-term equity investment obtained from a business combination under common control: where</p><p>the combining party pays cash, transfers non-cash assets, bears debts or issues equity securities as</p><p>combination consideration, the initial investment cost is the share with reference to the carrying value of</p><p> Annual Report 2022</p><p>the owners" equity of the combined party in the consolidated financial statements of the ultimate</p><p>controlling party on the combination date. The difference between the initial investment cost of the long-</p><p>term equity investment and the carrying value of the consideration paid for the business combination or</p><p>the total nominal value of the issued shares is adjusted to capital reserve. If the capital reserve is not</p><p>sufficient to offset the difference, the retained earnings are adjusted.</p><p>For a long-term equity investment obtained from a business combination under common control through</p><p>multiple transactions by step, the Company judges whether the transactions are a "package deal". If yes,</p><p>the transactions are subject to accounting treatment as one deal that has acquired control right. If no, the</p><p>initial investment cost is determined on the basis of the share with reference to the carrying value of the</p><p>net asset of the combined party in the consolidated financial statements of the ultimate controlling party</p><p>on the combination date. The difference between the initial investment cost of long-term equity investment</p><p>at the combination date and the sum of the carrying amount of long-term equity investment before business</p><p>combination and the carrying value of newly paid consideration for additional shares acquired on the</p><p>combination date is adjusted to the capital reserve. If the capital reserve is not sufficient to be offset, the</p><p>retained earnings are adjusted.</p><p>(2) For a long-term equity investment obtained from a business combination not under common control,</p><p>the fair value of consideration paid for business combination is regarded as the initial investment cost on</p><p>the acquisition date.</p><p>For the long-term equity investment achieved by the Company via a business combination not under</p><p>common control through multiple transactions by step, the relevant accounting treatment is based on</p><p>individual financial statements or consolidated financial statements:</p><p>sum of the carrying value of the equity investment originally held and the newly increased investment cost.</p><p>"package deal". If yes, the transactions are subject to accounting treatment as one deal that has acquired</p><p>control right. If no, the equity of the acquiree held before the acquisition date is re-measured at the fair</p><p>value of the equity on the acquisition date, and the difference between the fair value and its carrying value</p><p>is included in the current investment income. If the equity of the acquiree held before the acquisition date</p><p>is related to other comprehensive income under the equity method, the other related comprehensive</p><p>income is converted into the current income on the acquisition date, excluding the other comprehensive</p><p>income derived from changes in net liabilities or assets due to re-measurement on defined benefit plans</p><p>by the investee.</p><p>(3) For a long-term equity investment obtained by means other than business combination: If it is obtained</p><p>by cash, the initial investment cost is the actual payment; If it is obtained through issuing equity securities,</p><p>the initial investment cost is the fair value of the issued equity securities. If it is obtained through debt</p><p>restructuring, the initial investment cost is determined based on the Accounting Standards for Business</p><p>Enterprises No. 12 - Debt Restructuring. If it is obtained through the exchange of non-monetary assets,</p><p>the initial investment cost is determined based on the Accounting Standards for Business Enterprises No.</p><p>For a long-term equity investment controlled by the investee, the cost method is adopted for accounting.</p><p>For a long-term equity investment in associates and joint ventures, the equity method is adopted for</p><p>accounting.</p><p>multiple transactions</p><p>(1) Individual financial statements</p><p> Annual Report 2022</p><p>For disposal of equity, the difference between the carrying value and the consideration actually received</p><p>is included in the current profit or loss. The accounting of remaining equity is completed by equity method</p><p>in case of significant influence on the investee or implementation of joint control with other parties.</p><p>However, in case of no control, joint control or significant influence on the investee, the accounting of</p><p>remaining equity must comply with the relevant provisions of the Accounting Standards for Business</p><p>Enterprises No.22 - Recognition and Measurement of Financial Instruments.</p><p>(2) Consolidated financial statement</p><p>belonging to a "package deal"</p><p>Before the loss of control, the difference between the price of disposal and the subsidiary"s net assets</p><p>entitled from the disposal of long-term equity investment cumulatively calculated from the acquisition</p><p>date or the combination date, is adjusted to capital reserve (capital premium). If the capital premium is</p><p>insufficient to offset the difference, the retained earnings are adjusted.</p><p>When the control over the original subsidiary is lost, the remaining equity is re-measured at fair value as</p><p>at the date on which the control is lost. The difference between the sum of the consideration received from</p><p>equity disposal and the fair value of the remaining equity and the net assets of the original subsidiary</p><p>proportionate to the original shareholding accumulated from the date of acquisition or business</p><p>combination is included in investment gains of the period during which the control is lost, and meanwhile,</p><p>the goodwill is offset. Other comprehensive income related to the equity investment in the original</p><p>subsidiary is transferred to investment gains of the period during which the control is lost.</p><p>belonging to a "package deal"</p><p>All transactions are regarded as one transaction disposing the subsidiaries and losing the control right for</p><p>accounting treatment. However, the difference between the amount received each time for disposal before</p><p>the control is lost and the net assets of such subsidiary corresponding to the disposal of investment is</p><p>recognized as other comprehensive income in the consolidated financial statements, and is transferred to</p><p>profit or loss of the period during which the control is lost upon loss of control.</p><p>(1). In case of a cost measurement model:</p><p>Depreciation or amortization method</p><p>and building leased-out.</p><p>depreciated or amortized with the same method as that for fixed assets and intangible assets.</p><p>(1). Conditions for recognition</p><p>√ Applicable □ Not applicable</p><p>Fixed assets are tangible assets that are held for use in the production or rendering of goods or services,</p><p>for rental to others, or for administrative purposes, and have a service life of more than one accounting</p><p>year. The fixed assets are recognized when the following conditions are satisfied at the same time: the</p><p>economic benefits are likely to inflow to the Company. The costs of such fixed assets can be measured</p><p>reliably.</p><p> Annual Report 2022</p><p>(2). Depreciation method</p><p>√ Applicable □ Not applicable</p><p> Depreciation Depreciation life Annual</p><p> Category Residual value</p><p> method (year) depreciation rate</p><p> Houses and Straight-line</p><p> buildings method</p><p> General Straight-line</p><p> equipment method</p><p> Dedicated Straight-line</p><p> equipment method</p><p> Means of Straight-line</p><p> transportation method</p><p>(3). Recognition basis, valuation and depreciation of fixed assets under financial lease</p><p>□ Applicable √ Not applicable</p><p>√ Applicable □ Not applicable</p><p>economic benefits are likely to inflow to the Company; the costs of such construction in progress can be</p><p>measured reliably. Construction in progress is measured at the actual cost incurred to make the assets ready</p><p>for their intended use.</p><p>condition for service. When construction in progress has achieved serviceable conditions but final</p><p>settlement has not been finished yet, it is first transferred to fixed assets as per estimated value. After final</p><p>settlement is finished, the estimated value is adjusted based on actual cost, but the depreciated amount is</p><p>not adjusted.</p><p>√ Applicable □ Not applicable</p><p>Borrowing costs incurred by the Company, which are directly attributable to the purchase and construction</p><p>of assets eligible for capitalization, are capitalized and included in the costs of the related assets. Other</p><p>borrowing costs are recognized as expense in the period in which they incur and are included in the current</p><p>profit or loss.</p><p>(1) Capitalization of borrowing costs begins when the following three conditions are fully satisfied: 1)</p><p>expenditures for the assets have incurred; 2) borrowing costs have incurred; 3) acquisition and construction</p><p>or production that are necessary to enable the assets reach the intended usable or saleable conditions have</p><p>commenced.</p><p>(2) Where abnormal interruption of the assets eligible for capitalization occurs during the acquisition and</p><p>construction or production process and such interruption has lasted for more than 3 consecutive months,</p><p>the capitalization of borrowing costs is suspended; the borrowing costs during the interruption are</p><p> Annual Report 2022</p><p>recognized as current expenses till resumption of purchasing or production of the assets.</p><p>(3) Capitalization of borrowing costs is suspended during periods in which the qualifying asset under</p><p>acquisition and construction or production is ready for the intended use or sale.</p><p>In case of special borrowing for the acquisition and construction or production of assets meeting the</p><p>capitalization conditions, interest amount to be capitalized is recognized after deducting the bank interests</p><p>for the unused portion or the investment income for temporary investment from the interest costs</p><p>(including recognized depreciation or amortization of premium under effective interest method) actually</p><p>incurred in the current period of specific borrowing; for general borrowing occupied for the acquisition</p><p>and construction or production of assets meeting the capitalization conditions, the interest amount to be</p><p>capitalized shall be determined by the result obtained by multiplying the capitalization rate of occupied</p><p>general borrowing with the weighted average value of the asset expenditure for the accumulated</p><p>expenditure exceeding the specific borrowing portion.</p><p>□ Applicable √ Not applicable</p><p>□ Applicable √ Not applicable</p><p>√ Applicable □ Not applicable</p><p> Refer to "42. Lease" in "V. Significant Accounting Policies and Estimates" of "Section X Financial</p><p>Report" of this report for details.</p><p>(1). Valuation method, service life and impairment test</p><p>√ Applicable □ Not applicable</p><p>at the cost.</p><p>life in accordance with the expected realization method of the economic benefits related to the intangible</p><p>assets. If the expected realization method cannot be reliably determined, the straight-line method is used</p><p>for amortization. The specific year information is shown as below:</p><p> Item Amortization period</p><p> (year)</p><p> Land use rights 40 or 50</p><p> Unpatented technology 5</p><p> Office software 3 - 10</p><p> Patent right 5</p><p> Customer resources 3</p><p> Trademark right 10</p><p> Annual Report 2022</p><p>(2). Accounting policy regarding the expenditure on the internal research and development</p><p>√ Applicable □ Not applicable</p><p>Expenditure incurred during the research phase of the internal research and development projects is</p><p>included in the current profit or loss when actually incurred. Expenditure incurred during the development</p><p>phase is recognized as an intangible asset when all of the following conditions are satisfied simultaneously.</p><p>(1) The technical feasibility of completing the intangible asset so that it will be available for use or sale.</p><p>(2) Its intention to complete the intangible asset so that it will be available for use or sale.</p><p>(3) How the intangible asset will generate probable future economic benefits. Amongst other things, the</p><p>Company can demonstrate the existence of a market for the output of the intangible asset or the intangible</p><p>asset itself or, if it is used internally, the usefulness of the intangible asset.</p><p>(4) The availability of adequate technical, financial and other resources to complete the development and</p><p>to use or sell the intangible asset.</p><p>(5) Its ability to reliably measure the expenditure attributable to the intangible asset during its development.</p><p>√ Applicable □ Not applicable</p><p>For such long-term assets as long-term equity investment, investment real estate measured with the cost</p><p>model, fixed assets, construction in progress and intangible assets with limited service life, in case that</p><p>there are signs indicating impairment on the balance sheet date, the recoverable amount should be</p><p>estimated. Whether there is a sign of impairment or not, the goodwill acquired through the business</p><p>combination and intangible assets with indefinite service life is tested for impairment each year. The</p><p>impairment test on goodwill is carried out in combination with its related asset group or asset group</p><p>portfolio.</p><p>In case the recoverable
关键词: